var title_f15_24_15744="MR in atrial fibrillation as heard at the apex";
var content_f15_24_15744=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic2\" style=\"width: 1102px;\">",
"  <div class=\"videoplayer\" h264=\"./images/CARD/56783/mrafapex_conv.mp4?title=MR+in+atrial+fibrillation+as+heard+at+the+apex\" style=\"width:512px;height:458px\">",
"  </div>",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Mitral regurgitation in atrial fibrillation as heard at the apex",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 444px; height: 232px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Electrocardiogram and phonocardiogram of mitral regurgitation as heard at the apex. After S1 (closure of mitral and tricuspid valves) there is a harsh, holosystolic murmur of mitral regurgitation. Following S2 (closure of the aortic and pulmonic valves) there is a third heart sound (S3) which results from rapid filling of a dilated left ventricle. An early diastolic murmur is due to the large volume of blood flow from the left atrium into left ventricle, a result of mitral regurgitation.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Provided by John M Criley, MD, The Physiological Origins of Heart Sounds and Murmurs, Little, Brown, Boston, 1996, 1-800-527-0145. This program contains a complete interactive tutorial integrating over 200 heart sounds and murmurs with cineangiographic, echo-Doppler, and hemodynamic motion picture sequences.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f15_24_15744=[""].join("\n");
var outline_f15_24_15744=null;
var title_f15_24_15745="Uterine leiomyoma ultrasound";
var content_f15_24_15745=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F64825&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F64825&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Cystic degeneration of uterine leiomyoma",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 314px; height: 252px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Ultrasound of a degenerated uterine leiomyoma (arrow) which has the appearance of a complex mass.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Jorge Londono, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f15_24_15745=[""].join("\n");
var outline_f15_24_15745=null;
var title_f15_24_15746="Lactotroph macroadenoma shrinkage dopamine";
var content_f15_24_15746=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ENDO%2F86088&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ENDO%2F86088&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 538px\">",
"   <div class=\"ttl\">",
"    Shrinkage of a lactotroph macroadenoma in response to dopamine agonist treatment",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 518px; height: 175px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCACvAgYDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD3r4ofEDSvhxoFvq+uW99PbT3S2irZojOHZHYEhmUYwh7+leYf8NVeCP8AoFeJP/AeD/49R+2p/wAkt0r/ALDUX/oievKvgR8H/C/jrwBqniHxNqOq2ZsbyWFjayxpGsSRRuWIaNjn5279AOKAPVf+GqfBH/QK8S/+A8H/AMeo/wCGqfBH/QK8Sf8AgPB/8erivhd8Hvhb8SdMvLzQdS8YQi0mEMsN3LbJIMqCrYWNhtPOOf4TxXzEvSgD7S/4ap8E/wDQK8Sf+A8H/wAerZ8K/tBaF4s1H7D4e8M+Kr65AyVjt7cBR7sZgB+Jr5G+GXw/1Xx/ri2enoY7RDm4umHyxr/U17xqHinT/BunT+Dfhg9nataxltV1+UZWAdGYH+J+w9+BQB6f4k+NmmeHNWg0zVvDXiJNRn+5awmznk/FY7hiPxxWRqX7SHhfTr37HdaJ4iF0OsUcdrIy+xCznB9jXzUt5JcpMNMlntrackzXjEm8vz3Z3PKIf7o/HNUFthptxE8CosPRlQdPcnqaAPqGT9pTwrGB5mh+JVz6w24/9rURftK+FZSRHofiZiBk4gt+P/I1fOUqLLGQeQep61X02AwpIH5Yucn1HagD6ZP7R/hgeZnQvEgKbcgxW2Tu6YHn5P4VIf2iPDgGf7A8S/8Afu2/+P18yGPdeJO2cKMCra4I7c/zoA+h0/aW8KvIUXQ/ExcdR5Fv/wDHqJf2lvCkMkaS6L4kQyfdLQ2wB9s+fivnOKGOHdtUfMSWI6k/Wq06edcKAkUiAESiVdysOwI/rQB9P6N+0R4b1nVYdNsND8Qm8mbbGkotIQx9Nz3AGfx5rQ8afG7TvBTW48T+FfFNiLjPlt5drIrY6jck5GfbOa+O9R0+SGHEG94FIbygctH7oT1/3TXqHgv4j2epaGfCXxGVtU8M3OEt79zma17Bievy/mPcUAenf8NU+CP+gV4k/wDAeD/49R/w1V4I/wCgV4k/8B4P/j1fMPxR8BXvgPXRbyP9q0q5HmWN8nKTxnkcjjPrXFnmgD7S/wCGqfBH/QK8S/8AgPB/8epP+GqvBH/QK8Sf+A8H/wAer4upKAPtL/hqrwR/0CvEn/gPB/8AHq9P+F/xA0r4j6BcavodvfQW0F01oy3iIrl1RGJAVmGMOO/rX5umvtP9iv8A5JZqv/Yal/8AREFAB/w1X4I/6BXiT/wHg/8Aj1H/AA1V4I/6BXiX/wAB4P8A49XzB8GfClj43+JWj+HtVluYbK887zHtmVZBshdxgsCOqjseK9Uuvhv8L7bUr63mHj8Wtlqo0ae+EtkYluCcAbQPMIPqEoA9L/4aq8Ef9ArxL/4Dwf8Ax6l/4ap8Ef8AQK8Sf+A8H/x6vnr9oX4f6V8OPGllpGh3F9cW02npds146M4cySKQCqqMYQdvWvP9D0i91zVINP0uBp7uY4VR29z6AetAH2PF+1N4LmlSOLR/E8kjnaqLbQkk+gHnV1t/8YLTTtKOo6h4V8R2lmFDmS4NlHge4a5Bz7YzXhFjaeHfg1p8byw/2v4wnjyoUD91n0z9wZ4z1Ncr4n1a8luIb/xnM2pazJ+8s9FQ/urcHo0g7fjzQB9ASftJ+FotOF9NofiWO1Y4V5Ibdd/+6DPlvwBpo/aW8KGBZjofiZUb7u6C3Bb6AzZNfLMxnvrs3moyC4uz0P8ABCP7qL0wPX/9dV0DRXp3HcZF4c8knvk0AfVcn7TfhGIgSaL4mXPTMFv/APHqkH7SnhVhkaH4lx/1xt//AI9XytdRK0PIz3GPWpVIK5P1oA+sdL/aB0DVPP8AsPh/xI4gXfKWS1QIPUlpwBWf/wANM+EtrN/YviUqDjIgtzn6fvuR7ivloM6ySIjkRzxFZlH8a5B/nTyMDK0AfU2l/tJ+F9Vvls9P0HxPPdMCRGtvb5IAyes1RTftNeEobs202ieJo5+m17e3XP0zNzXyO5mg1H7RayPBIGyrRsVPv09asW3mTWzQXSx3FtuJCNnKMeu1uo/lQB9l+HfjlpHiJJW0bw74huTEcOmbNHX6o1wG/Ss3X/2jfDfh+9+yax4e8UWs+MgNb25BHsRMQfwNfJlldTaPewTpdzQFCBDfR/6yA9lcfxLXsunalpfxF0ptB8VRQw6x5e+KVPuy+ksTfzHUe4oA7v8A4aq8Ef8AQK8Sf+A8H/x6l/4aq8Ef9ArxJ/4Dwf8Ax6vk/wAdeD9R8HasbTUE3QvkwXC/dlX+h9RXNmgD7T/4aq8Ef9ArxJ/4Dwf/AB6j/hqvwP8A9ArxJ/4Dwf8Ax6viykNAH3p4C/aA8K+N/Flj4e0qw1uG9vPM8t7mGJYxsjZzkrIT0U9jzWh8T/jV4d+HHiC30fW7LV7i5ntlulazijZArO6gEtIpzlD29K+T/wBlz/ku3hn/ALev/SWWus/bT/5KrpP/AGBof/R89AHq/wDw1L4L/wCgT4k/8B4P/j1H/DUvgv8A6BPiT/wHg/8Aj1cDB8HvAdp4Q8F6hqt54quNY8SW9uYLLT5bbMkzwiRgvmIAqgnGWbjIyepqv8RPgx4c8P8Awt1vxLYL4sstS0+WKL7Jq7W+CWmjQn90hV12vkFHIz15BFAHo3/DU3gv/oE+JP8AwHg/+PUv/DUvgv8A6BPiT/wHg/8Aj1fGo+vPpSgg9OlAH2R/w1L4L/6BHiX/AMB4P/j1L/w1L4L/AOgR4l/8B4P/AI9Xxtk4x2HpXV+AvAeueNrll0qKKGziP7++uX2QxAdeT1OOwoA+nT+1N4KHXSfEg/7YQf8Ax6uq8NfGO38TRebongzxhcx9n+zW6A/i04rwzRbPwB4O3QaRp1x468RBcNME2WiN3wx7fQfjWd4j+JHjTW7a5tob6DRrK3xizsCLaPHTaH++38qAPqK58b3lqsZu/Buv24kJCedc6cm4gZOM3Y7Utt43u7pttt4P12Y4ziO701v5XdfD14t64WW+vLWaRugeZ5mUdiST+gq5cPo1vpcR0+WdtVwMuZDHFkdf8g0AfZup/EG70yCSa98C+LI4YzhnC2bAe+RcHj36VxGpftK+F9LuTb6j4f8AFVtN/dltYFz9P33NeAeGPiB4s0ycxWXiO5tgpGy3nuPPif2IcEAV6CvxN0nXdul/E3wpY3uF+a5sFCygH+IR5+b6q34UAdr/AMNS+C/+gR4l/wDAeD/49R/w1L4L/wCgR4l/8B4P/j1eVeLPgraarpb698K9STV9P6tZb8yx/wCzzyG9mFeH3MM1pPLb3MTwzxna8ci4Kn0IoA+xP+GpfBf/AECfEn/gPB/8eo/4al8F/wDQI8S/+A8H/wAer43z2PJoOfpQB9kf8NTeCv8AoE+JP/AeD/49R/w1L4L/AOgT4k/8B4P/AI9XxrigjgnGOKAPsf8A4ar8D/8AQK8Sf+A8H/x6j/hqvwP/ANArxJ/4Dwf/AB6viqigD9RPD2qwa9oGmavZrKltqFrFdxLKAHVJEDAMASM4IzgmisX4T/8AJLPBv/YFsv8A0QlFAHlf7an/ACS3Sv8AsNRf+iJ6474C6DrPij9nDxPofh25tLW7v9YeCSa5ZlVYTDb+ZjapJJXK49zyK7H9tP8A5JbpX/YZi/8ARE9fFuB3xQB99+BPhlqHgf4hS6lpWqLd+H7vTIrO6iutiTiWEBYmVYo1QqEAXnnkk5r4w+G3gjUfHWvRWFirLbqQZ58cRr/jWBoumXGs6rbafZJvuLhwijHT3r6X8RG2+HHhCy8H+HZFh1nUYt97eD71vDj55CezHkCgCp4m1uHSoIfht8MnjgBBXUNSU9AB+8Jfsqjq3c8CvJtbubAolvo1uRoduwQOf9ZfyL/y2m9uu1fSte7vrbTPBVxDp8UkGpa5cNA7Ou1orKPGAO/zZBJ7kmqEUUKQoiqBGAABigCW2lWWIMuCCO1NlB83BwVI70JCsUjNEoXdyVHQmpmXjI6980AFqu2MIe1SAhQfWmqeD1/CmyKWHcD2PNADblyIJSOy5x+FRRTEXKIx4YCpYTBau0tzH50QidCpOMZHDZ9QahgCTeXJuzt6Ed6ALbHIwKjh/jOOM4qTk5Ax04oRMDAGTigCAuckdR2rLlAs7mSWOITQyL+/twfv/wC2no46++K1Xh3Nljx6UzykVsgDI9KAOi8D+KLKfTpPBnjUfbfDk4Dwy7fntiek8J9B/Eo98dxXAfEnwRfeBteNncutzYTr5tlfR8x3ER6MD6+op166wO8cbNmNjPaEDIRsguh9Aev516n4Ov7DxRo0HhDxI27RdSTdp1yx+awuewBPQE5GOlAHz4aQ1seLPD994W8Q3mj6omy5tn2k44cdmHsRWQaAENfaf7Ff/JLdV/7DMv8A6Igr4sr7S/Yq/wCSWar/ANhmX/0RBQB8/wD7Ln/JdvDP/b1/6Sy179q3wZ1691HxO8Mfh63n1bWv7RttcWaT7dYRbw2xFEQ5IB48wDk/Wvi0UUAfRP7X2n3WqfGLQrCyjaa5m0iFEHqfPn5NSLFp/wAI/D0VjpiQXfi+/i8yW5kGVt4+7n0Udl79TWV8F9EtfDHhTUPG+sxAlImNsrDt2x9T+lc7bTS63rkt7rshaS53X98x/ggj5EY9ATtFADpfM0KBNd1D/S/EWpEvYpc8lB3uJAe+Og6AYrmJJNu/fI093dndcXchyz/7I9BUl5dS6/ql3qbl0SdsIGbcUT+4PQUxrTcArOWXOQD2+hoAuJ0A/nTZkBw3dTkUkExdjvGGXg1OV3CgBq4KjNBGOaVV2jB7c5odgOT3/SgCmDtupGcgIIuD7lqsKcjGc5HWm7VkWcuBgIu0H+I7ufypVj+bNAEFxFuuYRjgEk478VY2bBuI/KpNo7/nimSZOACevWgCs6ecwHRAeR13ex9qbFK2mBB5khslcSKYyRLZv2dD6e1WioA4HNRum7njPTnp9PpQB6jperWfj/SX8LeK2jGrFN9ndx8CbAyHx0Bx+fIrwjxHo134f1i407UE2zQnGezDsw9jXSWfmxn7PbvILuyH2mzZWwxQcvGD6j7w/H1rvPHNpH8QfANv4gsAsmsacu26VRhmXGSce4+YfjQB4bSGig0Aeqfsuf8AJdvDP/b1/wCkstdZ+2n/AMlW0n/sDQ/+j565P9lz/ku3hn/t6/8ASWWus/bT/wCSraT/ANgaH/0fPQB7fpvhC/1zwL8Jde0Oe1TVtA062mihuyywzpJbRq6FlBKnAGGwcelJ+0E2sP8AAPxQ+vxafBctLbFIbKV5URPtMOAZGVSzZyc7VHIGDjJ+HSiZ+6v5UbVzwoB+lADsk89qOnJ4pOpruPBXhWKW1h17xBC8mk+ZstbNTtk1GUfwqf4YwfvP+A56AFnwT4MspbGLXfGMs1vpUgLWdhBxc6mV67f7kY7ufwrb17xPFqkcEK2awaeibLXSbDKW8SDozfxSN6s3WovFWr3kWqSEXqSapLGFnKJ+6s0HAiT/AGQPlC/1zVPT7ZI4cAhnYZZz1f6+v0oAq291qFxvtILk2lseTHG2W/Fh0+gqC500w4aRjInQuTgr9QK0rSAJcSPFtBDYOK05IVlhI25yCCD3oAztFt5LCF3s3WB5ACHWJSy46EEjj3rXbXdSnafbKRPMFW5lwCrBeFCR42p6kgZJpkMO2AA88Y+tRbSrMwP4/wBKAKOq2zXMDLM4kQfMfMA+T6EDIrHXTrmWIKkjGEHhZlznHTBHIrrGQSEAgbgOhHWorgCMfKuT0xQBmaB4g1Hw5rEV3ps8tlqUOAs0R3GYDHDA8SL6g8/SvQ9d0vSvjHbYiis9F+INvGW8tOLfUFA/g9/UHke9efXVmJAfMO8E5ZT0z7dwffrWfBPNp13GZWkZEcGObcVaM9juHRh2YUAcZqlhd6XqNxY6lbyW17buY5oZBhkYetVT717z4n0//hZ2i25miX/hMbaFjZX+0RjWYUHMbjtOo6ev414QQQxDKyuOCG4IPcEUAN6UvOCTSZH4UevpigCjRRRQB+lXwn/5JZ4N/wCwLZf+iEoo+E//ACSzwb/2BbL/ANEJRQB5X+2n/wAkt0r/ALDUX/oievi7jPFfaP7af/JLdK/7DUX/AKInr4u2lmCr1JwKAPef2aPDduHv/E+pqBBbIwjZuihRljWJruq3HiG51PWLktv1WYIhPG2EsEQD8Oa9A1WMeF/gXbabb5S41MR2oI6ndy5/IGvO50VVs4iMR/abdR6AeYv+FAFXxHHjxdf2v2me6g0pRYQSTkFyq8nOPc4/CoNi8ZHzHjOKS4k83XdccnltQm6/7xpeTzk9elAD4wRgZzkZ5qUHnnmo17f5xTi4HUn/ABoAk9cYoHX1FNVhgEHg9M0+XDM3l/dB4zQBWlUygp95PvFTyPxp8YQ8rjpzimJNFJI0ZfbIo+dDxx6j2qudRRpBFZL583QEfdA9SaANFemM/jSEkA9aithKkJEzh5SeoAAx6YpznDcr1/lQA18ke46D3pqgqOvXrnvTyw9jikZeQc/4UAZmvRZsTIoG6I7wB7f5IrXsLdV0u2iLIBcQpeRmMnERbjHPcEA/jVS6AaB0z1FWNAkM+iaScfNbR3Fs/vtdWB/JsUAdh8R9NHj/AOG0PiSND/wkOhKLe+AHMsQ4DH3HX8/Wvn/qPavfvBd1BZeKLdrgn7PdwNbzDJx8w2sCOh45/wCA149430KTw34q1LSpeBBKwQ9iueCKAMLtX2j+xX/yS3Vf+wzL/wCiIK+LjX2l+xX/AMkt1X/sMy/+iIKAPioVf0HT31XWbOxiUs08oTA9M81QHWvU/wBnvTFu/GLXUig/Z0+TPQMe/wCVAHe/Fq4W3tdE8LW4C20EQu7lBx8q8IpHuefwrzidjH4Z8SXIP72eSDT0J9CdzYrpPF91/aHiDV9QLblubk28PPPlxcflnNcjfzBtA06DOBcapPcMfUIAo/rQA1AkUYVcBV4FJLuaImP71RW8ZkiUyjgjIU8kfWrB4AGM0AVYImRmJJO7v6VbiJCnOOv4U5EwSSOvOKdnjgfSgAH40xo1Y5YnipAQQM9DUZdTIEY4J6Bv4vpQBDNHuddpwAw/Gp4wwBDA1G1t++3q7gD+DtSvLHBtWVxuY4C9WJ+lAEuOvr3pu3B71Ky7Tg8EUzJA+tADX+UfSq/mkk7VPBx0qTJY4bA9BTFU7jkYOfzoAr3jPAUvIW2zWpEsbe45IPsRkV2vgrVo/D3ixCvy6XeFIp4z0EUw3Rt/wFiR9K46+GbaQE4GKsQst9pmmqeJTZvayc/xRP8AKfyIoApfFjw6vhvxjdW8CFLWf99EMcAE8gfQ1xpr2j4oxt4i+HGh+ICu64gUQzN3yPlb9QDXi56UAeqfsuf8l28M/wDb1/6Sy11n7af/ACVbSf8AsDQ/+j565P8AZc/5Lt4Z/wC3r/0llrrP20/+SraT/wBgaH/0fPQB4Znmj60UKrMwRFLMx2gDuT0FAHYfDjwrD4hvby91d5IfDmlR/aNQmQfMwz8sSH+85wPzNd3qGvi8i1HW7hYoms0itLLT4vlS2DA+WiD/AGRz7nJNWtd09PCnhvRPCSOpZIhq2qY/jncfu1b6DtXN6/aYuNNszcec5gF5ISm3b5gyq8cHA79eaAKdnp7+UWkYtK/zPnnJ960rFGRSkgHoAO4ojjkUKN2cD0q7CCSNy4Pb2/GgCIRCKRiBjdgnHc+tW40AAI4zT9gYgHnFPC8YAyB/OgCrPIV4VST3x1pjKWiifawXe6nJ5PA5xV5lHJwCcemapSxzSuPKPlopJ+bqT64oAnhdXhi243LHhx68nH6GoZ1O5cDJ7irFum3oF5xk1I6AMCACf50AZlzHkgDOKr3ECSRGKRVZG4INasiAqcj6VRmhQjJJLD0oAy9FWaLU0sZJz2a2kMvl+UQchw3Zl/XNW/Huir4m0+88Q2MHl67ZLv1e3jX5LiPOPtSY4DZxvUf73rVLUtPnuIHlh+cwgyqVYbzj7wx6YrprPVzpVzo3iPT1inhki3SwJnYVB2SRnPUlevY5oA8S64x0oPTFdp8WvC9v4X8VkaWTJoWpRLf6bIRgGJxnb/wE5H4VxZ6GgCjRRRQB+lXwn/5JZ4N/7Atl/wCiEoo+E/8AySzwb/2BbL/0QlFAHlf7af8AyS7Sv+w1F/6Inr480KD7TrVjCB96Zf519h/tqf8AJLdK/wCw1F/6Inr5P+H9ubrxjpcQHJlB4+tAH0L8VFV5PCOng/u0jmuMdlAVVB+nNec6tFshmCspMLpKpHfawP8AIGvUfGWyfxddxSKP9F8PsEHo7OT/ACU15TKBLpYKMu+S2LjB9MkA++BQBjTkw65rCMfvXkj/AK//AKjUysGwRyOuaqWOpNf6fqSNZ20kd3cCaO4kGJYmAGdreh9KJL2GOJjMCjrgMCOn/wBb3oAul85x2FQq5mwF/wBXn0+9UMD/AGiJH5WM8gA9fTNW4yM4HagCdQAo4z9KXoWU5z16VHu+YA9c4NPJ5IJ6dO+KAKlxCn2qCXBbhomIGCFIPOD2FV9ItmthIZShycIykEED0xVy4lEUbO2Tgd+1Z/hzK6YecgyOy+3PagDYOSR1IwOcU2UBkG78uxpAT5YORuPX8e1DEEc8nvQBXhj8tfJBZlB45yR7fSpWb5cnt2pgkZGDoRvUH5h71SSZrm62RyM8K/NLuGcj0zQBYb/SEzE4GyRflII80jkqvrwPpW34bjlg0/w7ZSp897HqLBSOiFQQf++lzmucuzcS3yQQv+6ihaSds8AHsSenYVqeGZJX1G6vYZJGs7C0kjtS7E43OqsR7ZYgUAbVpELg2yQkrcOrshzwWH3fzPH40z496d/aFnonieGPYbiAQXS9SkqfKwP5VpeFrMz+JLe1HWMKfoDIg/qfyrsvFWlDVvC/ivSkQERStqFuCOcNgsPyoA+VTzX2j+xX/wAkt1X/ALDUv/oiCvjCRDG7I3VTg19n/sWf8kt1X/sMy/8AoiCgD4qXrXufwDA07w1r+qsAuyJ2VyPu7VPSvDBXv/hy3+wfAi/dBtkuI8Z/3mAx+tAHN3Wf9Dt2GGgto9/qWf5yf/Hq5+0W2vW0u1ubn7MsNtcy79u4GRnO1T6ZwBXUapj+2rh1dQ+5EKDrgIAPwOK4XSTlr1GAxJJlueRhsjHtzQBrR5KAkYyOlOAwe+aifcp4NVprwI/lIpeY8BPU/WgC48oRQcj/AOvUkbHZl+M9B3NUoYXBDzsGkPUDov0/xq+vAGOfSgA6E5/AVV1RN1lKDgYGQatZz+dRXrBbaTgkupUAc5JHSgDJurqdbO0UOwZ03Me5xwKv6bai3iViMzMMs56/Squopujsx5aqSVQbRgDjpitVAV+XAJxzQAgzwO3vSsQuBnHpS9+hPr9KjnXcvXkUAKdp696Tjb8vSqrSFRyeKdDKWGWUexB6igCK8V2yBkjHAHeotDlP20QEYZJJmP4qP6irNz/qnwcEcjH86paCu7WZZP4Vhbt3yBQB6XpyG/8AhX4p04DJtLkyIPRXUN/PNeE9q97+Hzs7eKrIDmawjfHqVyp/Q14POnlzSJ/dYr+VAHqP7Ln/ACXbwz/29f8ApLLXWftp/wDJVtJ/7A0P/o+euT/Zc/5Lt4Z/7ev/AEllrrP20/8Akquk/wDYGh/9Hz0AeGZrrvhNoia/8QNHs5ztgEyySH2Brke9er/s8/6JrutasQv+g6fM4ZhnB2HBHvnFAE3izUDqmu67qBLbZ7iQIT1EaZRB+AFRX5VvE16qg7YYLeJcnJwIlqO5tjDZW8cx/fNDub0G5c/nzUJkRNe1By/DeWpJ7kRr/wDXoA0UBDY7Zq0nAyc8c1XiIkIINTM5DFE5J4oAnUgHkH1NTx88E4J/zzVSIHd15q0flYEEfWgBGYbgm7k8DtmmBWV23HI7Y6inXEMc8Jjcbgw4PofWufmW9meztHkkTcmDk4OMnJPr0oA3op4jcLArgynJIHOPr6VJjI6n8qhtIIrWMR242qOfc/WpivysVxn0NAFeWMMTzkCq80YBxgk9KtqSUJZTtHeq9wGK4Q8noT2oAy5FNrcJcxcbW3MPbof0ptg0cdlcWO8E2ty8iKD0Vl6fTirFxHJNEVJ2kjbWZGZP7Tv5CAu94wVC8Hg9/wAKAN/xLatrfwclikGbrwxe5hPc283O36A5rxrt+Fe9+Af9J1HVdIkIEOr6RLEwJ6tH86/jwa8Hnha3mlgfhomKEfSgDOooooA/Sr4T/wDJLPBv/YFsv/RCUUfCf/klng3/ALAtl/6ISigDyv8AbT/5JdpX/Yai/wDRE9fM3wai834gafgcg8Z7V9M/tp/8ku0r/sMxf+iJ6+avgnIIviBpzNjJcAD1JzQB7pr6ufFuv3EcMk4hsbZCijll+befbhhXmsCWz6dbWykmRVKbx0wT8uffBxXsFpOIPidrtneRsLN9MMiyQnMjglc8dMD+VeXa/YJpPiC8gQq8LoJ7dk+6yt6DtznjtQB53o6RWs99bzTqjRksFIPJHYe9aW0TxbcAhhyDTfEGnpY+Mrtt2YrlUniOOoI5B9CDmpETLkAd6AKxMNqixmRUTptLc/WrVud2TF+8Qc7hyBUNzYQTyLLNCr4OQTQ1vbyTRG4SVo0ypSN9m5fSgCyzjHIGO3vSnAYscnsO1ZltJHbg26KoAZhHHu7E8cn+dS6jJDZzI1zMrLuCMIW3AHsM/n0z0oAi1RJ72WOytoppRL8zrGuSVB6e1X0hvodguNLvLdFUjc8f7tAB0yOldha6W1poluUcx3blZJSpG7aeiH04q7bvO0atP80gO0rnIIPb8qAOEWcErgZUnPA60XTFrd1UDcan1mD+zPEN7ptwVSa3DOCjbonjPIZCOowe3fNVLqURRJLNkF1Lxhf4hQBk6hcPHaiMZWSY7Rnt64q/paqmnRLgluWLetQarZG6EUtvIrbY8hWBXaSOV9/rVyzh8qJV3EhQM57UAVr1Xmt54lIQHGRt++QOM/zrb0W4+2aKY4U2LDDHaP7uMyN/MVQfaRhcgHqKteFlYaLdkbSgvZHZxyCcBRg0Aeg+AGe/8S6rfYjTybaJ3YLhVPO0YHTkA/hXZaKstlqrrcEOZIMS7uyqQjAeueDWN8D7SO40DWJ72N2hv9Qa3YrwXRFCgKfrnntWlbS+fcWNxGHkhSG7ikKt8xfzQQuT7A8+9AHzt8VvDx8OeL7y3UfuGfdG3YqeQfy/lX0/+xZ/yS3Vf+wzL/6IgrxX9pIx/wBt2KLjzYrWMP6knOP0r2r9iz/kluq/9hmX/wBEQUAfFSjJAHU19LXMKR/CfRbLeiPdPGoVmxvw2cD1J9K+bIP9fHn+8P519Jav5c3gDwXJ8p2X0IBx905wefX3oA5vx5BFbeJ0khUJFPBHOoUdOx/UV55bIYNXvIiCChKsw+6cnI/SvV/izYpa+IrBYtwjkSWFQTk8NuHP4mvPtcKr4iuIwIwtxFHMRGm0AgbSP0zQBEAGx6+tVZQsEwlbADfKxP6VMAUOQTx681X1GzluGjaJyoJG9T0A9qALcXzd8g9Md6cX2sARwehzxmkiXZEo54AFRPu5AOKALMJyvBz2NOYA9RjHSufuLm9sJhISkivxjGADVqz1GaRyJwGXH307f/WoA0mT5kJxlTkA9jTx65+tVorlDgFhySFPrSm8g814/NXeo3MOgFAFgHJ57d6jkYY4603LSHKEkEclTmlDAgnAoArscpnPUelQacXa3ySuMnGM0k0rebHCEKA/Mz5GWX29KuLsRBtGBjoOlAEFwJGBG1fL6tzzSeElMsNxMRy5SIH8Sx/Uio9QnCQn5grN8uSegx1/KtLS4WtNFt4VGJWBkx/tN0H5YoA7/wCG1uYfEt1FJz52lMfr8/FeG68nl61fKO0zfzNfRPhi0+y+MUTH7qPSRCD78ZP4nNfPnij/AJGHUf8Aru386APQP2XP+S7eGf8At6/9JZa6z9tP/kq2k/8AYGh/9Hz1yf7Ln/JdvDP/AG9f+kstdZ+2n/yVbSf+wND/AOj56APDD3PavVPhEskXg/xrdR4ybBouvZiF/rXlmDXr3welWPwd4lBJUPGqE/wkF+jflQBL4kdH8QaoWGIg8Kr6Ivkr0/z61znhWa5kt70tMMTTfvI8ZB28D6V1XinTo9M1tbaKQywXNpDcbj1YMMEEdsEEYrkfD9xEl3ewxQ7EWTYjk9cdc0Ab0lzHDHhg27JATHJ7jn0qzCSASxG8gA+gHpUShZlxIOnbNNiniurmSFGMkkeC23t9aANKDGM856fWpe5A5xx9fpVdM4+UZI7elOGQwVvlcnOCMGgCZTyM9jzVHyX+3RTswchWQj0ycjmroOASMg1GpLSDjtnnigCQDpjOT3NOJx71Gdo79ODSlhz0GPWgCC6RhKskZHHDDsw9PzqKdgAN+cnpg064+dshtq9TjvVSJ1vZd0Lfu4nKg45JHWgB0hYKSMfQ96xbe/il1VoYomzHJ5vmM3OApG0jpyTn8K3JgrcEbl7qDjI7jNc94ftke6vrgH94zbCmOV5LfyAFAHoPgRBFrel6qeFh1BbR0UcvG8Tbj9OQK8d8f2n2Hxjq8G3AWZsCvbvCs1mPDcGpMyRNb6jmdVQjzN77FOewCqeK8g+LAx471QhduXPBOe5oA4OiiigD9KvhP/ySzwb/ANgWy/8ARCUUfCf/AJJZ4N/7Atl/6ISigDyv9tT/AJJbpX/Yai/9ET18l+C9Q/svxLY3R6I4b8jmvrT9tP8A5JbpX/YZi/8ARE9fGEbmN1dfvKc0AfX2r3a2XxI8H6shX7PexGzYkZH7xSFz6jO386534sacLW60rUFUgPuhkx+YqPwsreNfhrp5hnZNT0wN9lf/AKaLhkDe3AFXfiD4hs9X8GWc8M0C3srLvsZeHhcHkj8QV/8A10AecazZ2t3NYzXt4LKCJislx5LS7U2nB2ryfmCj8c08ab4fwP8AirAff+x5/wDGl8Sxn/hD50ljBecb4lx8ylT83Nc5YOJLKFyT5hHIA4rmrUJ1JXjUcfJcv6xbGml0Ok/s7QeQfFn/AJR5/wDGvQfCPgnwZqXgOa71PVUhSG5kjTVFjNmTkBihWTIc5Y84zztB4ryBVOc9T1A65pz58uJRJIwiyEVnLBASS20HoMknA7mvOxuWYjEQjGGJlFpp3tH9Ir87eTLjNLdE2t6fp6a21ppt5FqFoCES+eFocc4+6eQBnr37V1babp89nDbeTBd2kGFhxyhK9174/wAmuOijFxdxxOT5bttcL1C9CR+Fb/hfRItFik8q5ubmF3byFl+RQA33l9QcdePpXr04uEFGTu11drv7rL8DNnRxq8xkXco3ZPpyKWWJorUtGMfwhlHCZ4pYJ/OwJAodTxgHgVsXV+E8Mz2USgNJcJKSecqB0zVgcbd2NtP9m81Al1b8RTg4MfPT6VzviSbTpdRFpb3MUs0S5uEgA2CQcEqw5OepHY11MQmKSSKVRlUsrOM5+vtXnel32nTaleQpZJb3srEebvLbyD/CP4c+lAGgowhO0EHgA9qUsNhwnX0qJ2+dkIZCuPkZSCPfnmhmVDyQMdyaAIbgNIfJTILMqfgWAP04NbdrIn2G6uLZdlrJNK0YHTaHIH6LVO2024u7CTUokeKxtVeSWdlwo2qSMZ65OBReytZeErKBBtZLAEr3LuP/AK4oA94+D8Ytvhx4ZY45jku37fMzsSf1qp4D2zeEtB3sB53nXLn2eQnJ/wCAg1xniDxReeH/AA1BpemXBtbXTNOS2lkVQzSvs5AJ6ckiuv8ADlv9h8C6TG2V/wCJWwBPUARN/UmgD53+Juuvr/iu9u2YlZZWcD0XOFH4KB+dfUv7Ff8AyS3Vf+wzL/6Igr4yu3L3UzH+8RX2b+xX/wAkt1X/ALDMv/oiCgD4qU4II7c19C2Pmal8HLGSHJaxu/Ocf7C4bNfPQr6L+HM8GnfDq2ttTYr9v3bEC7mfcNoAHvk/lQBe+NTQTLosqufM83eDjjZIvHPrntXlvidUhk0i5UEMwkgk+uQR+lbviXVprrSdMtdXktxBp0jQQOEPmMw+XGejdPqKg1zSL3UEtp8LDa2zRlpLhgiIHYJuZuyrkZ9ue1JtJXYGErMB8qjjjpUiFto3cN9K3R4Z6geJPC2PbU//ALCl/wCEaxj/AIqTwtn1/tP/AOwri/tLDfzfg/8AIrkZhOPlHH1qs+1QSfwr1v4f/DCx8TWOqxT6zZtexOjxXGm3X2lVDAjbIhAAHy5GCCctk8CuQ1Dwu2geMIbJtQ0zVY7dvNkNu3mKArDKyL/Ce+3JrHDZzhcTiJYWnL349LP777fqN05RXMzlL/QdQ1DSVurIRSWo+cujHLAdQFxkkd8cVnaPIJmt9PSFZHkPloRwTnt/9eu4s9V1fxLrepavazx22g6fKYY7YADg5KhR6nqfStSPSfDc91Z6jeQXUV2jiR5LN9gYjkbh7+or1CDzq8W206e4sri3fzY2w67uhFZelW63dxM84zGo+QY5OT+or0s+F/Dh1Wa8F1d3/myNL5VwNq5JzhiOSPao/EMUuoDRbSDSEmNzKbaO4gXa1sN3TA7Y5544oA4qLT0injntZGgZTn5CcH8Kt5Jyzd6mvIDYahd2fmJMYJGj81OVkA43D2NImNgPY849KAK5thKwOcDrnufallVi/BG3HapmAIA6A+lVmDqxC4OBwP8A69AFOSySe+s4T92SYFx6gdf0rtdOtzf+IrOGMR/NKGIY4RVHJLHsoGM1zWi4nmlvT8qxoIoxnox5Yn3AwK7/AOGGnDUNYnuph+4twFx6s3agDo7SN18f37+ezW+n6aPOKEiOWRgTnB9M8e1fOGuS+fq95KOjysf1r6Ctr8tp3jjVWGIHlaOBs8sFG38uK+cpmLSuzdSxJoA9R/Zc/wCS7eGf+3r/ANJZa6z9tP8A5KtpP/YGh/8AR89cn+y5/wAl28M/9vX/AKSy11n7af8AyVbSf+wND/6PnoA8NP1+tep/CJ3l8M+J7WEEzmzdogOSWDA8CvK+hNd/8HtT/s/XXTP+tUqM9PmBHPtkCgD0D4ixW66t4entYykU2mx5LNkFhg5JPfk1xcDK+q6mApwZvMG4AcMB2HuDXQeI9RN5aaMkhXzLSHyZYT/yzdXYHn0xiuQ1C9jHiaF4J4fL8oRSEOCGxnB+tAHRxZD7jgc9+9SJbqm4qijdzwOp96oQXNuRuNxDx1/eDP4VsaBZXniC7uYNGhS7e3iExjjlXzGXOGIU4BA+XPOfmGAeazq1oUYOpUdkur2Gk3oiFj834dPaqiW8NrcSy+bJudQF8xi23Hpn+VWrkvDdvb3EMkE6f6yKZCjr6ZU4I/Guy+H9lAkF9q2oThrCKJ/OsZIwReRBTxuYcHf0x6VcZKSvF3QjgrPURdiRYEEuzIG185I6g+9MimvlMgCrOW5VCxXYe4J/wq7f6HHNpltrHh+wurW3uVMz2Lr+9QZx5i46qfSq06Typp0WnC5ubmeLdKixnKtuIx046dTTAswXRl2pLtE4O0ovQAdKW4d1VmVDIwBITcF3H0yelWp/CI0SxXUntb/UL64dBKlofkjGOAc+/A9fapte0y60XVGsr/yBNtEgETblUH+EH1HQ0AU1kYBdihNygFcgspxzg/1qKEKjMyqqjvSqUCls+oFK5VR0zmgCFnUkhRgn0rJ0+RY01G8T543mkdWAxuAGP6GrGsSNDp9xIjBCi7vU4HXHvioLpUt9FitkO1TCqZI5wePxPJoA9S8OaOlp8O9L+Znub7UrQyRAfKqkl8g+vXj2rxD4rsH8c6m6nIaRznp/Ea991eSJNF8HaVHcTWqSXYuCIkJYrFCAD9CzEHPvXz38R7k3vim6uM/NIWc856saAOKooooA/Sr4T/8AJLPBv/YFsv8A0QlFHwn/AOSWeDf+wLZf+iEooA8r/bS/5JdpX/YZi/8ARE9fF+cLX2h+2n/yS7Sv+wzF/wCiJ6+MY4zNIkS/fdgo+pNAHvvwzMuh/D3T0814bnVZZJEYEKAg4xk8DIPFU9ZtJL+DXY9KY7WhW6t/MGSj4KyJn13JnPQ5r0C60GBtP0uxe3LotqIITjPlOpU7v51jX8VxJp1zBPF5V3DavbF4wFV1ySpA9s849aAOD8I+MtEs/D1nLqhnmv4Ttbf8wHJB49xg/gRUU2m6Lq+oM/hHWrMJKSw069JjZDnkK/p6Zp3g7wJZahLqNtqztHqllNseyA2lAeknuDxzWd/whVzqkNxPCqRR28rxspG4rt9QvzD680AXtc0DVvD+nfbdWtJI4lYIGjIkDsei7hVDVNP1axS0eaydLy7OIbMsDIVOMOQOQpz1NPXRHewSO71K/u4kbcsBuSIVI6Ed811HhbTVvVvJY7P/AEpYPK+1mdizD0bJye2KAG+HvCsLalaxa6Li125lncMo+QdVHqT0rCvtdbRfEF3FeWt9FoV1MWtHkUM8PbAwcEYwcA8V1/jrTL+OHQreBLR5EslQwt95GJyd3HANYPg2KHVC+ja1fXhgt5GeHS3bbEr9yOM/rQBs2d9YXEQltNTs7iHGRIW8sD2bdjBrdkt2KpGdkkTrvkkRgEUEZ4NY174V0CSFhJBNaZP3o5iCO2eeD9KxtW0nwvpKA6p4sutRgiGFsPM27/8AeAOePSgDD8QeKlistXhtId0ouvJt5EPyrHjkkepOcU34feALy/vLPXJbq0TTbSRZ7lGlxMgzz8mMntyPWvQtZtdEtNJ83VrHTlhliPkRBMygYG047Y461neH7jXY4rPT5mX+xrpk8uRztkYk43HHJ4yMelAGz4hFx4tt5En8Oadc2TTPFDPNM8M8mwjLb04VSflBPWuT1zw3qmlPDdaR4P1C1uImHnGab7Tayp7kjr7iu48e2NnYazZRG2uDKtuQ0sSAoCDwef51wt/d3VyxE13dzNycSTMVA7HGcf0oAb4nvvE2pWS2mpaRLbWAbmKEER4/u7sY4rN1ZbnUreDbZvEzbLYZ+78p6k46DGa7LwLrmorrKWU97dXNlKpElu7GRWGOynv71N41uGtTHbWZcROSyBhgg9D7nHbPNAHEeNLHUdU1HStCtLWZbSVkZ534M7N/FjrgDPH417B4skXQfAl3IxyLOwMIOe7Hbj8hXK/DG2TUPEck16xn8mPZCjsScnqx9hwPpWl8eJXT4b3gBI33EKn6UAfMBJOSep5r7S/Yr/5Jbqv/AGGZf/REFfFtfaX7Ff8AyS3Vf+w1L/6IgoA+QPCejya94isNNiBzcShWPovUn8ga+irzwtLfa1a3Qu3t9Os0EdtbxHaQykAN+PNePfAvC/EK2c9Ut52H18s1734gWUQQ20D+XuYRs45I2ruP5nigDyD4n2/2LSbd5FxcnUZp4Rjou7n+hrOtfiDqJkYXdl9ss2jMUkbJ8jKeoPrXa+LPDV7rcL31pHLdPaKX2udwUgjAIzwp/WsHUIbXXLDw+0Ki1tr2RllRflCOBgofbcKAMzSLDT9ebytF1JIJB/y7XjYdR7H+IfrUN3pV/Y3bWtxBI1wnO1I2YFP74OMY96bq/hBLK6jEzzCNs7JFxuUjqNw9PerGk+dpF400F9qwLIVOy5Ad8D5QTjoPSgBdJm1W4jv9GtNRa3tmfzLqNZgsZ+UDLMv3hgfdJIBzwMmtzS/D5gvEtLW+VfMQTJOMLI4AzsVTyCf5VnQaUILmcQbpbW3tjeTSPDsa4J5AI7/MeM+lYbxXd3dSK9vcXWoAKUVwVliOQQykf14xURhGDbirX38wub+iWWpWGn6tbi3dQLn7QdowwJBGMfSrdveSRWy4iOC3CspBA/HrVC31vVNM8RQ3uq2N79gk+W6tpicsCMEqf/r11F5q3g6+RW0/UZrGfOVS+UooPpuPGR9asCkZWkUArGpIwMHAb6Zq1pOrWiGS1a1ed5omVGDbRu7hOmSOuas/214Y0KBbq41OC/vo1Jjhs18ws/Yk49a4tdVuL7TU8t1m1WS589VlZVEbE5LE9j7cUAQ6/GhnjlhwqiMI2TzkdB9azkOIyRitbVtWn1iylZ7VlNuqm6ZFyp5xuB9O3vVW00t9Q1JbHSpGu5Ps/wBqIiiOVGM7Tnof0oAoRs25lYECo7mXaP3QLuSEUDqzHgD8zWppej3epwSzWoZRG/lyCZdmw55BOeo64rQ006BoOpC6vdQhuLqAM8EZXcquBwT2Leg6ZoAy7GAWVk1o33llcsevzZ/+tXV+EvEQ0Pw5eqIJZLySUpbJ0WSRumB3xkZP0Fc/qmuWEuhXk+0G/ZQVYNgKT2A7mtnTrK6s/DulzqZJL6C0fU5i/PAICIB2HJJx1NAGz4ssV8L/AA2urTzp5ZrmWPzGlOfn25cIP7uc18/E55r2z4r35u/BNnLGWKSTF9x7llB/rXiR6UAeqfsuf8l28M/9vX/pLLXWftp/8lW0n/sDQ/8Ao+euT/Zc/wCS7eGf+3r/ANJZa6z9tP8A5KtpP/YGh/8AR89AHhhFb3giOd/E9n9mJUoGkkPYIBkk1h7h27V6N8JtPjay1vUJuF2raggEnBO58e5GBQBY8UywxabrL2lwdzLHKm9dxdmGHAPbHoe2KyrX4l+NZJEK6o0oDDK/ZoBn1GdldvrPhz7PNeJaxQvHdwLErHOWzzkg9tuB7Vxfh/QrO71CW1uWeJVOI1AH+c1hWwtHEW9tBSttdJ/mNSa2OpsvHerXrhYNbk80/wDLEwwh8+mNnP4VveF/iNq+hX93PqJl1BzEI4I5RHEiuT8xbaobIwOMYO48ggVwut+C3tdHfULVkM0DAYB5HOBhev4jpXUeCrrVNdu57LWTMbmdRsldw6bVXkgkfeJA796462TYGtB05UY2fZJP71qUqkk73Jdb1zWfHWpWo1SSMpG5ZPKjCRwcckdWPHqxqyl2thomtandENplmkUEKbsh3dsBAO/Ck/rWTere2t1cya5DNexKSkqw4jdAON2BjJ46VR8aapp2pQ2cFhPcyabCPNiU2nlM8uMfMvTIGOR1rtw+HpYamqVGKjFdES227s9T1uafWbOw1m1jexk8nbuifzIlAAAQ46HgcH1rhLjxhq7xyWtxcxoWUqXVQGIPbiu4+Fl/pV3pdqZGjW4IIuLV22iRuzFMjgiuzu77wZY2Erw2mmW7rk+dJKrmP3QnkVsI4nQ/E76LNoGkXUUhF9iGa7cELgYxHnuwJGT07VzXiBn1W1nmSNAbG4l3f3gucEE/l+VYnxC8RWnie++y2Mtw6wDMd7ISELA9MdhjpjFJNNenTrXVrm8t47mZGjeASq/2thwGaPqox/FxQBS85f4M+gPbFNVyjNkVdtrR20WPUJNOlFusvkyT+b+7Vm+6cAZx1/KsO41+00/7ZCqjUL5JDHE6w5iIHRxk/wBKAJ5YTfXlrZuVjSTMk8rkBEjUE9T6nA960fFelf2VBDeTXFu+mu3l288UgcNgAcDrmuOig1LVmfCyYkbLsVLAt7/4DpSf2FeWOq6Wt46PZmdSpRyehGcDsaAPQ7LUZtPtr2BwzTW1t9nExkyImPzMg9cAjP0NeLatdC9v5pk+591f90V7Ha27Ta/qljLG3lXErS5YdEIPfuef5147q9o2naneWcoIaF2Tp27H8qAMWiiigD9KvhP/AMks8G/9gWy/9EJRR8J/+SWeDf8AsC2X/ohKKAPK/wBtIZ+F2lf9hmL/ANET18caUQNUsmPQTp/MV9kftpcfC7Sf+wzF/wCiJ6+NIMrPC65+V1P60AfYuoXbxWVm1uA1zMiomTgA8kmozEk1mGe0QSvnk8A47kd/oKz7iRyNMbcF8vT1c5HGWOCf0FOmmWSNSvmzTxDf1+8evH+c0Act4+dp7aDxTYWQttW0bCyurktcQqRujlxxjbnBPOBioNRtxN4qiuNK3NFrdj9rhZGw2VAOVI6sAfrwRWxFqCS3MC2SNcafdZt7iMffmRgeT9DniuR8HalJoPinSNGuJg0+jao9vaTSDrBcRsEJyD0fb9M0AVb8FIztcOzN8zL3PqRXbfD+EJok8zQxsySYJZM7F96ik8Ix6te3c32h4JmcyXjLEWgiYtghSOrZ/h7V1HgzRrq58K6hJDBckzL9ntxMDE7lHHzFffHftmgCh8SdPGnajYarJAJoN629wFk+ZW7HPY4PeuE8U+Hrb7b/AGnpE0qTI+ZEdufbA6hvpwa931X7JqOg3mizJpQ1eR1+0eaTsTBG0huOQOMnFeeeK/BsGnG5vE1S3WW2ZYpLd9xDE8jy26H6dRQBjXdsL3Tyt8u5GiVmJXIPHfuPwrxO1gh1jx3BHECIHuQo5ySq+/4V7vZSpNa/vkO9F5jJ7fWvFNFlEHxCtDHGqqb8gDPIDdv1oA9J8f2c1zd6bcpGJIRmKUDoGznn6itK4heO98NCSMwt54VJB93Ht34qfELTTw6hfizsQ48xmQuzfNjCr7Hv2rp9U0PSbbVGsf7Ta6mtkM9nZgEujCPJaRgSqj0PGRQBpeOY7+z0ANHCLgZGRcEBAh5JOOcAYxXjuo3FpcyKkFukEe4hzEcgn2J5Oa6zSfGkaeEZNI8WadNfwXILQ3aMAwQ54weWwc42kHHFZvg3QLXxDfzLb31xdwQK0aRx2Z3QH+FnUH7o9fWgDBOn3V3ZX1xaFbCCzTzBOScAry2T3OBzVqbXrvxNo0fibUIoUMjNbxQxrhE2nAIA9sfjXQ/ELw0/9saD4Ujs7/T4pkle4eSZcXMEY3uxUdCzADOTXIW9zu+HXhGwtsqsazzydw0pkbH5DmgDc8CzxadqHnPGWmMYdTuIMTbsKRjr3Jzx1rrfjbard/DzWGjKsiCGVWU5BxxkflXJ+FrRf7VkeeSORY1Hy5Kl8DBA9+ePWun8fQNZfC3X43JEaxQ7Qf4d53baAPlXr7V9pfsV/wDJLdV/7DUv/oiCvi5fujpzX2j+xZ/yS3Vf+wzL/wCiIKAPmf4Itt8fW57eRLn/AL5r3jVb+0mjhEdwkrtcyBvK+bY2OVb0PT868E+C/wDyO65zxaznj/rma9v1Xa8ltOuJJWhX7qAAqMEEgfzPJoAr6Vfw2tyilbtLp5BbM4IGFcFgCT1PHAFcN4gt47NNatgoaKy1eG7VBxmGcDOPTnP4102oTM0uJ5I5IEUKkpGWRwdwZT6ryo+tc741vob++1K7tViWPUNEJ2xtn97byA5b/axzQBWvUmOp3Vu299jcoxySOzD3x3FV9IiS41mCKSMOjOFZSeSK68eHIdX0WS7GpxnW4ZGf7RgQwyIFDeVg/NvUHO7G0jpVTwZo13eXcV5ARPDBPuhaMZ3OPvbv4ggHU4+lAHQeJtLFr4c1CSyDho/KeVXG53RTn5W/u+3rXL63pUs2n6Zq+jXiT3tsu773ztGeRn2HIwelewWXla5bx296ZorXyZJWmjG2N3kBBCIM/LgD5mOR6c15RHpGpQ6Ha6hZ2sz21izRXKbQSq5zuIHDIR19CKAL1hfm9tllVA5kUnyJDlS2OmD0Ga5rUdb8Lw2avqukXukajIxilhgbKbccsAeM+4Fb+jbmsfkKsGYuCBgDPpXjnju9uLrxHeLcOXWN9sanooPpQB6Xodp4VvLNZdOstUuXIH76+kAjX6BetZviqPSPPhsdNsYjq7vtRoTs2k/3vWug0W0lh0OysLSLzJlhX5RxuY89aXS3sNMvpINOto767OTPMF8xQRywU9W9Cw4HagDK0rQ2try+sVvJLjz7B0kJU7SRgnaOwB6E1iSwQQS+UYy7m18p5UmaMht2QeMZx6HivRvCFtdanHqGs/ZZvNuUZYUgGFjjHOweucfl61zXjuOJL2zitVdgY1ZjKQG555x2HQE9qAOH/slGVgb29jLn5wsmfM9z60jeEm+yG6E9ukQOB5zfO3uBW2qwW48ybdO+cBQML+Pel8QNJDbQ2brGtzNEbiZcYFtEOn/Aj0GfWgDl/wCwlkljijbcxjEkiq/yRj1Y9q+hNJt7Yw2vlgPK9tEMnGNm3AAHp1rE8H6DZ6ZpEC6rbbri4jFzcDK5y33FJOQRgfhTbBJ5p11JVKXM0u+JeyLnG3HoRQBl/FLT2m8KXzL92ARzKAOB2b+VeAnpX1D4tg83w1qqOhGbVwVPYg18vdqAPVP2XP8Aku3hn/t6/wDSWWus/bT/AOSraT/2Bof/AEfPXJ/suf8AJdvDP/b1/wCkstdZ+2n/AMlW0n/sDQ/+j56APDT1r1r4ZXv2PwkEQqJJLosM9N2QBn6YryXjFdz4JRrnSRBuwBKzAUAeplp722i067v08/LSW79SGzu2k+56Dt0rgvFGLXUra/swU+YSSbl25O7n/IrpdMkhS8tme3SRlkXaXJ+Vs4LY9cUnjWwN9pFxp8bN5tlMzRoUwVzz175oAy7Wa51G2kv5igNw5jsrdSSzZPzSH6DIz2r0LQdGdV0+yM8MV3dkhI1z8oBz19z39gK5r4fafbnQNOnvdbjtZoVEaWaL5kzAk7lwPuA8nOevWvQ11TSNOnmKa3JcT29s8kdnIRGIX2YVVyPnwCSeeT0oA5610W4t9Wvbm+zPZXKlN8rcxMx28/QmuP8AEpa0P2XOJoG2HIwSR3+nFazX+sldGkurppIrnLYUDJAOQD64rg7+6e5urieaUuoOMt1xQA6axttTv0LzSQSlkQSoxBGT0P0re8SeF9MaxYsrQpYZjfY3+tbOBn371yqSsVyHO5ju6/lXYeL71LnStMuUBDzp5k/JG5sAfzzQBg6YI4p4bWMKYeCMjIJ9a6RNPs4bma/kMNvIy+UrBfvGuS0+Qpewk/KFbAHcV6toOm2M13pl1dpvhjRpViK7o96qSWf2Bwcd8UAOsvtkGk6ZAALZp0MolkGFyDgHHTtXmjDGqzNPhSJMMVAG055Ar3PxD5Wp3mkuAGimR4knaMqVLJnnsvc/n6V5Dq9rYXF69xpSXMlrC22eSWM4kYdcY6A44zQBZ065EUr21pJJ5TLlmU44HJbHbHNZ+iCK4mOtamTJ9oDfYLUrx5anhj7Z/Oqniy9k02TWbW2kk3yxW9rCGHzgugLDjvggVqShbeytoljIhgRIomIxkgAfqc0AdZpiW7WIuI3b7QrAvk8MzZJxXjXxatRb+L5ZF6Twq5Pqf84ruLousOYGO9CGGehPqRXG/FeQT6vbSckmEZ4x/CDQB5xRRRQB+lXwn/5JZ4N/7Atl/wCiEoo+E/8AySzwb/2BbL/0QlFAHlf7aX/JLtK/7DMX/oievj2x/wBJu7aBI8NLKi5/GvsP9tL/AJJdpX/YZi/9ET18ieHSkOuaXKxwPtCsfoDQB9QXMeNU8jn91YxdOwyajsk89VcOywsCAwHQ1a1ZQ/jKzRFylzpYZecAkOf8aq2gS2klG51hEYO0/dzk5xQBz8WpwQeK9St5oUaPyVXduC4z0YDH3s/nXI/GOzuFnsNct08qWMpblxweCGRm9DuH607xVbz33xHjtIJ2t4pxH5xXqQD/AIV2fji3GpaXqGlyokcUiCO2OOS6j5ST68UATa141gfw9o154Rup7a61jE1+hUAwFBgoOME7t3zYzjFUdA8Qa0ZwkuqXd1PMwbMsvyxYPHHdvc9K848LXbt4XghRCs8F0/mP3AbqMfUGur0e4hx5cflrchTKFdjlwOu0DqfagD1e88NXuuLJNaaratqqwCKSKclfMIOQQ+Py9/asjx/qN1baHZ2M1zfG6lbLw3DKUAUc52nG7I/HrXJ6B4quRrJhHmK9tHhQeNynqGH6VP4gRbjw9azfaISpncqgk/eqeuGHYDsR1oAXSZsWsrE5IBwu3GMV4/oNvc33jSzZIvnS7Epf0weleoaVKsmwlQsbZBPPJ+hq/pWgW1trX2q3CoCu4AjvzQBQurj+0tVuw0giSMsqblJ8wk8jjp9TXY+BdPt9Xsl1eOGS2lsbaXT5NswKSM3dx975uCAeBiuc8PgQ3E86BlLSs7DqTjtzWh8PruK38RTxxOv2e/hdwJfkUyKcgEnp1IzQByTAx6MujamGSS3lkhkVx/qmJ+VgewP/ANeq2im80TVFvLG7ntbsqYHkifaXB/hbHUHjrxXR/EFC+uTTNE8QuIF3xOOcjvnoR6EVzFqn2qWOHzPLdiFy38J7Z/HFAHdW95dux1LVW8280vRLhxKWydpztB547j8K878N7YNC0qFULyeVuyexbk4ro7+/uI/h946lnRY7yW6ttHx0y5A3/puNZsIjt1WCP5UhXCnHJx2+negDoPC1m815cOnlgrFvXcTkEMANo67s5x9M1qfGS4EXwivfLct5t4kLMTksVHJNU/A0VxetdxW0W8tsV2aTb5SDJzjHzcjGeMZ96X48Ktp8I9MiRQPNugxIGNzYYk/rQB80jOAK+0f2K/8Akluq/wDYal/9EQV8W9BX2l+xX/yS3Vf+wzL/AOiIKAPmL4OZ/wCEwfby32G5x/36NetW6sul2rRhpXSL92MkKvGfmPb6eleWfA1RJ4/hjIyHtbhMfWM16ppTRy6bAhuEEiJ5bEKRkqSBkHqexxQBQ1eR1sDKIYgBHtkEZLopPTGfU964df3nibTLUnbHcpPEQeeXjI/niuk8UzJc2UctmtxEzBl3MMI5Xk7T/EK5szLH4g8N6gPuRXsQceisw/8Ar0AdfqdrHpfg+LVy0Mmo6zawxRBJfMEAKhWX/ZOFJIOea5iDW721EdvBcGBFB+WMbXdfRmHJX2J5q9rMipb3OiKQJdN1O4AB/iQnKH8MkVhW6JDK+0CVnOXfGA/sP9mgD1zwLNqd3p32+WaK6u2UrbQyqEiiTuxxjjHarXj+8vdGsiiabb6W10gBawvvMCuBjAQ87SDk5GKi+H99Lc6JN9p2GUMGKhQFVf8A62K5DxNfprHi2a8tHkmtivkguMbcdSp9P50ASaPMLPRTNGTtRGdg/RcdwK8T1K5a9vLm6cE+axYH2r1pfPuNB1fTl++E8qIjqdx6k1x8vgLUNy28bgvgbgwwPXg0Ad4l6w8JaVNO8yCS3jEhhHzkYxhfr0zXQ6I3hm50CNrbTLmHUFYedbx75ZZOcLEGGFAJxnnpXMatbvcahaaZAG+y2kcY+9jJwB16V0PhCOFPEN9omrWcM6AfbINzMjeYuCCCp547UAbGq+NpLe4Wz1Kz+xWiW/2Zo0bfNAWHG5eBgH+HsOhrgdVhGtuL+G7to7kyeSVPCtgctnt9D+tXfHioniWWOSMRo8KqWX+IZ4b2INcvpF7daVPdJEVZZ1MMyuAVkU9/z5FAHYJ4W0+wja51vXbBL1ome1i3F4jIBlS+PvfQVgaLbyapdW91qs37zVJDe3M7LwtnAPvEdgzdvpWlcaTbX/w70kXsAmvVWW301lJVkZpAMP8A3hgkjpjms7WblRf6jZWhBiR49NjPrFbqC34Fzn8KAN+21i31i5uzFbxWdrPlGt1PMqE9x0XOOgq/Asdu1vaedPvLYja0wHjY9DzwO1c34YtVW6ZTyrgtgjPTpn8a6rQYpbm5CwXf2S6kBId8KFbnGSeOKAL3i6fyfDOts38CNEcnvxXy4elfQnxGvDa/D5y7KZbqViWXoQOMj64r58bpQB6n+y5/yXbwz/29f+kstdZ+2n/yVbSf+wND/wCj565P9lz/AJLt4Z/7ev8A0llrrP20/wDkq2k/9gaH/wBHz0AeHEfrXpXgmEQeGbWZgB50rDJGe9eaAH1716B4YvTJ4csrfIxbzqwA6j5zn+dAHTyFpOUO0AYXn8c1tXkk1z4hLO4LzRIWbHPTnn2rA3ZiJByT+ArReVhtn84LNsCDAzjjnNACQarcaXNcWuk20Qskm82QOg3Nn/a646/jmuU1G7XUtauLmZSsykSEn+EZ4xXURajBHcP9oiaSF0/hG7BHriuZji87VZo4U852HyEnJOegP50Ad9obPd3NjbzyLGlrEZtzd1281wl6kc99fvFxAZWCAjrjgdK3Ihcm61JzE/k2sbAlG/ujBz7dawbLULaCWMJBJMEOVGdqE9yTQBHdWbQRqDE6vgdf4jULXc9xBFbMv+qjKgHnqa6O612G5sbiG4LTXmwlXWPasAA4HPPPT61x2khjcTPIHbLEbhzhO34k0AWoztkwMhk5Yj2616d4Zu57rTYbWJ2jaSJnhw+MnP8AEOh5H6V5w8UZmUo4YsckdxXWaNdmLQJWRisturLGx6jn/wCvQB2EvjfTL+5ttOt55lZAkTSqP3byAk9PUHOD9aq3WrafcatNomvM2m20uWNzbKArsMkFgOpIz9DiuB03Yt2kpi3Rqx+VeC3rg+tVdS1H7RPObotIEico38XAOM/SgCmt9DqHiqOdxK1tHM0xZ+W5+VCfcACuzvpBI+PMLRJ8vzDnI7/1rzvw8ZfIkmITazr9/kHb3rszeC5k+8ASM7QMAfQdvpQAtxKGglYE5VHPXviuI+JEhfWY0bI2RKOD3CgV1YcvHKOQWbYGHcEgcVxPj+QSeI7jaeFyP1/+tQBx1FFFAH6VfCf/AJJZ4N/7Atl/6ISij4T/APJLPBv/AGBbL/0QlFAHlf7af/JLtKx/0GYv/RE9fGkEhRo2HVGzX2Z+2l/yS7Sv+wzF/wCiJ6+MMEcdqAPrNGGraD4O1uBwA1lJZyH0bgj9V/WoyhuIkXAVHySQckMvbHeud+A16/iL4c6x4fRg2o2EgvLRSeTzyv4nj/gVdho8drcQwpJMLT7QDiR+ArdcE9iCCPrQBx+t6U3/AAkWn6ivIj+Uso+X6g966DxRF59ojQhiyDfk/wAxXUDwuqW0nlXSXKswJVGG5R2dcfeU/nWTcWLXW2DarP8Ad3KSB9TQB4vZWy6XcazeiNnsk2SSxLyyCXIUgdwJFK+28VpWVrp11Bs13zbOdvmiurXlrduxPqBWx4n0G58N3VxFNE8sOp2TQIVBP71ZFkVfbv8AnWbc27x3UMUwAdlLMOw5/lQBX063vZr28R2jk1WywZJYz8lzAeBInv0yvvWnLmezuVRogIJcFO+7uMVa8NXBtdT1jVJHjgtYrVFjJI3edwo2565Gc1avdMtbOKNreOV96+c7SnbvkYdcelAEVgkUekS3Erqptsuu4ZB+lYGl+O7MKY5ZAHBIbHfntU+u5tvBN0gZhKT8nPXceQa8WYoZ2KrgdQKAPo3Qby01fTZ7+zOYWdk6bSMcZFZKo8s7211IskUkbxKVbGCB3rz34Y+J5NKv30+4YNY3bcbv+Wch4yPY9DXqF/Iq6lBm2GVIChF3b2x3A6/4UATWXhy5Phi5ea7XzTIRZ20snMyqPm257jsO9cjZKrX8CNklplXB7AsAf516Be3Di3i064iU3fL75FCm2J+7jvgj271yNzaz291HczLh1I8zHPzA5DZ70AReKEDQ6dp6/cu9dvtRlx/ct8Rp/I1XhtZZ7aOaU+X5h6Y5P+FRaDNLcah4cu59xS4sL2JMc7ZlnLv+OCPzrcs4nup8RbnjUd+ig9s0Ab/gzybSxuxM0yJcgeWIx8820HCrjoMnknA4qj+0Y234Y6ApBG6cYz/1zGee/PGa6nRbHyrVnhjgKRqPM3sChTP888ba5H9qqZbXQvC+mKcbd77fQAKP55oA+bsc19pfsV/8kt1X/sNS/wDoiCvi71r7Q/Yr/wCSWar/ANhqX/0RBQB82fAjn4iWoHUwTY+uw16qytBJdGNSEjnZkKEeYjA54H17V5B8F7gW/wARdLJOA5ePP1UivbNUSO31y/8AkY71DOBjkduO/IoA5PxZcNJqcE1zcGbgyeSp+VC3VQOi9+lcTr4A02Q2IdhbyCUM/DbVORkeo6V3WvQCWxPybZQwkDDoB6Vzl1APsN0sgGGtn+YdGBU8g0AWfEbxnxHrc4QF7t7edWz90PECTjvkis3ToHuNQgt4CzSzOEHc89/pU17d74LdWXNxJptgxb0Cqw/M8Ve8NTjSB/a8oi8/PlWay/dMh43kdSooAtwS31lfT2EbyRCEPFcqBy4PU/kOKSzhHlBGDruY7Y8cD0z71avbmU25udSkV9XkLCWaNMI6k4DEdh706FUggWQ3EUm/5sKc7D0I96AEsN0Gp7BgyzYVRj0rdg2LqF0scnmsoy3OSeOx9Aa4rUvEdvb6/pcEsdu8LhhJwQRk/KSfrXWXmq6fHYzXAItkVNrBeqr6UAZ0Nz5ks068ksQ2BnkdverELLb6vp2qzxyWcMc/kyTA5VVKnkA9qyPC+r2+qae5SE27rk53AkrngkUavK6MtrMGe3ZGKxscKSR1x70AT+NNTm1K/jknigOyIxrPE2UnXPDD0Ht2rmJXIVywHyj5cDB+tauqaTdaZoenXU8TJb3JbZnop7Aj3HSqOiKLrV7W2li8yOWRVZB12ng4PbFAHZLqMUH2fZtOn+HrE30zDpJO4IjGfxzj3rz/AEGKc2kc10SbictKBjkbzn9evNaerOBodtpoYyPrGpyXEhHG+2hOxB9Dg/lTRIrSPkKBjB7AL6f0oA3PDEBS7CR3MctxKQMI2T7Y9q34YIVha2xBJiQozDLbmz1B6flWD4RKSTai91PcWyNDw1uCH68qMdMjjmuv0K3t7u4hEMMqW0Izhzhg/bp0wKAOC+PN6sNvpWlxnaI49xUe/T9BXjRrsfipqv8AavjG9dWzHG5jX6Dgfyrjz0oA9T/Zc/5Lt4Z/7ev/AEllrrP20/8Akq2k/wDYGh/9Hz1yf7Ln/JdvDP8A29f+kstdZ+2n/wAlW0n/ALA0P/o+egDw3+ddN4PuNq3EJAJKkge4w39K5noKv6JcfZNQRyfl7+/+QTQB6OJlWJQOVOTz2+tSXFwGRAGIwOvqaoo0cdwqzsVi6Fl7DsfyxUt40TyBbdB5R4Xac4/+vQBn6hdvFfwMHYYB3FWKk+1WbCcadcC/jBdRltxP3GA4Dfj3rO1yCRSkuFLY5Td8wHuO1WLU7beFJD8rxukhPdcd/oelAGxZ6tNaeDrmEbhLfhg5/vHPTP4mm6GHOnOYoxCkI2zTY3BS3QAHqeKoawCunadEI87EMh25JO5uKqR3U0dj9nP/AC0fzflOcjpg/SgDq7eKwksZ3YbLZSGkdm3M7dAP/rVU0+KIf2ldiYvPGFKxlQAQp46dsVy66pPwsYJt4ycISPvd+PWp7bWZ7W4WYQOATsdSQAUPBFAGtMLWPTGmKh45yfLwATG+fu59O4q54UtxLZ6lA84MsSB13HrntiuXv2ezaW23/IrqVwcq2TkH8sVf0K8eK/AVSTMrR4HUg8/0oA1oJrawULcJ5kuCCQ+0Ip7j1NYOrK0DXwWQFHh+RgO7EBf0NXtd2mGyYphmBUj0Oay71Hm0uyncsZEcqUI+8ikEGgCzDCseyCJQI0G0DOenetPfHFEHAzIB079apWqBTnuwzjvzT7iXy3UOFCtwD1x/9egC1E6wzrvYkITMwJ67QW/nivNtVm+0X00jHJJwa7HV7zyLKaVSMyDyk/3Ry35nArheqMxJyeaAM+iiigD9KvhP/wAks8G/9gWy/wDRCUUfCf8A5JZ4N/7Atl/6ISigDyz9tEZ+F+k/9hqL/wBET18Yt9/GK/Svxr4O0LxtpUWm+J7H7dZRTC4SPzpIsSBWUHKMD0dhjOOa4v8A4Z++GX/QtH/wYXX/AMdoA+Qfgx4mbwp49sbxmP2ViYrhR3jbgn3xwfwr6l8Y6PELh7nTtg+0He69Udj0dfQn9frW0vwA+GasGXw2wYdCNQus/wDo2t0fC/wwsCwqmtCFVCBBr1/tCjoMed09qAOG8Iw+db3cUiwXRyCELbCh7n1Gf5itJ47fTLhI3jUSMchi4bf7bu9dDH8JvCMc5njttWWb/nout3wb8/OzSz/Cfwlcf6+31aX/AH9cvm/nNQB5Pr2o6zo+ti4u4H1CxWQPFHNjAU/3G7Ee9N8ceGofEdxb6jokAtyo3XDRLlZoyM5KHuPbmvXJvhX4VmhSKaHWJIk5VG1y+Kr9B53FD/Crwo8XlvDq7R/3Drl8R+XnUAfLmpaLdr4j0fS7tAtmJvtIypKnH97OPwFdx45ls7EeTskZZRuO05CE9hnnbmvZpfhH4PlEYltNUcRjCBtavTtHoP33FRyfBzwTLIJJNP1B5AMBm1i9JA9M+dQB8u+IYpH0KaVlbySpIzkDIHJHsK8fgUOx38A5PXFfoDP8GvBFwhS406/lQjaVfWL1hj05lrPHwA+GY6eG29P+Qhdf/HaAPhuyt5olivIkZo0fBIGCp7GvaLLVJLmawnicCWNFeUgnJOMAflX0FH8Cfh3HG0cehTpGxyVXU7sAn6ebUqfBLwEjbk0i7VvUateD/wBq0AeASXH9r+KraS1s57ZJOWjkctuA+8289cmuquIBwSivHj5on7jp+FevD4QeDQVIstSBVdin+2r3hc5wP33T2px+Efg85zaaoc9c61fc/wDkagDwew8C6a3iW3e2n1HTJEdpFiadXgLMMsQrD5d3ALDI6V2h0uW1VYmit7aBVAXygPnz/ET3PuO1ejRfCjwnEcxW+rIfVdcvh/7Wqab4Y+GpsecNbkwMDfr1+eP+/wBQBwtnYxGPTLSNT59xcq8nHPlpy3t1x+deGftVX4n8b2NkrZNrbAMPQkk/1r6sb4YeGWZGZdbLIpVSdev8qD1A/fcCsrUfgb8PtTu2utS0W5u7l/vS3GqXcjn6sZSaAPz8P3cjjJ6V9ofsWf8AJLdV/wCwzL/6Igrqv+Gffhj/ANCyf/Bhdf8Ax2u08FeDtC8E6VLpvhix+w2UsxuHj86SXMhVVJy7E9EUYzjigD84fCl4dP8AEVhdA4McoNfSnihFmutN1GFgqyoYXbGeGG5f1yK9WH7PvwxBBHhkgjoRqF1/8drUb4P+DGhWFrHUjEuNqHWb3aMdOPO7UAfPx8v5VYcAEyfLkmuL8a6Bf2mnT3diks2mNGzAxAsIj3U4+6fr2r61k+D3guQgyWOouQcgtrN6ef8Av9UcPwZ8DwOzw6bfRu/LFNXvQT9f3tAHyPaQx69rgurG1vH0u2soLZIsbHl2r6ngDOeatSabOL2TUdQeLdEPLtoYzuWBf6ntmvrFPg74LTdssNRXdw2NZvRn6/vqif4K+BHGH0q9Yeh1a8P/ALVoA+R31S6ji8uSYyQ7yryEYJB7GuimCxwgW6x4K71Vhx+NfSP/AAo34e+W0f8AYlzsY5K/2pd4J+nm1Ifgn4CKKh0m7KKNoX+1rzAHp/raAPh3XdPuPKkvbiQMzSHfxwvPQegqLRbq9vbmK1nuJJLdTny2OQQPX1r7ik+Bfw8lRkk0O4dG+8rapdkH6jzaZD8BfhxC+6Hw/LG3qmpXYP8A6NoA+aNI0pLWZ5YIzvdcO7nao9hV9Hto/F+lrfhXg8vZyeGY9K+k3+C/gZ12vpl8y+h1e8P/ALVqN/gl4BeRHfSLtnTAVjqt4SuOmD5vFAHgvjLU7DUFltbPWIft33TbOhKMR2Vugb0B4rz3S5106ea458yKKRUQ8HzGG1R+bZ/CvrwfBHwCFZRo93tblh/at5g/X97TH+Bnw8dtz6JcM24Nk6pdk5HQ/wCt60AfJ00Pn+IbsxH91plvFp0RXuUQb/zOfzqSZIP3aW6llABkYjG5/b2FfVy/A/4fqXK6Ncgu5kfGq3nzMerH97yfel/4Uf8AD/Of7Gus+v8Aat5/8doA+cdAivo0hktWSOQvxIACc+wPH510mpXv9g+E7/UZpXkuirKJGI5duABjjI5PFe4R/BrwPHt8vTb9NvTbrF6Mf+RaS8+DHga9txb3mmX1xApyI5dXvHUfgZcUAfnrcSmeeSVjksSTURr7/wD+Gffhj/0LP/lQuv8A47R/wz78Mf8AoWf/ACfuv/jtAHyp+y5/yXbwz/29f+kstdZ+2n/yVbSf+wND/wCj56+k/C3wd8CeFdetdZ0HQvsmpW27ypvtc8m3cpRvlZyDlWI5HerfjX4XeDvG2qxal4n0f7dexQi3ST7VNFiMMzAYRwOrMc4zzQB+eWctkGiNikiuOxr7v/4Z/wDhn/0Lbf8Agwuv/jtH/DP/AMM/+hbb/wAGF1/8doA+TdKuYLixtxcFsgGMuOxHQ/kRWNf307XL/Zh5O35cKeMj+IfWvtBPgP8ADlFCpoEqqDnA1K7HP/f2mn4C/DcnJ8PyE++pXf8A8doA+RYJILyCKWQfvZMbyeu4df1qe3hN3co8mUswQsuOmM5x+lfWq/Aj4dIMLoMy/TU7sf8AtWpB8D/h+IvKGjXIj/uf2reY/LzaAPkXUNSjupr4xSbWLBIUB4VF4zVbSYSga4kGY9pIJ7Yr6/X4D/DlW3LoEobGMjUrvOP+/tSp8EPAEa7U0e6VcYwNVvAMf9/aAPjaVIZwsnILENhePxqOeJSEQSM+WCkHnNfZI+BXw7AwNCnAHpqd3/8AHaP+FE/DrIP9hTZByP8AiZ3fH/kWgD471XkTq2OFVQP7wAxTFuDHOs2SNpBBHt2r7Ik+Bfw8kOZNDnc/7Wp3Z/8AatIfgR8Oiqg6DNheg/tO74/8i0AfK06te6QZF2K1tcGRS3I2sOnvzioLTbcRNLcMo28k54Ue3419aD4IeABEYho10IzyUGq3mD+Hm1GfgT8OiGB0Kchhg/8AEzu+fr+9oA+TobmKYs0bgs2VQHhiajmiMTRo8bKM4x3J9PrmvrRfgP8ADlSNugSj6ald/wDx2pT8EPABwDo90QOmdVvP/jtAHxB4mvVmuTFER5cY8sY6ZB5P5/yrD52ke1feR+APw0Y5bw4xPvqN1/8AHaT/AIUB8M/+hbb/AMGF1/8AHaAPz+or7/8A+GfPhh/0LP8A5P3X/wAco/4Z8+GH/Qs/+T91/wDHKAOr+E//ACSzwb/2BbL/ANEJRXQaTp9rpGlWem6fF5NlZwpbwR7i2yNFCqMkknAA5JzRQB//2Q==);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Shrinkage of a lactotroph adenoma in response to treatment with the dopamine agonist cabergoline as shown by post-gadolinium magnetic resonance imaging. A 37-year-old man presented with headaches and was found to have an enormous sellar mass (A, arrow) and a prolactin of 7248 ng/mL. He was treated with cabergoline and after two months the prolactin had decreased to 745 ng/mL and the size of the mass had decreased markedly (B, arrow). After 12 months of cabergoline treatment, the prolactin had decreased to 9.2 ng/mL and the mass had decreased even further (C, arrow).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Julia Kharlip, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f15_24_15746=[""].join("\n");
var outline_f15_24_15746=null;
var title_f15_24_15747="Homatropine: Pediatric drug information";
var content_f15_24_15747=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"1\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Homatropine: Pediatric drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_general\" href=\"UTD.htm?34/43/35508?source=see_link\">",
"    see \"Homatropine: Drug information\"",
"   </a>",
"   and",
"   <a class=\"drug drug_patient\" href=\"UTD.htm?7/46/7908?source=see_link\">",
"    see \"Homatropine: Patient drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F179245\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Homatropaire;",
"     </li>",
"     <li>",
"      Isopto&reg; Homatropine",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list_set htclist drugH1Div drugBrandNames\" id=\"F1059254\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Therapeutic Category",
"    </span>",
"    <ul>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Anticholinergic Agent, Ophthalmic",
"      </span>",
"     </li>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Ophthalmic Agent, Mydriatic",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block dos drugH1Div\" id=\"F1059251\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Usual",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_general\" href=\"UTD.htm?34/43/35508?source=see_link\">",
"      see \"Homatropine: Drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Ophthalmic:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Children:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Mydriasis and cycloplegia for refraction: Instill 1 drop of 2% solution immediately before the procedure; repeat at 10-minute intervals as needed",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Uveitis: Instill 1 drop of 2% solution 2-3 times/day",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Adults:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Mydriasis and cycloplegia for refraction: Instill 1-2 drops of 2% solution or 1 drop of 5% solution before the procedure; repeat at 5- to 10-minute intervals as needed",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Uveitis: Instill 1-2 drops of either 2% or 5% solution 2-3 times/day up to every 3-4 hours as needed",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F179232\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Solution, ophthalmic, as hydrobromide [drops]: 5% (5 mL)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Homatropaire: 5% (5 mL) [contains benzalkonium chloride]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Isopto&reg; Homatropine: 2% (5 mL); 5% (5 mL) [contains benzalkonium chloride]",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F179219\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Yes",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F1059257\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Ophthalmic: Finger pressure should be applied to lacrimal sac for 1-2 minutes after instillation to decrease risk of absorption and systemic effects",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F1059256\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Producing cycloplegia and mydriasis for refraction; treatment of acute inflammatory conditions of the uveal tract",
"    </p>",
"   </div>",
"   <div class=\"block mst drugH1Div\" id=\"F7727193\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Safety Issues",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Sound-alike/look-alike issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       Homatropine may be confused with Humatrope&reg;, somatropin",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"block arm drugH1Div\" id=\"F179273\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Gastrointestinal: Xerostomia",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Local: Burning, irritation, stinging",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Ocular: Blurred vision, eczematoid dermatitis, edema, exudate, follicular conjunctivitis, intraocular pressure increased, photophobia, vascular congestion",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Miscellaneous: Thirst",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F1059260\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to homatropine or any component; narrow-angle glaucoma, acute hemorrhage",
"    </p>",
"   </div>",
"   <div class=\"block pre drugH1Div\" id=\"F1059250\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Precautions",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Use with caution in patients with hypertension, cardiac disease, increased intraocular pressure, obstructive uropathy, paralytic ileus, or ulcerative colitis",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F13299448\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     None known.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F6220810\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     AbobotulinumtoxinA: Anticholinergic Agents may enhance the anticholinergic effect of AbobotulinumtoxinA.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Acetylcholinesterase Inhibitors (Central): Anticholinergics may diminish the therapeutic effect of Acetylcholinesterase Inhibitors (Central). Acetylcholinesterase Inhibitors (Central) may diminish the therapeutic effect of Anticholinergics. If the anticholinergic action is a side effect of the agent, the result may be beneficial.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Aclidinium: May enhance the anticholinergic effect of Anticholinergics.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Anticholinergics: May enhance the adverse/toxic effect of other Anticholinergics.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Levocabastine (Nasal).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Cannabinoids: Anticholinergic Agents may enhance the tachycardic effect of Cannabinoids.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Ipratropium (Oral Inhalation): May enhance the anticholinergic effect of Anticholinergics.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Mirabegron: Anticholinergic Agents may enhance the therapeutic effect of Mirabegron. This may result in acute urinary retention.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     OnabotulinumtoxinA: Anticholinergic Agents may enhance the anticholinergic effect of OnabotulinumtoxinA.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Potassium Chloride: Anticholinergic Agents may enhance the ulcerogenic effect of Potassium Chloride.  Management: Patients on drugs with substantial anticholinergic effects should avoid using any solid oral dosage form of potassium chloride.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Pramlintide: May enhance the anticholinergic effect of Anticholinergics. These effects are specific to the GI tract.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     RimabotulinumtoxinB: Anticholinergic Agents may enhance the anticholinergic effect of RimabotulinumtoxinB.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Secretin: Anticholinergic Agents may diminish the therapeutic effect of Secretin.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tiotropium: Anticholinergics may enhance the anticholinergic effect of Tiotropium.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Topiramate: Anticholinergic Agents may enhance the adverse/toxic effect of Topiramate. Specifically, the risk of oligohidrosis and hyperthermia may be enhanced.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F179229\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     C (",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F5630949\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Animal reproduction studies have not been conducted.",
"    </p>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F1059249\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Blocks response of iris sphincter muscle and the accommodative muscle of the ciliary body to cholinergic stimulation resulting in dilation and loss of accommodation",
"    </p>",
"   </div>",
"   <div class=\"block phd drugH1Div\" id=\"F1059259\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Ophthalmic:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Onset of accommodation and pupil action:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Maximum mydriatic effect: Within 10-30 minutes",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Maximum cycloplegic effect: Within 30-90 minutes",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Duration:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Mydriasis: Persists for 6 hours to 4 days",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Cycloplegia: 10-48 hours",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 13352 Version 37.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-122.72.80.101-9C98E7F444-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f15_24_15747=[""].join("\n");
var outline_f15_24_15747=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F179245\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1059254\">",
"      Therapeutic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1059251\">",
"      Dosing: Usual",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F179232\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F179219\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1059257\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1059256\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F7727193\">",
"      Medication Safety Issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F179273\">",
"      Adverse Reactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1059260\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1059250\">",
"      Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13299448\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6220810\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F179229\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5630949\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1059249\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1059259\">",
"      Pharmacodynamics",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_PED/13352\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_PED/13352|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?34/43/35508?source=related_link\">",
"      Homatropine: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?7/46/7908?source=related_link\">",
"      Homatropine: Patient drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f15_24_15748="Ultrasound of early breast cancer";
var content_f15_24_15748=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=SURG%2F52790&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=SURG%2F52790&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Ultrasound of early breast cancer",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 374px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Left breast ultrasound demonstrates a hypoechoic nodule with posterior acoustic shadowing that corresponds to the mammographic abnormality.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Pierre J Sasson, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f15_24_15748=[""].join("\n");
var outline_f15_24_15748=null;
var title_f15_24_15749="Quinapril: Patient drug information";
var content_f15_24_15749=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Quinapril: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"UTD.htm?23/29/24024?source=see_link\">",
"     see \"Quinapril: Drug information\"",
"    </a>",
"    and",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?41/24/42375?source=see_link\">",
"     see \"Quinapril: Pediatric drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F216351\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Accupril&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F216352\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Accupril&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt war-os drugH1Div\" id=\"F10020749\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warning",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700281",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take if you are pregnant. Use during pregnancy may cause birth defects or loss of the unborn baby. If you get pregnant or plan on getting pregnant while taking this drug, call your doctor right away.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10020751\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691888",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat high blood pressure.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691384",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to help a weak heart.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691388",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to help heart function after a heart attack.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691575",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to protect kidney function in diabetic patients who have protein loss.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10020750\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2702837",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to quinapril or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s3915366",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have high blood sugar (diabetes) and are taking aliskiren.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701080",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are pregnant or may be pregnant.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10020755\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696820",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not run out of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697282",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have kidney disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698421",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Have your blood pressure checked often. Talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698463",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Have your blood work checked often. Talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696833",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take antacids within 2 hours of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697100",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are taking a salt substitute that has potassium, potassium-sparing diuretics, or potassium, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697111",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are taking this drug and have high blood pressure, talk with your doctor before using OTC products that may raise blood pressure. These include cough or cold drugs, diet pills, stimulants, ibuprofen or like products, and some natural products or aids.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696618",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Avoid beer, wine, or mixed drinks.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696701",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Be careful in hot weather. Drink lots of fluids to stop fluid loss.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697740",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Use birth control that you can trust to stop pregnancy while taking this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697636",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are breast-feeding. You will need to talk about any risks to your baby.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10020756\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698051",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling dizzy. Rise slowly over a few minutes when sitting or lying down. Be careful climbing.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698119",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Headache.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697983",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Cough.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698249",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Muscle pain.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10020758\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699077",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of infection. These include a fever of 100.5&deg;F (38&deg;C) or higher, chills, very bad sore throat, ear or sinus pain, cough, more sputum or change in color of sputum, pain with passing urine, mouth sores, wound that will not heal, or anal itching or pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699023",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad dizziness or passing out.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698640",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Trouble breathing.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698650",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you have too much sweat, fluid loss, throwing up, or loose stools. This may lead to low blood pressure.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699062",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       A big weight gain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699094",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Swelling in your legs or belly.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698998",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Cough that does not go away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698634",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Dark urine or yellow skin or eyes.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10020753\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695786",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take as you have been told, even if you feel well.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695887",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take on an empty stomach. Take 1 hour before or 2 hours after meals.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694865",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Follow the diet and workout plan that your doctor told you about.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10020754\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696563",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take a missed dose as soon as you think about it.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696496",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If it is close to the time for your next dose, skip the missed dose and go back to your normal time.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696475",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take 2 doses at the same time or extra doses.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696457",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not change the dose or stop this drug. Talk with the doctor.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10020759\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699336",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store at room temperature.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699266",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store in a dry place. Do not store in a bathroom.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10020760\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 11011 Version 36.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-122.72.76.133-512E5AB897-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f15_24_15749=[""].join("\n");
var outline_f15_24_15749=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F216351\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F216352\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10020749\">",
"      Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10020751\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10020750\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10020755\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10020756\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10020758\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10020753\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10020754\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10020759\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10020760\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?23/29/24024?source=related_link\">",
"      Quinapril: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?41/24/42375?source=related_link\">",
"      Quinapril: Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f15_24_15750="Levonorgestrel: Patient drug information";
var content_f15_24_15750=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Levonorgestrel: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"UTD.htm?24/47/25336?source=see_link\">",
"     see \"Levonorgestrel: Drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F188202\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Mirena&reg;;",
"     </li>",
"     <li>",
"      My Way&trade;;",
"     </li>",
"     <li>",
"      Next Choice&reg;;",
"     </li>",
"     <li>",
"      Next Choice&trade; One Dose;",
"     </li>",
"     <li>",
"      Plan B&reg; One Step;",
"     </li>",
"     <li>",
"      Skyla&trade;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F188203\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Mirena&reg;;",
"     </li>",
"     <li>",
"      Next Choice&reg;;",
"     </li>",
"     <li>",
"      NorLevo&reg;;",
"     </li>",
"     <li>",
"      Plan B&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt war-os drugH1Div\" id=\"F10028995\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warning",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700605",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug does not protect you from diseases caused by having sex.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700602",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Sometimes drugs are not safe when you take them with certain other drugs. Taking them together can cause bad side effects. This is one of those drugs. Be sure to talk to your doctor about all the drugs you take.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10028997\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691546",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to stop pregnancy.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691877",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat heavy bleeding during monthly periods (menstruation).",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10028996\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2702385",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to levonorgestrel or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701080",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are pregnant or may be pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s2705596",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <span style=\"text-decoration: underline\">",
"        Uterine device:",
"       </span>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2703204",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any of these health problems: Active liver disease, blood clots, breast cancer, tumor where estrogen makes it grow, or vaginal bleeding.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2703182",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any of these health problems: Pap smear that is not normal, endometritis after a birth, infected abortion in the last 3 months, pelvic infection, pregnancy where the fertilized egg was not in a normal position, uterine or cervical tumor or growth, uterine fibroids, or untreated cervicitis or vaginitis.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2703163",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an IUD (intrauterine device) in place.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2703875",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you or your partner have sex with more than one person.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2703888",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your body is weak at fighting infections.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10029001\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s2705324",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        <span style=\"text-decoration: underline\">",
"         All products:",
"        </span>",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696640",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Avoid cigarette smoking. People older than 35 years of age and/or smoking more than 15 cigarettes per day have more chance for heart disease.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697636",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are breast-feeding. You will need to talk about any risks to your baby.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697712",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       To protect from diseases caused by having sex, use a latex condom.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s2705490",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        <span style=\"text-decoration: underline\">",
"         Oral:",
"        </span>",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697710",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug will not end a pregnancy.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697680",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug is not for regular use to stop pregnancy.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s2705574",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        <span style=\"text-decoration: underline\">",
"         Uterine device:",
"        </span>",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697197",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have high blood sugar (diabetes), talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697261",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have heart valve problems, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697265",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have high blood pressure, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697290",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have liver disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697307",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have mental illness, talk with your doctor.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10029002\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s2705324",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        <span style=\"text-decoration: underline\">",
"         All products:",
"        </span>",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698392",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Weight gain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698119",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Headache.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698272",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Upset stomach or throwing up. Many small meals, good mouth care, sucking hard, sugar-free candy, or chewing sugar-free gum may help.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696435",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Pimples (acne).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697923",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Enlarged breasts.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       For women, vaginal yeast infection. Report itching or discharge.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698231",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Period (menstrual) changes. These include lots of bleeding, spotting, or bleeding between cycles.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698105",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Gallbladder disease, blood clots, heart attacks, and other blood vessel problems may rarely happen.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s2705574",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        <span style=\"text-decoration: underline\">",
"         Uterine device:",
"        </span>",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698016",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Pain while the device is being placed.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698134",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       High blood pressure.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697986",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       A cyst on the ovary may rarely happen.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10029004\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s2705324",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        <span style=\"text-decoration: underline\">",
"         All products:",
"        </span>",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699031",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad headache.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699008",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad belly pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699042",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very upset stomach or throwing up.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699086",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Sudden change in eyesight, eye pain, or irritation.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698598",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       A lump in the breast or breast soreness.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698666",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       For women, if you are pregnant or may be pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s2705490",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        <span style=\"text-decoration: underline\">",
"         Oral:",
"        </span>",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698724",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you throw up within 2 hours of taking this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s2705574",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        <span style=\"text-decoration: underline\">",
"         Uterine device:",
"        </span>",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698613",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Cannot feel string.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698638",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Device comes out.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698994",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Painful sex.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698634",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Dark urine or yellow skin or eyes.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699008",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad belly pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698485",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Follow up with your doctor after using this drug for 3 months.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10028999\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s2705490",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        <span style=\"text-decoration: underline\">",
"         Oral:",
"        </span>",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696087",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Start this drug less than 72 hours after unprotected sex.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2762619",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you throw up within 2 hours of taking this drug, take 1 more dose.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s2705574",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        <span style=\"text-decoration: underline\">",
"         Uterine device:",
"        </span>",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695936",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       The device is placed in your uterus. This will be done sometime during the first 7 days of your monthly period cycle or right after an abortion. This must be changed every 5 years for Mirena&reg; or 3 years for Skyla&trade;.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10029000\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s2705490",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        <span style=\"text-decoration: underline\">",
"         Oral:",
"        </span>",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696446",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Call your doctor to find out what to do.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696475",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take 2 doses at the same time or extra doses.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10029005\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699556",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store tablets at room temperature.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699663",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Device will be placed in your uterus in a doctor's office. You will not store it at home.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10029006\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 11779 Version 40.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1103-89.32.226.102-F0948400E7-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f15_24_15750=[""].join("\n");
var outline_f15_24_15750=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F188202\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F188203\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10028995\">",
"      Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10028997\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10028996\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10029001\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10029002\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10029004\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10028999\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10029000\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10029005\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10029006\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?24/47/25336?source=related_link\">",
"      Levonorgestrel: Drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f15_24_15751="Budd-Chiari syndrome - recanalization";
var content_f15_24_15751=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F53805&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F53805&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 474px\">",
"   <div class=\"ttl\">",
"    Budd-Chiari syndrome - recanalization",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 454px; height: 382px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Recanalization of a clotted hepatic vein.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Marshall M. Kaplan, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f15_24_15751=[""].join("\n");
var outline_f15_24_15751=null;
var title_f15_24_15752="LASIK PRK LASEK and Epi LASIK procedures";
var content_f15_24_15752=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F53888&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F53888&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 562px\">",
"   <div class=\"ttl\">",
"    Differences among the LASIK, PRK, LASEK, and Epi LASIK procedures",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 542px; height: 463px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    In laser-assisted in situ keratomileusis (LASIK, first column), a stromal flap is created mechanically with a microkeratome, or more recently using a femtosecond laser. Part of the stromal bed is then removed with an excimer laser to provide the refractive correction before repositioning the LASIK flap. In photorefractive keratotomy (PRK, second column), the central corneal epithelium is removed and stromal tissue is excised from the stromal surface with an excimer laser. In laser epithelial keratomileusis (LASEK, third column), an epithelial flap is formed with the&nbsp;help of dilute ethanol and special instruments, and stromal tissue is excised from the stromal bed with an excimer laser. The surgeon hopes to retain the epithelium in LASEK, but in some cases it is lost, and then the procedure is then similar to PRK. In epithelial laser-assisted in situ keratomileusis (Epi-LASIK, fourth column), an epikeratome, which is a mechanized blunt blade, is used to separate the epithelium from the underlying stroma.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f15_24_15752=[""].join("\n");
var outline_f15_24_15752=null;
var title_f15_24_15753="Management of bronchopulmonary dysplasia";
var content_f15_24_15753=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Management of bronchopulmonary dysplasia",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?15/24/15753/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?15/24/15753/contributors\">",
"     James M Adams, Jr, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?15/24/15753/contributors\">",
"     Ann R Stark, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?15/24/15753/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?15/24/15753/contributors\">",
"     Joseph A Garcia-Prats, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?15/24/15753/contributors\">",
"     Gregory Redding, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?15/24/15753/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?15/24/15753/contributors\">",
"     Melanie S Kim, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?15/24/15753/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jul 6, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Bronchopulmonary dysplasia (BPD), also known as neonatal chronic lung disease (CLD), is an important cause of respiratory illness in preterm newborns. Most patients with BPD gradually improve as healing occurs and lung growth continues. Management is directed at minimizing further injury, providing an optimal environment to support growth and recovery, and to detect complications associated with BPD.",
"   </p>",
"   <p>",
"    The management of BPD is reviewed here. Pathogenesis and clinical features, prognosis, and potential strategies to prevent BPD are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/22/18793?source=see_link\">",
"     \"Pathogenesis and clinical features of bronchopulmonary dysplasia\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/51/25398?source=see_link\">",
"     \"Outcome of infants with bronchopulmonary dysplasia\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/14/27880?source=see_link\">",
"     \"Prevention of bronchopulmonary dysplasia\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     RESPIRATORY SUPPORT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Respiratory care is supportive and should minimize additional injury.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Mechanical ventilation",
"    </span>",
"    &nbsp;&mdash;&nbsp;In patients with established BPD who require mechanical ventilation, small tidal volumes are preferable to avoid additional mechanical injury. Maintaining a positive end-expiratory pressure (PEEP) of 5 to 7 cm H",
"    <sub>",
"     2",
"    </sub>",
"    O may minimize atelectasis, and counter the development of pulmonary edema. Infants with bronchomalacia may require prolonged use, as well as high levels, of PEEP to splint open large airways. A slightly prolonged inspiratory duration of 0.4 to 0.5 seconds sometimes is needed to promote uniform lung inflation. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/22/18793?source=see_link&amp;anchor=H10#H10\">",
"     \"Pathogenesis and clinical features of bronchopulmonary dysplasia\", section on 'Mechanical ventilation'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Under close monitoring, attempts should be made to wean ventilator support progressively as tolerated. To facilitate weaning, arterial carbon dioxide tension of 55 to 65 mmHg, or somewhat higher in severely affected infants, is acceptable as long as pH is in the normal range (ie, 7.3 to 7.4). Infants who can maintain this PCO",
"    <sub>",
"     2",
"    </sub>",
"    level with spontaneous breathing can be weaned to continuous positive airway pressure and then to supplemental oxygen alone.",
"   </p>",
"   <p>",
"    In addition to ongoing lung injury, prolonged ventilation is associated with acquired subglottic stenosis and laryngeal injury, especially in infants who require multiple intubations. The appropriate timing of performing a tracheostomy in patients requiring chronic ventilation is unknown. We typically begin to consider tracheostomy in infants who are 48 to 52 weeks postmenstrual age and expected to need continued ventilator support.",
"   </p>",
"   <p>",
"    Suctioning is associated with tracheal and bronchial injury. Suctioning is limited to only when it is needed, and ensuring that the passage of the suction catheter does not go beyond the distal tip of the endotracheal tube (\"calibrated suctioning\") is recommended to avoid injury and protect the airway mucosa.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Oxygen",
"    </span>",
"    &nbsp;&mdash;&nbsp;The use of supplemental oxygen in preterm infants with BPD is challenging because of the competing needs of avoiding both hypoxia and exposure to excess oxygen use. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/22/18793?source=see_link&amp;anchor=H11#H11\">",
"     \"Pathogenesis and clinical features of bronchopulmonary dysplasia\", section on 'Oxygen toxicity'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Supplemental oxygen is often necessary to ensure adequate tissue oxygenation and avoid alveolar hypoxia, which results in increased pulmonary vascular resistance and the development of cor pulmonale [",
"    <a class=\"abstract\" href=\"UTD.htm?15/24/15753/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]. Hypoxemia also may increase airway resistance in infants with BPD [",
"    <a class=\"abstract\" href=\"UTD.htm?15/24/15753/abstract/3,4\">",
"     3,4",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    However, increases in inspired oxygen concentrations, even small changes, may have a negative impact on the clinical course, such as increasing the risk of retinopathy of prematurity or exacerbating pulmonary dysfunction.",
"   </p>",
"   <p>",
"    Determining the optimal range of oxygen saturation is an ongoing active area of research. Guidelines for targeted oxygen saturation goals continue to evolve with the accumulation of new evidence. The challenges including a description of the available data in determining oxygen target levels are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/61/29656?source=see_link&amp;anchor=H18#H18\">",
"     \"Oxygen monitoring and therapy in the newborn\", section on 'Oxygen target levels'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     NUTRITION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Nutrition is provided to meet the increased total energy needs of infants with BPD and ensure appropriate growth. Total energy needs in some infants may increase to 150",
"    <span class=\"nowrap\">",
"     kcal/kg",
"    </span>",
"    per day, and protein intake of 3.5 to 4",
"    <span class=\"nowrap\">",
"     g/kg",
"    </span>",
"    per day. Because fluid intake is often restricted, the desired nutrients may need to be contained in a reduced volume of feeding. (See",
"    <a class=\"local\" href=\"#H17\">",
"     'Growth'",
"    </a>",
"    below and",
"    <a class=\"local\" href=\"#H6\">",
"     'Fluid restriction'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    We recommend infants with BPD receive fortified human milk that is supplemented to meet their needs for adequate growth because of the intrinsic benefits of human milk. Alternatively, formula designed to meet the needs of preterm infants may also be used. Regular consultation with a pediatric nutritionist experienced in the management of chronically ill infants is helpful. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/22/23912?source=see_link&amp;anchor=H17#H17\">",
"     \"Growth management in preterm infants\", section on 'Bronchopulmonary dysplasia'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/6/23655?source=see_link\">",
"     \"Human milk feeding and fortification of human milk for premature infants\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/47/32505?source=see_link\">",
"     \"Infant benefits of breastfeeding\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     FLUID RESTRICTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Based upon clinical experience, current BPD management restricts fluid intake to avoid pulmonary edema and to improve pulmonary function. Although data based upon clinical trials comparing restrictive versus liberal intake are limited, there appears to be a trend towards better outcome with a more restrictive approach in reducing the risk of BPD and a decrease in mortality [",
"    <a class=\"abstract\" href=\"UTD.htm?15/24/15753/abstract/5,6\">",
"     5,6",
"    </a>",
"    ]. Adequate nutrition, however, must be provided to ensure proper growth. As a result, caloric density of feeds may need to be increased in patients who are managed with a more restrictive fluid intake.",
"   </p>",
"   <p>",
"    Most infants can be managed with modest fluid restriction of 140 to 150",
"    <span class=\"nowrap\">",
"     mL/kg",
"    </span>",
"    per day. Human milk with added fortifier or a commercial premature formula typically is used in preterm infants. Additional calories",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    protein may be added as needed [",
"    <a class=\"abstract\" href=\"UTD.htm?15/24/15753/abstract/7\">",
"     7",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/6/23655?source=see_link&amp;anchor=H11#H11\">",
"     \"Human milk feeding and fortification of human milk for premature infants\", section on 'Fortification of human milk'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/22/23912?source=see_link&amp;anchor=H17#H17\">",
"     \"Growth management in preterm infants\", section on 'Bronchopulmonary dysplasia'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In severely affected infants, fluids are often restricted to 110 to 120",
"    <span class=\"nowrap\">",
"     mL/kg",
"    </span>",
"    per day. In this case, formula or human milk should be supplemented to 30",
"    <span class=\"nowrap\">",
"     cal/oz.",
"    </span>",
"    Infants receiving restricted amounts of special formulas require supplemental iron and vitamins.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     DIURETICS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although diuretic therapy has been shown to improve pulmonary mechanics, there is little evidence that the long-term use of diuretics improves clinical outcome of infants with BPD [",
"    <a class=\"abstract\" href=\"UTD.htm?15/24/15753/abstract/8\">",
"     8",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Agents",
"    </span>",
"    &nbsp;&mdash;&nbsp;The two classes of diuretic agents used in infants with BPD are:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Thiazide diuretics &ndash; Acute and chronic administration of diuretics that act on the distal renal tubule (thiazide",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?17/0/17414?source=see_link\">",
"       spironolactone",
"      </a>",
"      ) improve lung mechanics in preterm infants with BPD [",
"      <a class=\"abstract\" href=\"UTD.htm?15/24/15753/abstract/9\">",
"       9",
"      </a>",
"      ]. However, in a systematic review of six studies, data were inadequate to show that distal diuretic administration improved long-term clinical outcome in infants with established or developing BPD [",
"      <a class=\"abstract\" href=\"UTD.htm?15/24/15753/abstract/9\">",
"       9",
"      </a>",
"      ]. Further clinical trials are needed to determine whether there is a role for chronic use of thiazide diuretics.",
"     </li>",
"     <li>",
"      Loop diuretics &ndash; The loop diuretic most commonly used and best studied in the management of BPD is",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?5/26/5544?source=see_link\">",
"       furosemide",
"      </a>",
"      . In a systemic review of six trials, one week administration of furosemide either enterally or intravenously to infants with BPD older than three weeks of age improved pulmonary mechanics and oxygenation [",
"      <a class=\"abstract\" href=\"UTD.htm?15/24/15753/abstract/10\">",
"       10",
"      </a>",
"      ]. Pulmonary mechanics were also improved after a single intravenous dose of furosemide (1",
"      <span class=\"nowrap\">",
"       mg/kg).",
"      </span>",
"      However, no benefit was demonstrated in clinical outcomes, including need for ventilator support, length of hospital stay, survival, or long-term outcome. No consistent effects were found when intravenous furosemide was given to preterm infants younger than three weeks of age with developing BPD.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Complications",
"    </span>",
"    &nbsp;&mdash;&nbsp;Diuretic use causes urinary loss of sodium, potassium, and chloride, and often results in serum electrolyte abnormalities, especially hyponatremia and hypokalemia [",
"    <a class=\"abstract\" href=\"UTD.htm?15/24/15753/abstract/8\">",
"     8",
"    </a>",
"    ]. Hypochloremic alkalosis is a frequent complication. Dietary supplementation with",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?11/17/11542?source=see_link\">",
"     potassium chloride",
"    </a>",
"    usually is needed to prevent these abnormalities.",
"   </p>",
"   <p>",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?5/26/5544?source=see_link\">",
"     Furosemide",
"    </a>",
"    increases calcium excretion, sometimes leading to nephrocalcinosis",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    nephrolithiasis [",
"    <a class=\"abstract\" href=\"UTD.htm?15/24/15753/abstract/11,12\">",
"     11,12",
"    </a>",
"    ]. Furosemide is potentially ototoxic, especially with rapid intravenous administration. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/47/26356?source=see_link&amp;anchor=H2#H2\">",
"     \"Nephrocalcinosis in neonates\", section on 'Pathogenesis'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Our approach",
"    </span>",
"    &nbsp;&mdash;&nbsp;Despite the lack of evidence for long-term benefit, we use diuretics in infants with BPD to improve pulmonary function in patients who remain ventilator-dependent despite modest fluid restriction. Diuretic therapy also may reduce the need for severe fluid restriction and, thus, facilitate optimal nutrition, although this has not been studied.",
"   </p>",
"   <p>",
"    The use of chronic diuretic therapy is considered for infants approximately three to four weeks of age who remain ventilator-dependent despite modest fluid restriction (140 to 150",
"    <span class=\"nowrap\">",
"     mL/kg",
"    </span>",
"    per day). In these cases, we generally begin with a thiazide diuretic agent, such as",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?20/27/20919?source=see_link\">",
"     chlorothiazide",
"    </a>",
"    (oral dose of 20 to 40",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    per day divided into two doses [maximum does of 375 mg], or intravenous dose of 2 to 8",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    per day in two divided doses). We do not use a combination of",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?17/0/17414?source=see_link\">",
"     spironolactone",
"    </a>",
"    with chlorothiazide. In a small controlled trial, 33 infants were randomized to receive chlorothiazide alone or combination therapy with chlorothiazide plus spironolactone for two weeks. Intake of sodium and potassium was similar. Lung mechanics, serum electrolytes, and FiO2 did not differ significantly between the two groups. Intake of sodium and potassium was similar [",
"    <a class=\"abstract\" href=\"UTD.htm?15/24/15753/abstract/13\">",
"     13",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    We reserve a longer course of",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?5/26/5544?source=see_link\">",
"     furosemide",
"    </a>",
"    for ventilator-dependent infants with severe BPD who had a short-term positive response to furosemide during an acute exacerbation, or as a trial in infants who remain unstable after modest fluid restriction and the administration of daily thiazide diuretics. The duration of furosemide therapy is dependent on the individual's response. However, we avoid the chronic use of furosemide, if possible, because of its potential complications of ototoxicity and nephrocalcinosis.",
"   </p>",
"   <p>",
"    In our practice, intermittent or single dosing of",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?5/26/5544?source=see_link\">",
"     furosemide",
"    </a>",
"    (1",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    per dose intravenously or 2",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    per dose orally) is used to treat acute pulmonary exacerbation attributed to pulmonary edema. Furosemide is often given during or following packed red blood cell transfusion.",
"   </p>",
"   <p>",
"    Serum electrolytes should be measured one to two days after initiating diuretic therapy, with an increase in diuretic dosing, and at least weekly with chronic use. Electrolyte supplements should be administered to compensate for increased urinary loss. We usually start with 2 to 4",
"    <span class=\"nowrap\">",
"     mEq/kg",
"    </span>",
"    per day of",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?11/17/11542?source=see_link\">",
"     potassium chloride",
"    </a>",
"    , and adjust as needed.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h1\">",
"     BRONCHODILATORS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Inhaled or subcutaneous administration of beta-2 agonists (eg,",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?38/54/39782?source=see_link\">",
"     albuterol",
"    </a>",
"    or",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?17/52/18245?source=see_link\">",
"     levalbuterol",
"    </a>",
"    ) acutely decreases airway resistance and increases compliance [",
"    <a class=\"abstract\" href=\"UTD.htm?15/24/15753/abstract/12,14,15\">",
"     12,14,15",
"    </a>",
"    ]. Changes in neonatal management (ie, use of surfactant, antenatal glucocorticoid therapy, and less aggressive mechanical ventilation), however, have reduced the risk of airway injury, resulting in fewer clinical episodes of reactive airway disease in infants with BPD and reduced use of beta-2 agonists during the early hospital course.",
"   </p>",
"   <p>",
"    In the one available trial that examined clinical outcomes, inhaled bronchodilators did not affect the course of BPD. In this study, 173 infants born at less than 31 weeks gestation and ventilator-dependent at 10 days of age were randomly assigned to receive treatment for 28 days in one of four groups: placebo and placebo, salbutamol and placebo,",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?34/40/35456?source=see_link\">",
"     beclomethasone",
"    </a>",
"    and placebo, or salbutamol and beclomethasone [",
"    <a class=\"abstract\" href=\"UTD.htm?15/24/15753/abstract/16\">",
"     16",
"    </a>",
"    ]. There were no significant differences among the groups in regards to survival, developing and severity of BPD, or duration of ventilator support or oxygen therapy.",
"   </p>",
"   <p>",
"    These agents also have known adverse effects of tachycardia and hypertension, and possibly arrhythmias. As a result, we do",
"    <strong>",
"     not",
"    </strong>",
"    recommend",
"    <strong>",
"     routine or chronic",
"    </strong>",
"    use of inhaled B2 bronchodilators in infants with BPD because of lack of evidence of long-term efficacy and their known adverse effects.",
"   </p>",
"   <p>",
"    However, in some infants with severe BPD (",
"    <a class=\"graphic graphic_table graphicRef64789 \" href=\"UTD.htm?31/10/31916\">",
"     table 1",
"    </a>",
"    ) especially those who remain ventilator-dependent, acute episodes of bronchoconstriction can occur. In this setting, inhaled beta-2 agonists (eg,",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?38/54/39782?source=see_link\">",
"     albuterol",
"    </a>",
"    or",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?17/52/18245?source=see_link\">",
"     levalbuterol",
"    </a>",
"    ) may improve short-term function [",
"    <a class=\"abstract\" href=\"UTD.htm?15/24/15753/abstract/15,17\">",
"     15,17",
"    </a>",
"    ]. An initial trial of beta-2 agonists is administered through a metered-dose inhaler with a spacer. The infant should be observed for clinical benefit, as evidenced by improved gas exchange (improved SpO2 values",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    decrease in PaCO2), decreased respiratory effort, or fewer episodes of respiratory decompensation. If beneficial, the beta-2 agents can be used up to a 48 hour period, then progressively weaned. If no benefit is seen, treatment should be discontinued. (See",
"    <a class=\"local\" href=\"#H13\">",
"     'Acute exacerbations'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Bronchomalacia with large airway collapse is also seen in infants with BPD, although the reported incidence varies widely [",
"    <a class=\"abstract\" href=\"UTD.htm?15/24/15753/abstract/18\">",
"     18",
"    </a>",
"    ]. It is important to differentiate these episodes of acute airway closure from inflammatory airway edema or true reactive airways, because use of bronchodilators may worsen the airway stability of bronchomalacia. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/27/29114?source=see_link&amp;anchor=H27#H27\">",
"     \"Congenital anomalies of the intrathoracic airways and tracheoesophageal fistula\", section on 'Bronchomalacia'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h1\">",
"     CORTICOSTEROIDS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Corticosteroids may reduce inflammation and improve lung function in infants with evolving or established BPD.",
"   </p>",
"   <p>",
"    Although systemic corticosteroids improve lung mechanics and reduce the need for assisted ventilation infants with established BPD, concerns about long-term neurologic sequelae have led to the recommendations of restrictive use of systemic glucocorticoid therapy in the preterm infant by both the American Academy of Pediatrics and the Canadian Paediatric Society",
"    <span class=\"nowrap\">",
"     (AAP/CPS)",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?15/24/15753/abstract/19\">",
"     19",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In our practice, we follow the recommendation of the",
"    <span class=\"nowrap\">",
"     AAP/CPS",
"    </span>",
"    and do",
"    <strong>",
"     not",
"    </strong>",
"    routinely use systemic",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?34/33/35344?source=see_link\">",
"     dexamethasone",
"    </a>",
"    to treat BPD [",
"    <a class=\"abstract\" href=\"UTD.htm?15/24/15753/abstract/19\">",
"     19",
"    </a>",
"    ]. We reserve this treatment for the exceptional infant with severe BPD who cannot be weaned from maximal ventilatory and oxygen support.",
"   </p>",
"   <p>",
"    It is uncertain whether inhaled glucocorticoid therapy is beneficial in the management of infants with BPD. Currently, we consider the use of inhaled glucocorticoid only in selected infants with severe BPD who are dependent upon substantial pulmonary support (eg, mechanical ventilation and high concentrations of supplemental oxygen).",
"   </p>",
"   <p>",
"    Glucocorticoid therapy and its adverse effects in the treatment of BPD are discussed in greater detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?3/17/3353?source=see_link\">",
"     \"Postnatal use of glucocorticoids in bronchopulmonary dysplasia\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h1\">",
"     ACUTE EXACERBATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Infants with severe BPD may have acute episodes of pulmonary decompensation. These may be associated with infections, severe airway reactivity, pulmonary air leak, increased pulmonary edema, displacement of endotracheal tube in ventilator-dependent patients, or the development of tracheobronchomalacia. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/40/17034?source=see_link&amp;anchor=H20#H20\">",
"     \"Pulmonary outcomes of bronchopulmonary dysplasia\", section on 'Acquired tracheobronchomalacia'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Evaluation",
"    </span>",
"    &nbsp;&mdash;&nbsp;The evaluation of an episode of acute pulmonary deterioration should include the following:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Evidence of recent fluid retention by assessing weight and fluid balance &mdash; A recent weight gain may be evidence of excessive fluid retention that contributes to pulmonary exacerbation.",
"     </li>",
"     <li>",
"      Lung examination &ndash; Auscultation of the lungs should be performed. Episodes of bronchoconstriction may be manifested by wheezing or decrease air movement. Rhonchi or decreased breath sounds are suggested of a consolidated process, such as pneumonia. Rates may indicate pulmonary edema. Absent breath sounds may be due to pneumothorax, or displaced endotracheal tube in ventilator-dependent infants. Evaluation should also include assessing the work of breathing during both inspiration and expiration. If the infant requires ventilatory support, the lung findings should be described as either in the context of ventilator produced breaths versus spontaneous breaths.",
"     </li>",
"     <li>",
"      Chest radiography &ndash; A chest radiograph should be obtained to detect pulmonary parenchymal changes, which may be suggestive of infection or increased pulmonary interstitial fluid, or detect pulmonary air leak or displacement of the endotracheal tube. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?4/33/4631?source=see_link\">",
"       \"Pulmonary air leak in the newborn\"",
"      </a>",
"      .) The chest film should also be evaluated for presence of hyperinflation or collapse, diaphragm position, and any changes in heart size.",
"     </li>",
"     <li>",
"      Evaluation for possible ventilator associated pneumonia &ndash; Although there is a lack of consensus on the definition of ventilator associated pneumonia (VAP) in infants with BPD, acquired pulmonary infection is always a concern in ventilated patients. In our practice, a tracheal aspirate for culture and gram stain should be obtained if secretions have become purulent, changed in volume or quality, or a new consolidated area (suggestive of an infectious process) is detected on chest radiography. If bacterial pneumonia is suspected, blood culture should also be obtained. Rapid tests for viral pathogens may be considered, followed by viral culture, depending on season and possible exposures.",
"     </li>",
"     <li>",
"      Laboratory testing includes:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Complete blood count to detect leukocytosis, which may indicate an infectious process.",
"     </li>",
"     <li>",
"      Capillary or arterial blood gas sample to monitor PCO",
"      <sub>",
"       2",
"      </sub>",
"      and pH levels, and to decide if ventilator changes are required in ventilator-dependent patients, or if intubation and ventilation are required in infants who are not intubated.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Management",
"    </span>",
"    &nbsp;&mdash;&nbsp;Management is directed towards the suspected underlying cause of acute exacerbations.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Infection &ndash; If bacterial infection is suspected, antibiotic treatment should be initiated while awaiting culture results. Clinical findings suggestive of infection include a new localized consolidation on chest radiography or physical examination, leukocytosis, or the presence of fever.",
"     </li>",
"     <li>",
"      Pulmonary air leak &ndash; Management of the various forms of pulmonary air leak in the neonate is discussed separately. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?4/33/4631?source=see_link\">",
"       \"Pulmonary air leak in the newborn\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Displaced endotracheal tube &ndash; The endotracheal tube is correctly repositioned above the carina of the trachea.",
"     </li>",
"     <li>",
"      Airway reactivity &ndash; Episodes of severe airway reactivity in infants with BPD should be treated immediately in a step-wise approach. The goal is to re-establish adequate airflow and ventilation before severe deterioration results in a life-threatening situation. Therapy is initiated with the least toxic measures to limit, as much as possible, adverse effects. Management of acute bronchospasm is based upon guidelines for asthma therapy published by the National Asthma Education and Prevention Program; however, many medications and doses cited do not apply to infants younger than one year of age [",
"      <a class=\"abstract\" href=\"UTD.htm?15/24/15753/abstract/17\">",
"       17",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?32/16/33034?source=see_link\">",
"       \"Acute asthma exacerbations in children: Outpatient management\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    We begin treatment with",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?38/54/39782?source=see_link\">",
"     albuterol",
"    </a>",
"    , administered as one to two puffs (90 microgram per puff) by metered-dose inhaler with a spacer (MDI-S) every four to six hours. If there is severe airway obstruction, albuterol can be initially given as one to two puffs every 20 minutes for three doses. Albuterol therapy is weaned by decreasing the dosing frequency as airflow improves, and is withheld if the heart rate exceeds 200 beats per minute.",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?17/52/18245?source=see_link\">",
"     Levalbuterol",
"    </a>",
"    can be used as an alternative beta-2 agent administered as one to two puffs (45 microgram per puff) though MDI-S.",
"   </p>",
"   <p>",
"    If acute bronchospasm occurs in an infant already receiving inhaled corticosteroids, the dose is doubled for seven days. If treatment with a beta-adrenergic agent and inhaled corticosteroids fails to re-establish stable pulmonary function, we consider a short (7 to 10 days) tapering course of systemic",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?34/28/35264?source=see_link\">",
"     hydrocortisone",
"    </a>",
"    (initial dose 5",
"    <span class=\"nowrap\">",
"     mg/kg).",
"    </span>",
"    However, we try to limit this treatment to ventilator-dependent infants older than term PMA because of concern of adverse effects on long-term developmental outcome. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?3/17/3353?source=see_link&amp;anchor=H3#H3\">",
"     \"Postnatal use of glucocorticoids in bronchopulmonary dysplasia\", section on 'Systemic steroids'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h1\">",
"     MANAGEMENT APPROACH",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although data on efficacy are lacking, comprehensive care is based upon a combination of therapies directed at minimizing further pulmonary injury, including development of pulmonary hypertension, and providing adequate respiratory support and nutrition to maintain adequate growth and prevent long-term neurodevelopmental impairment. The following discussion is based upon our approach to managing infants with BPD, and includes the care and monitoring that is provided during hospitalization and after discharge.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Growth",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients should be weighed every one to three days while in the hospital, and length and head circumference should be measured weekly (",
"    <a class=\"graphic graphic_figure graphicRef70389 \" href=\"UTD.htm?25/54/26471\">",
"     figure 1",
"    </a>",
"    ). Nutritional monitoring includes periodic measurements of blood urea nitrogen, calcium, phosphorus, and alkaline phosphatase concentrations. Serum electrolyte concentrations should be measured periodically in infants on diuretic therapy; once stable, measurements can be obtained less frequently.",
"   </p>",
"   <p>",
"    The nutritional intake is revised based upon the growth of the infants and the results of laboratory evaluation. A dietitian experienced in the management of chronically ill infants should make periodic evaluations of dietary profile and growth parameters.",
"   </p>",
"   <p>",
"    Growth monitoring and nutrition after discharge from the neonatal intensive care unit are discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/22/23912?source=see_link&amp;anchor=H17#H17\">",
"     \"Growth management in preterm infants\", section on 'Bronchopulmonary dysplasia'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Infants with BPD may have oral motor dysfunction and feeding disorders that adversely affect growth, and require specific intervention. The evaluation and management of these patients are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/4/21576?source=see_link\">",
"     \"Sucking and swallowing disorders in the newborn\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Oxygenation",
"    </span>",
"    &nbsp;&mdash;&nbsp;As discussed previously, oxygen saturation based upon pulse oximetry (SpO2) is targeted to avoid both hypoxia and the use of excess oxygen and is discussed separately. (See",
"    <a class=\"local\" href=\"#H4\">",
"     'Oxygen'",
"    </a>",
"    above and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/61/29656?source=see_link&amp;anchor=H18#H18\">",
"     \"Oxygen monitoring and therapy in the newborn\", section on 'Oxygen target levels'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    During hospitalization, oxygen saturation is monitored continuously by pulse oximetry. The oxygen concentration (or flow rate in infants receiving supplemental oxygen by nasal cannula) may need to be increased during feedings and sleep to maintain SpO2 in the targeted range.",
"   </p>",
"   <p>",
"    Discharge criteria for oxygenation include having a stable oxygen requirement with mean pulse oximetry measurements greater than 90 percent without frequent episodes of desaturation. After discharge, oxygen saturation should be measured for at least six to eight hours every one to two weeks in infants. This should include periods when the infant is awake, sleeping, and feeding. Some clinicians use continuous monitoring, especially in infants receiving supplemental oxygen. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/58/21414?source=see_link\">",
"     \"Use of home cardiorespiratory monitors in infants\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/40/17034?source=see_link&amp;anchor=H26#H26\">",
"     \"Pulmonary outcomes of bronchopulmonary dysplasia\", section on 'Oxygen therapy'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Ventilation",
"    </span>",
"    &nbsp;&mdash;&nbsp;In ventilator-dependent infants, acceptable PCO",
"    <sub>",
"     2",
"    </sub>",
"    levels are between 55 and 65 mmHg as long as the pH is in the normal range (ie, 7.30 to 7.40). We initially obtain daily or every other day blood gas samples (usually capillary blood gas) to monitor PCO",
"    <sub>",
"     2",
"    </sub>",
"    and pH. Frequency of sampling decreases as the clinical condition stabilizes with few ventilator changes. Blood gas sample and chest radiograph are obtained to evaluate any episode of respiratory decompensation. (See",
"    <a class=\"local\" href=\"#H13\">",
"     'Acute exacerbations'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Pulmonary artery hypertension",
"    </span>",
"    &nbsp;&mdash;&nbsp;Infants with BPD may develop pulmonary artery hypertension (PAH) due to structural disruption of the pulmonary circulation associated with alveolar injury, regional alveolar hypoxia,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    inadvertent periods of hypoxemia. This condition is associated with high mortality, especially in patients with severe PAH [",
"    <a class=\"abstract\" href=\"UTD.htm?15/24/15753/abstract/20-24\">",
"     20-24",
"    </a>",
"    ]. Although the prevalence of PAH in infants with BPD is unknown, the risk of PAH rises with increased severity of BPD.",
"   </p>",
"   <p>",
"    As a result, we screen infants with severe BPD with an echocardiogram to assess pulmonary artery pressure based upon the following criteria: gestational age less than 32 weeks and one of the following conditions at 36 to 37 weeks PMA:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Dependent upon assisted ventilation",
"     </li>",
"     <li>",
"      Require supplemental oxygen greater than a FiO",
"      <sub>",
"       2",
"      </sub>",
"      of 30 percent to maintain adequate oxygen saturation greater than 92 percent",
"     </li>",
"     <li>",
"      Carbon dioxide tension (PCO",
"      <sub>",
"       2",
"      </sub>",
"      ) greater than 60 mmHg",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Echocardiograms are usually repeated monthly and some infants may require cardiac catheterization.",
"   </p>",
"   <p>",
"    PAH, including its pathogenesis, course, and monitoring in infants with BPD, is discussed separately (see",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/40/17034?source=see_link&amp;anchor=H12#H12\">",
"     \"Pulmonary outcomes of bronchopulmonary dysplasia\", section on 'Pulmonary artery hypertension'",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h2\">",
"     Systemic blood pressure",
"    </span>",
"    &nbsp;&mdash;&nbsp;Systemic hypertension is common in infants with BPD [",
"    <a class=\"abstract\" href=\"UTD.htm?15/24/15753/abstract/25-27\">",
"     25-27",
"    </a>",
"    ]. It is usually a transient finding in the first year of life and lasts approximately four months [",
"    <a class=\"abstract\" href=\"UTD.htm?15/24/15753/abstract/25,28-31\">",
"     25,28-31",
"    </a>",
"    ]. About one-half of patients with BPD will have received medical therapy for blood pressure control.",
"   </p>",
"   <p>",
"    The pathogenesis for hypertension is uncertain and may be caused by increased levels of catecholamines, angiotensin, or antidiuretic hormone, or altered neurohumoral regulation [",
"    <a class=\"abstract\" href=\"UTD.htm?15/24/15753/abstract/32\">",
"     32",
"    </a>",
"    ]. Hypertension is also associated with glucocorticoid treatment.",
"   </p>",
"   <p>",
"    In our practice, blood pressure is monitored at least weekly in infants who remain hospitalized and at each outpatient visit after discharge. If blood pressure is elevated, an evaluation to determine the underlying cause should be performed. Persistent elevations may require treatment. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/60/37833?source=see_link\">",
"     \"Etiology, clinical features, and diagnosis of neonatal hypertension\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h2\">",
"     Development",
"    </span>",
"    &nbsp;&mdash;&nbsp;Neurodevelopmental outcome is worse in infants with BPD than in unaffected infants of similar gestational age and birth weight. Developmental assessment should begin during the infant's hospital stay and continue after the infant is discharged. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/51/25398?source=see_link\">",
"     \"Outcome of infants with bronchopulmonary dysplasia\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/29/11738?source=see_link&amp;anchor=H9#H9\">",
"     \"Care of the neonatal intensive care unit graduate\", section on 'Screening'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h2\">",
"     Vision and hearing",
"    </span>",
"    &nbsp;&mdash;&nbsp;Serial eye examinations are performed in very low birth weight (birth weight less than 1500 g) infants to detect retinopathy of prematurity and other eye disorders. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/29/11738?source=see_link&amp;anchor=H11#H11\">",
"     \"Care of the neonatal intensive care unit graduate\", section on 'Vision'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?10/32/10762?source=see_link&amp;anchor=H18#H18\">",
"     \"Retinopathy of prematurity\", section on 'Screening'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Screening for hearing impairment should be done prior to discharge, or before three months corrected age if still hospitalized, to allow early intervention by an audiologist, if needed. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/13/27865?source=see_link&amp;anchor=H14#H14\">",
"     \"Screening the newborn for hearing loss\", section on 'NICU admissions'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h2\">",
"     Left ventricular hypertrophy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Left ventricular hypertrophy (LVH) is associated with BPD. Although the pathophysiology is unclear, the etiology is likely multifaceted. The LV posterior wall thickness is directly correlated with the severity of BPD [",
"    <a class=\"abstract\" href=\"UTD.htm?15/24/15753/abstract/33\">",
"     33",
"    </a>",
"    ]. LVH may cause an elevation in left atrial (LA) pressure and increase pulmonary congestion and edema, which may impact on pulmonary function [",
"    <a class=\"abstract\" href=\"UTD.htm?15/24/15753/abstract/34\">",
"     34",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    These abnormalities are usually found during screening for PAH and may be associated with systemic hypertension. Patients with persistent LVH or those with signs of LV dysfunction should be evaluated by a pediatric cardiologist.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h1\">",
"     COORDINATION OF CARE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Infants with BPD typically have a prolonged and complicated birth hospitalization, and require considerable supportive management after discharge to home. Optimal patient care is provided by a multidisciplinary team, which is directed by a neonatologist",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    pediatric pulmonologist. Other team members include nurses, respiratory therapists, a social worker, a child life specialist, a nutritionist, physical and occupational therapists, and an audiologist.",
"   </p>",
"   <p>",
"    The team should meet regularly to monitor the patient's clinical course, and review and refine goals. It is important to try to minimize the adverse impact of hospitalization upon infant development. An appropriate environment that minimizes noise, discomfort, and exposure to bright light should be identified for each patient. Primary nursing should be encouraged to allow the infant to be cared for by a small group of individuals. The clinical team should work closely with parents to promote infant-parent bonding, and provide a friendly, play-oriented environment using the infant's own toys and possessions.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h2\">",
"     Discharge planning",
"    </span>",
"    &nbsp;&mdash;&nbsp;The transition from hospital to home requires substantial preparation. In many cases, a step-down unit or rehabilitation facility is an intermediate step before discharge home. Lung function often remains abnormal during the first year and infants require monitoring and supportive care. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/7/27765?source=see_link\">",
"     \"Discharge planning for high-risk newborns\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Some infants continue to require supplemental oxygen after discharge [",
"    <a class=\"abstract\" href=\"UTD.htm?15/24/15753/abstract/35\">",
"     35",
"    </a>",
"    ]. Arrangements should be made for the necessary equipment for home care and nursing support, if needed. Education of the parents about the use of this equipment should begin well before anticipated discharge. In rare cases, infants who remain ventilator-dependent for extended periods are discharged to a continuing care facility or home on mechanical ventilation.",
"   </p>",
"   <p>",
"    Parents should be instructed in the administration of medications and preparation of feedings with nutrient supplements. Parents and other potential caregivers should learn cardiopulmonary resuscitation. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/22/23912?source=see_link&amp;anchor=H17#H17\">",
"     \"Growth management in preterm infants\", section on 'Bronchopulmonary dysplasia'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Severe respiratory failure may occur in patients with BPD who develop infection with respiratory syncytial virus (RSV). Prophylaxis should be provided with",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?40/0/40964?source=see_link\">",
"     palivizumab",
"    </a>",
"    for infants younger than two years of age who have required medical therapy for BPD within six months of the RSV season. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/17/15640?source=see_link&amp;anchor=H104278856#H104278856\">",
"     \"Respiratory syncytial virus infection: Prevention\", section on 'Immunoprophylaxis'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    As is true for all infants discharged from the neonatal intensive care unit (NICU), comprehensive continuity of care that addresses the needs of the NICU graduates and their families is required. The care of the NICU graduate including those with BPD is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/29/11738?source=see_link\">",
"     \"Care of the neonatal intensive care unit graduate\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?31/24/32129?source=see_link\">",
"       \"Patient information: Bronchopulmonary dysplasia (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The management of infants with established bronchopulmonary dysplasia (BPD) includes the following:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In patients who require mechanical ventilation:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      We recommend small tidal volume ventilation to minimize mechanical pulmonary injury (",
"      <a class=\"grade\" href=\"._grade_2?title=Grade 1B\">",
"       Grade 1B",
"      </a>",
"      ). We suggest targeting partial pressure of carbon dioxide (PCO",
"      <sub>",
"       2",
"      </sub>",
"      ) between 55 and 65 mmHg as long as pH remains in the normal range (ie, 7.30 to 7.40) (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      We suggest using a positive end-expiratory pressure (PEEP) between 5 to 7 cm H",
"      <sub>",
"       2",
"      </sub>",
"      O to minimize atelectasis and reduce the risk of pulmonary edema (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Monitoring with blood gases is used to ensure adequate ventilation. (See",
"    <a class=\"local\" href=\"#H2\">",
"     'Respiratory support'",
"    </a>",
"    above and",
"    <a class=\"local\" href=\"#H19\">",
"     'Ventilation'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      We recommend targeting oxygen saturation based upon pulse oximetry (SpO2) and postmenstrual age (PMA) to avoid hypoxemia and exposure to excess oxygen (",
"      <a class=\"grade\" href=\"._grade_2?title=Grade 1B\">",
"       Grade 1B",
"      </a>",
"      ). During hospitalization, oxygen saturation is monitored continuously by pulse oximetry to maintain SpO2 in a targeted range. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Oxygen'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H18\">",
"       'Oxygenation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Nutrition is provided to meet the increased total energy needs of infants with BPD and ensure appropriate growth. Dietary management includes monitoring of growth, and revision of dietary intake based upon growth and laboratory evaluation. We recommend using human milk with added fortifier whenever possible because of the intrinsic benefits of human milk (",
"      <a class=\"grade\" href=\"._grade_2?title=Grade 1B\">",
"       Grade 1B",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Nutrition'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H17\">",
"       'Growth'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?31/47/32505?source=see_link\">",
"       \"Infant benefits of breastfeeding\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      We suggest modest fluid restriction of 140 to 150",
"      <span class=\"nowrap\">",
"       mL/kg",
"      </span>",
"      per day (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Fluid restriction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We suggest",
"      <strong>",
"       NOT",
"      </strong>",
"      using chronic diuretic therapy in all patients with BPD (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). We reserve chronic diuretic therapy for patients who remain ventilator-dependent despite modest fluid restriction. In these patients, we recommend starting with a thiazide rather than a loop diuretic because of the increased risk of complications associated with loop diuretics (",
"      <a class=\"grade\" href=\"._grade_3?title=Grade 1C\">",
"       Grade 1C",
"      </a>",
"      ). We use loop diuretics (eg,",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?5/26/5544?source=see_link\">",
"       furosemide",
"      </a>",
"      ) intermittently in episodes of acute pulmonary decompensation and during blood transfusions, and on a longer term basis in ventilator-dependent patients who fail to respond to fluid restriction and thiazide diuretics. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Diuretics'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We recommend",
"      <strong>",
"       NOT",
"      </strong>",
"      using routine administration of bronchodilators (",
"      <a class=\"grade\" href=\"._grade_2?title=Grade 1B\">",
"       Grade 1B",
"      </a>",
"      ). Bronchodilators are reserved for episodes of acute pulmonary decompensation due to severe airway reactivity. (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Bronchodilators'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H13\">",
"       'Acute exacerbations'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We recommend",
"      <strong>",
"       NOT",
"      </strong>",
"      using routine systemic glucocorticoid therapy (",
"      <a class=\"grade\" href=\"._grade_2?title=Grade 1B\">",
"       Grade 1B",
"      </a>",
"      ). We reserve this treatment for the exceptional infant with severe BPD who cannot be weaned from maximal ventilatory and oxygen support. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?3/17/3353?source=see_link&amp;anchor=H3#H3\">",
"       \"Postnatal use of glucocorticoids in bronchopulmonary dysplasia\", section on 'Systemic steroids'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Current studies provide little evidence of benefit of inhaled glucocorticoids for infants with established BPD. Currently, we use this as short-term therapy only in ventilator-dependent patients who require high oxygen and have signs of airway obstruction or reactive airway disease. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?3/17/3353?source=see_link&amp;anchor=H15#H15\">",
"       \"Postnatal use of glucocorticoids in bronchopulmonary dysplasia\", section on 'Our approach to inhaled steroids'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Infants with BPD may have acute episodes of pulmonary decompensation due to infections, severe airway reactivity, pulmonary air leak, pulmonary edema, or displacement of endotracheal tube in ventilator-dependent patients. Management of these exacerbations is dependent upon the underlying etiology. (See",
"      <a class=\"local\" href=\"#H13\">",
"       'Acute exacerbations'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Assessing for complications of BPD includes monitoring for pulmonary artery hypertension, systemic hypertension, left ventricular hypertrophy, and neurodevelopmental, visual, and hearing impairment. (See",
"      <a class=\"local\" href=\"#H16\">",
"       'Management approach'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Optimal patient care for infants with BPD is provided by a multidisciplinary team to ensure coordination of care, an environment that fosters patient comfort and parental bonding, and facilitates discharge planning. (See",
"      <a class=\"local\" href=\"#H25\">",
"       'Coordination of care'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/24/15753/abstract/1\">",
"      Halliday HL, Dumpit FM, Brady JP. Effects of inspired oxygen on echocardiographic assessment of pulmonary vascular resistance and myocardial contractility in bronchopulmonary dysplasia. Pediatrics 1980; 65:536.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/24/15753/abstract/2\">",
"      Abman SH, Wolfe RR, Accurso FJ, et al. Pulmonary vascular response to oxygen in infants with severe bronchopulmonary dysplasia. Pediatrics 1985; 75:80.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/24/15753/abstract/3\">",
"      Tay-Uyboco JS, Kwiatkowski K, Cates DB, et al. Hypoxic airway constriction in infants of very low birth weight recovering from moderate to severe bronchopulmonary dysplasia. J Pediatr 1989; 115:456.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/24/15753/abstract/4\">",
"      Teague WG, Pian MS, Heldt GP, Tooley WH. An acute reduction in the fraction of inspired oxygen increases airway constriction in infants with chronic lung disease. Am Rev Respir Dis 1988; 137:861.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/24/15753/abstract/5\">",
"      Brown ER, Stark A, Sosenko I, et al. Bronchopulmonary dysplasia: possible relationship to pulmonary edema. J Pediatr 1978; 92:982.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/24/15753/abstract/6\">",
"      Bell EF, Acarregui MJ. Restricted versus liberal water intake for preventing morbidity and mortality in preterm infants. Cochrane Database Syst Rev 2008; :CD000503.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/24/15753/abstract/7\">",
"      Puangco MA, Schanler RJ. Clinical experience in enteral nutrition support for premature infants with bronchopulmonary dysplasia. J Perinatol 2000; 20:87.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/24/15753/abstract/8\">",
"      Stewart AL, Brion LP. Routine use of diuretics in very-low birth-weight infants in the absence of supporting evidence. J Perinatol 2011; 31:633.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/24/15753/abstract/9\">",
"      Brion LP, Primhak RA, Ambrosio-Perez I. Diuretics acting on the distal renal tubule for preterm infants with (or developing) chronic lung disease. Cochrane Database Syst Rev 2002; :CD001817.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/24/15753/abstract/10\">",
"      Brion LP, Primhak RA. Intravenous or enteral loop diuretics for preterm infants with (or developing) chronic lung disease. Cochrane Database Syst Rev 2002; :CD001453.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/24/15753/abstract/11\">",
"      Pope JC 4th, Trusler LA, Klein AM, et al. The natural history of nephrocalcinosis in premature infants treated with loop diuretics. J Urol 1996; 156:709.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/24/15753/abstract/12\">",
"      Hufnagle KG, Khan SN, Penn D, et al. Renal calcifications: a complication of long-term furosemide therapy in preterm infants. Pediatrics 1982; 70:360.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/24/15753/abstract/13\">",
"      Hoffman DJ, Gerdes JS, Abbasi S. Pulmonary function and electrolyte balance following spironolactone treatment in preterm infants with chronic lung disease: a double-blind, placebo-controlled, randomized trial. J Perinatol 2000; 20:41.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/24/15753/abstract/14\">",
"      Wilkie RA, Bryan MH. Effect of bronchodilators on airway resistance in ventilator-dependent neonates with chronic lung disease. J Pediatr 1987; 111:278.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/24/15753/abstract/15\">",
"      Sosulski R, Abbasi S, Bhutani VK, Fox WW. Physiologic effects of terbutaline on pulmonary function of infants with bronchopulmonary dysplasia. Pediatr Pulmonol 1986; 2:269.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/24/15753/abstract/16\">",
"      Denjean A, Paris-Llado J, Zupan V, et al. Inhaled salbutamol and beclomethasone for preventing broncho-pulmonary dysplasia: a randomised double-blind study. Eur J Pediatr 1998; 157:926.",
"     </a>",
"    </li>",
"    <li>",
"     National Asthma Education and Prevention Program: Expert panel report III: Guidelines for the diagnosis and management of asthma. Bethesda, MD: National Heart, Lung, and Blood Institute, 2007. (NIH publication no. 08-4051). www.nhlbi.nih.gov/guidelines/asthma/asthgdln.htm (Accessed on February 24, 2010).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/24/15753/abstract/18\">",
"      Doull IJ, Mok Q, Tasker RC. Tracheobronchomalacia in preterm infants with chronic lung disease. Arch Dis Child Fetal Neonatal Ed 1997; 76:F203.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/24/15753/abstract/19\">",
"      Committee on Fetus and Newborn. Postnatal corticosteroids to treat or prevent chronic lung disease in preterm infants. Pediatrics 2002; 109:330.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/24/15753/abstract/20\">",
"      Fouron JC, Le Guennec JC, Villemant D, et al. Value of echocardiography in assessing the outcome of bronchopulmonary dysplasia of the newborn. Pediatrics 1980; 65:529.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/24/15753/abstract/21\">",
"      Halliday H, Hirschfeld S, Riggs T, et al. Respiratory distress syndrome: echocardiographic assessment of cardiovascular function and pulmonary vascular resistance. Pediatrics 1977; 60:444.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/24/15753/abstract/22\">",
"      Goodman G, Perkin RM, Anas NG, et al. Pulmonary hypertension in infants with bronchopulmonary dysplasia. J Pediatr 1988; 112:67.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/24/15753/abstract/23\">",
"      Khemani E, McElhinney DB, Rhein L, et al. Pulmonary artery hypertension in formerly premature infants with bronchopulmonary dysplasia: clinical features and outcomes in the surfactant era. Pediatrics 2007; 120:1260.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/24/15753/abstract/24\">",
"      Slaughter JL, Pakrashi T, Jones DE, et al. Echocardiographic detection of pulmonary hypertension in extremely low birth weight infants with bronchopulmonary dysplasia requiring prolonged positive pressure ventilation. J Perinatol 2011; 31:635.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/24/15753/abstract/25\">",
"      Alagappan A, Malloy MH. Systemic hypertension in very low-birth weight infants with bronchopulmonary dysplasia: incidence and risk factors. Am J Perinatol 1998; 15:3.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/24/15753/abstract/26\">",
"      Anderson AH, Warady BA, Daily DK, et al. Systemic hypertension in infants with severe bronchopulmonary dysplasia: associated clinical factors. Am J Perinatol 1993; 10:190.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/24/15753/abstract/27\">",
"      Abman SH, Warady BA, Lum GM, Koops BL. Systemic hypertension in infants with bronchopulmonary dysplasia. J Pediatr 1984; 104:928.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/24/15753/abstract/28\">",
"      Tomashefski JF Jr, Oppermann HC, Vawter GF, Reid LM. Bronchopulmonary dysplasia: a morphometric study with emphasis on the pulmonary vasculature. Pediatr Pathol 1984; 2:469.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/24/15753/abstract/29\">",
"      Abman SH, Groothius JR. Pathophysiology and treatment of bronchopulmonary dysplasia. Current issues. Pediatr Clin North Am 1994; 41:277.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/24/15753/abstract/30\">",
"      Abman SH, Schaffer MS, Wiggins J, et al. Pulmonary vascular extraction of circulating norepinephrine in infants with bronchopulmonary dysplasia. Pediatr Pulmonol 1987; 3:386.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/24/15753/abstract/31\">",
"      Brownlee JR, Beekman RH, Rosenthal A. Acute hemodynamic effects of nifedipine in infants with bronchopulmonary dysplasia and pulmonary hypertension. Pediatr Res 1988; 24:186.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/24/15753/abstract/32\">",
"      Abman SH. Monitoring cardiovascular function in infants with chronic lung disease of prematurity. Arch Dis Child Fetal Neonatal Ed 2002; 87:F15.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/24/15753/abstract/33\">",
"      Shekhawat PS, Fong LV, Mitvalsky J, Yu VY. Spectrum of clinical and cardiac dysfunction in bronchopulmonary dysplasia: early prediction of long-term morbidity. J Perinatol 1997; 17:95.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/24/15753/abstract/34\">",
"      Malnick G, Pickoff AS, Ferrer PL, et al. Normal pulmonary vascular resistance and left ventricular hypertrophy in young infants with bronchopulmonary dysplasia: an echocardiographic and pathologic study. Pediatrics 1980; 66:589.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/24/15753/abstract/35\">",
"      Balfour-Lynn IM, Field DJ, Gringras P, et al. BTS guidelines for home oxygen in children. Thorax 2009; 64 Suppl 2:ii1.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 4977 Version 17.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0605-2.133.93.82-3DA446CC7F-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f15_24_15753=[""].join("\n");
var outline_f15_24_15753=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H27\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      RESPIRATORY SUPPORT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Mechanical ventilation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Oxygen",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      NUTRITION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      FLUID RESTRICTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      DIURETICS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Agents",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Complications",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Our approach",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      BRONCHODILATORS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      CORTICOSTEROIDS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      ACUTE EXACERBATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Evaluation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Management",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      MANAGEMENT APPROACH",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Growth",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Oxygenation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Ventilation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Pulmonary artery hypertension",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      Systemic blood pressure",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      Development",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      Vision and hearing",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      Left ventricular hypertrophy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      COORDINATION OF CARE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      Discharge planning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H27\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PEDS/4977\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/4977|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?25/54/26471\" title=\"figure 1\">",
"      Fenton growth chart premature infants",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/4977|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?31/10/31916\" title=\"table 1\">",
"      Definition of BPD",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/16/33034?source=related_link\">",
"      Acute asthma exacerbations in children: Outpatient management",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?11/29/11738?source=related_link\">",
"      Care of the neonatal intensive care unit graduate",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/27/29114?source=related_link\">",
"      Congenital anomalies of the intrathoracic airways and tracheoesophageal fistula",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/7/27765?source=related_link\">",
"      Discharge planning for high-risk newborns",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/60/37833?source=related_link\">",
"      Etiology, clinical features, and diagnosis of neonatal hypertension",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/22/23912?source=related_link\">",
"      Growth management in preterm infants",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/6/23655?source=related_link\">",
"      Human milk feeding and fortification of human milk for premature infants",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/47/32505?source=related_link\">",
"      Infant benefits of breastfeeding",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/47/26356?source=related_link\">",
"      Nephrocalcinosis in neonates",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/51/25398?source=related_link\">",
"      Outcome of infants with bronchopulmonary dysplasia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/61/29656?source=related_link\">",
"      Oxygen monitoring and therapy in the newborn",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/22/18793?source=related_link\">",
"      Pathogenesis and clinical features of bronchopulmonary dysplasia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?31/24/32129?source=related_link\">",
"      Patient information: Bronchopulmonary dysplasia (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?3/17/3353?source=related_link\">",
"      Postnatal use of glucocorticoids in bronchopulmonary dysplasia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/14/27880?source=related_link\">",
"      Prevention of bronchopulmonary dysplasia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/33/4631?source=related_link\">",
"      Pulmonary air leak in the newborn",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/40/17034?source=related_link\">",
"      Pulmonary outcomes of bronchopulmonary dysplasia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/17/15640?source=related_link\">",
"      Respiratory syncytial virus infection: Prevention",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?10/32/10762?source=related_link\">",
"      Retinopathy of prematurity",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/13/27865?source=related_link\">",
"      Screening the newborn for hearing loss",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/4/21576?source=related_link\">",
"      Sucking and swallowing disorders in the newborn",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/58/21414?source=related_link\">",
"      Use of home cardiorespiratory monitors in infants",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f15_24_15754="Cystic fibrosis: Nutritional issues";
var content_f15_24_15754=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"6\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Cystic fibrosis: Nutritional issues",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?15/24/15754/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?15/24/15754/contributors\">",
"     Robert D Baker, MD, PhD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?15/24/15754/contributors\">",
"     Chris Coburn-Miller, MSRD, CSP",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?15/24/15754/contributors\">",
"     Susan S Baker, MD, PhD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?15/24/15754/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?15/24/15754/contributors\">",
"     Kathleen J Motil, MD, PhD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?15/24/15754/contributors\">",
"     George B Mallory, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?15/24/15754/contributors\">",
"     William J Klish, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?15/24/15754/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?15/24/15754/contributors\">",
"     Alison G Hoppin, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?15/24/15754/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Oct 24, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Children and adolescents with cystic fibrosis (CF) frequently have growth failure, caused by the combination of malabsorption, increased energy needs, and reduced appetite. Nutrient delivery and correction of maldigestion and malabsorption are essential to achieve normal growth to support optimal pulmonary function and to prolong life.",
"   </p>",
"   <p>",
"    The CF Foundation (CFF) patient registry has documented substantial improvement in life expectancy of patients with CF (",
"    <a class=\"graphic graphic_figure graphicRef61930 \" href=\"UTD.htm?25/23/25981\">",
"     figure 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?15/24/15754/abstract/1\">",
"     1",
"    </a>",
"    ]. To a large degree, the longer life achieved by patients with CF can be ascribed to improved treatment of lung disease, pulmonary toilet, potent and tailored antibiotics, DNAse, and lung transplantation. However, greater emphasis on CF nutrition is considered important to improve longevity and quality of life. As a result, the CFF created a consensus report on nutrition in pediatric CF [",
"    <a class=\"abstract\" href=\"UTD.htm?15/24/15754/abstract/2\">",
"     2",
"    </a>",
"    ], and a more theoretic report on gastrointestinal outcomes and confounders in CF [",
"    <a class=\"abstract\" href=\"UTD.htm?15/24/15754/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The evaluation, monitoring, and treatment of nutritional problems will be addressed here. The diagnosis and management of CF-related pancreatic insufficiency, and screening for CF related comorbidities that affect nutritional status will also be discussed briefly here and in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/26/29095?source=see_link\">",
"     \"Cystic fibrosis: Assessment and management of pancreatic insufficiency\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/15/19706?source=see_link\">",
"     \"Cystic fibrosis: Overview of gastrointestinal disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     PATHOPHYSIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;CF is caused by a defect in the cystic fibrosis transmembrane conductance regulator (CFTR), a cell membrane protein that forms a chloride channel and that regulates chloride and water flux [",
"    <a class=\"abstract\" href=\"UTD.htm?15/24/15754/abstract/4\">",
"     4",
"    </a>",
"    ]. The spectrum of CF disease varies according to the genotype and with individual and environmental factors. The nutritional risks and requirements for a patient with CF also vary along this disease spectrum but do not precisely coincide with the severity of pulmonary disease.",
"   </p>",
"   <p>",
"    Insufficient production of pancreatic enzymes (pancreatic insufficiency) causes malabsorption of fat, protein, and several micronutrients including the vitamins A, D, E, and K. Malabsorption of fat is exacerbated by bile salt abnormalities if there is concurrent liver disease. Pancreatic function tends to worsen with age. Across all age groups, about 90 percent of patients with CF have marked pancreatic insufficiency. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/26/29095?source=see_link\">",
"     \"Cystic fibrosis: Assessment and management of pancreatic insufficiency\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Although pancreatic dysfunction is the major gastrointestinal contributor to malnutrition in CF, several other factors may contribute to the problem. These include CF-related liver disease, bile salt abnormalities, CF-related diabetes mellitus, altered gastrointestinal motility, and small bowel bacterial overgrowth. Gastroesophageal reflux, distal intestinal obstructive syndrome, and constipation can also negatively affect nutrition. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/15/19706?source=see_link\">",
"     \"Cystic fibrosis: Overview of gastrointestinal disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In addition to malabsorption and gastrointestinal dysfunction, two other mechanisms contribute to nutritional deficiencies and growth failure in patients with CF: chronic, progressive pulmonary infection with bronchiectasis leads to increased work of breathing and higher than expected nutrient needs [",
"    <a class=\"abstract\" href=\"UTD.htm?15/24/15754/abstract/5\">",
"     5",
"    </a>",
"    ], and chronic infection may reduce appetite and cause cytokine-induced catabolism [",
"    <a class=\"abstract\" href=\"UTD.htm?15/24/15754/abstract/6\">",
"     6",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     PANCREATIC INSUFFICIENCY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pancreatic insufficiency is a major contributor to nutritional problems in patients with CF. The diagnosis and management of pancreatic insufficiency in this population, including strategies for pancreatic enzyme replacement, are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/26/29095?source=see_link\">",
"     \"Cystic fibrosis: Assessment and management of pancreatic insufficiency\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The nutritional problems that may be caused by pancreatic insufficiency, including growth failure, fat-soluble vitamin deficiencies, and bone disease, are addressed below.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     ASSESSING AND MONITORING NUTRITION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The most effective way to maintain good nutrition status in CF, as in other chronic diseases, is to prevent suboptimal nutrition from occurring.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Growth",
"    </span>",
"    &nbsp;&mdash;&nbsp;The nutritional status of individuals with CF tends to decline during childhood. Data from the Cystic fibrosis Foundation (CFF) shows that the body mass index (BMI) percentile typically begins to decline at about five years of age but does not cross the 50th percentile (defined as \"below BMI goal\") until about nine years of age (",
"    <a class=\"graphic graphic_figure graphicRef85551 \" href=\"UTD.htm?15/13/15582\">",
"     figure 2",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?15/24/15754/abstract/1,2\">",
"     1,2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Careful and repeated nutritional assessments allow for early detection of nutritional deterioration. The CFF recommends that children with CF be seen at three monthly intervals. A thorough dietary history and measurements of height and weight should be performed at each visit. Additional measures are tracked according to a schedule for nutrition assessment (",
"    <a class=\"graphic graphic_table graphicRef76676 \" href=\"UTD.htm?24/26/25005\">",
"     table 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Each patient's height, weight, and BMI should be tracked against standard curves provided by the Center for Disease Control and Prevention (",
"    <a class=\"external\" href=\"file://www.cdc.gov/growthcharts\">",
"     file://www.cdc.gov/growthcharts",
"    </a>",
"    ). For children under two years of age, recumbent length is tracked rather than height, and",
"    <span class=\"nowrap\">",
"     weight/length",
"    </span>",
"    is used instead of BMI. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/14/31976?source=see_link&amp;anchor=H3#H3\">",
"     \"Measurement of growth in children\", section on 'CDC growth reference'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    For children with CF, the BMI target range is above the 50th percentile [",
"    <a class=\"abstract\" href=\"UTD.htm?15/24/15754/abstract/1,7\">",
"     1,7",
"    </a>",
"    ]. Children with BMIs between the 10th and 50th percentiles are generally considered at nutritional risk, and those with BMIs below the 10th percentile are in need of nutritional rehabilitation, although we would not intervene for children in the upper end of this range. Children with BMIs above the 85th percentile are considered overweight [",
"    <a class=\"abstract\" href=\"UTD.htm?15/24/15754/abstract/8\">",
"     8",
"    </a>",
"    ]. There are rare CF patients who are overweight and even obese [",
"    <a class=\"abstract\" href=\"UTD.htm?15/24/15754/abstract/8\">",
"     8",
"    </a>",
"    ]. For children younger than two years of age, the same percentile criteria are applied to weight-for-height rather than BMI. For adults with CF, the target is a BMI at or above 22 for women, and 23 for men [",
"    <a class=\"abstract\" href=\"UTD.htm?15/24/15754/abstract/7\">",
"     7",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Another important indicator of nutritional sufficiency is the achievement of full genetic potential for height. This can be estimated by a variety of methods, one of which is the mid-parental target height prediction (",
"    <a class=\"calc calc_professional\" href=\"UTD.htm?30/3/30769?source=see_link\">",
"     calculator 1",
"    </a>",
"    ). This and other methods for calculating height potential are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/60/18376?source=see_link&amp;anchor=H4#H4\">",
"     \"Diagnostic approach to short stature\", section on 'Prediction of height potential'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Anticipatory guidance to optimize nutrition should be provided to all children with CF. Those who do not meet target goals for BMI, whose linear growth is less than expected for their genetic potential, or whose growth rates begin to plateau require additional attention. These patients should be given intensive counseling to optimize nutrition. They should also be further evaluated to identify reasons for nutritional deficits and potential contributors to malnutrition, including inadequate pancreatic enzyme replacement therapy and small bowel bacterial overgrowth. (See",
"    <a class=\"local\" href=\"#H2\">",
"     'Pathophysiology'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    As soon as a decline in growth parameters is documented, intervention should begin. (See",
"    <a class=\"local\" href=\"#H23\">",
"     'Nutrition support'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Blood tests",
"    </span>",
"    &nbsp;&mdash;&nbsp;Several laboratory tests are recommended as part of the evaluation for nutritional status. The CFF has developed a panel of recommended tests and testing intervals (",
"    <a class=\"graphic graphic_table graphicRef56711 \" href=\"UTD.htm?27/43/28349\">",
"     table 2",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?15/24/15754/abstract/2,9\">",
"     2,9",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Evaluation for comorbidities",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h3\">",
"     Bone disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;Bone disease, characterized by decreased mineral density, increased fracture rates, and kyphosis, is common in patients with cystic fibrosis, even among those with pancreatic sufficiency [",
"    <a class=\"abstract\" href=\"UTD.htm?15/24/15754/abstract/10,11\">",
"     10,11",
"    </a>",
"    ]. Sixty percent of young adults have a kyphosis angle of &gt;40 degrees, contributing to height loss (mean 5.9 cm), chest wall deformities, and reduced lung function [",
"    <a class=\"abstract\" href=\"UTD.htm?15/24/15754/abstract/12\">",
"     12",
"    </a>",
"    ]. Children and adolescents with CF also have higher than expected rates of fractures [",
"    <a class=\"abstract\" href=\"UTD.htm?15/24/15754/abstract/13\">",
"     13",
"    </a>",
"    ]. In a meta-analysis of studies of adults with CF (median age 28 years), the pooled prevalence of vertebral and non-vertebral fractures were 14 percent and 20 percent, respectively [",
"    <a class=\"abstract\" href=\"UTD.htm?15/24/15754/abstract/14\">",
"     14",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Patients with CF have the following multiple risk factors for developing bone disease [",
"    <a class=\"abstract\" href=\"UTD.htm?15/24/15754/abstract/15\">",
"     15",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Failure to thrive",
"     </li>",
"     <li>",
"      Delayed pubertal development",
"     </li>",
"     <li>",
"      Malabsorption of calcium, magnesium, vitamin D, and vitamin K",
"     </li>",
"     <li>",
"      Hepatobiliary disease",
"     </li>",
"     <li>",
"      Reduced weight-bearing activity",
"     </li>",
"     <li>",
"      Chronic corticosteroid use",
"     </li>",
"     <li>",
"      Inadequate intake of nutrients",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The risk for bone disease increases with advancing age and severity of lung disease and malnutrition. As an example, the average bone density of adults with severe CF-related pulmonary disease is more than 2 SD below the expected value, and vertebral compression and other pathological fractures are common [",
"    <a class=\"abstract\" href=\"UTD.htm?15/24/15754/abstract/12\">",
"     12",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    To monitor for bone health, children with CF should have yearly determination of calcium, phosphorus, intact parathyroid hormone, and 25 hydroxyvitamin D levels (",
"    <a class=\"graphic graphic_table graphicRef56711 \" href=\"UTD.htm?27/43/28349\">",
"     table 2",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?15/24/15754/abstract/11\">",
"     11",
"    </a>",
"    ]. In addition, children older than eight years should have an evaluation of bone density using dual-energy X-ray absorptiometry (DXA) if risk factors are present (eg, BMI &lt;10",
"    <sup>",
"     th",
"    </sup>",
"    percentile for age, FEV1 &lt;50 percent predicted, glucocorticoid use of &ge;5 mg daily for &ge;90",
"    <span class=\"nowrap\">",
"     days/year,",
"    </span>",
"    delayed puberty, or a history of fractures).",
"   </p>",
"   <p>",
"    DXA scanning is now widely available. Standards have been developed for the pediatric age group, and the findings are expressed as Z-scores to reflect age-specific standards (rather than T-scores as in adults). However, interpretation remains problematic, and requires adjustment for bone size and pubertal status; the unadjusted DXA Z-score for age and gender may systematically underestimate bone density in shorter patients [",
"    <a class=\"abstract\" href=\"UTD.htm?15/24/15754/abstract/16\">",
"     16",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/37/42583?source=see_link&amp;anchor=H14#H14\">",
"     \"Overview of dual-energy x-ray absorptiometry\", section on 'Children'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    All individuals with CF should be counseled to ensure that intake of the recommended amounts of calcium, phosphorus, vitamin K, and vitamin D is achieved to support bone health (",
"    <a class=\"graphic graphic_table graphicRef82276 \" href=\"UTD.htm?43/5/44124\">",
"     table 3",
"    </a>",
"    and",
"    <a class=\"graphic graphic_table graphicRef85553 \" href=\"UTD.htm?36/10/37036\">",
"     table 4",
"    </a>",
"    ). Weightbearing exercise should be encouraged and low levels of vitamin D or vitamin K should be treated aggressively. (See",
"    <a class=\"local\" href=\"#H16\">",
"     'Vitamin D'",
"    </a>",
"    below and",
"    <a class=\"local\" href=\"#H18\">",
"     'Vitamin K'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    In our practice, we take the following additional measures depending on the results of the DXA scanning:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      If the DXA scan shows bone density within a healthy range (Z-score &ge;-1), we repeat the DXA scan every two years in growing children. The interval could be increased to every five years for adults with initial results in a healthy range [",
"      <a class=\"abstract\" href=\"UTD.htm?15/24/15754/abstract/11\">",
"       11",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      If the DXA scan shows borderline bone mineral density (Z-score -1 to -2), additional measures are taken to diagnose and treat any endocrine contributors to the bone disease (CF related diabetes, hypogonadism) and to minimize use of glucocorticoid medications. Additional low-impact, weight-bearing exercise is encouraged. Patients receive supplemental calcium, phosphorus and vitamin D (",
"      <a class=\"graphic graphic_table graphicRef82276 \" href=\"UTD.htm?43/5/44124\">",
"       table 3",
"      </a>",
"      and",
"      <a class=\"graphic graphic_table graphicRef85553 \" href=\"UTD.htm?36/10/37036\">",
"       table 4",
"      </a>",
"      ). DXA scans are repeated annually in growing children, and every two to four years in adults.",
"     </li>",
"     <li>",
"      If the DXA scan shows markedly decreased bone mineral density (Z-score &le;-2), vitamin D, phosphorus, and calcium status are reviewed and vigorously replaced, in addition to the other measures described above. DXA scans are repeated annually until normalized.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Some groups have suggested that bisphosphonate treatment be considered for CF patients with markedly decreased bone mineral density [",
"    <a class=\"abstract\" href=\"UTD.htm?15/24/15754/abstract/11\">",
"     11",
"    </a>",
"    ]. Bisphosphonates are essentially anti-reabsorptive agents. Although the exact mechanism of low bone density in CF is not known, in growing children with CF the problem may be decreased bone formation rather than increased reabsorption. Giving bisphosphonates in this setting would lead to slow bone turnover. Moreover, there are increasing concerns about the use of bisphosphonates in children, because these agents form bone with abnormal characteristics, have extremely long half-lives, and the long-term risks and benefits have not been fully explored [",
"    <a class=\"abstract\" href=\"UTD.htm?15/24/15754/abstract/17\">",
"     17",
"    </a>",
"    ]. For these reasons, we do not use bisphosphonates for children or adolescents in our practice.",
"   </p>",
"   <p>",
"    There is some evidence to support the use of bisphosphonates in adult patients with CF and bone disease. In a systematic review that included 237 adult subjects, oral and intravenous bisphosphonate treatment improved bone mineral density by 5 to 8 percent at several sites over 24 months of therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?15/24/15754/abstract/18\">",
"     18",
"    </a>",
"    ]. However, fracture rates were not different between treated and untreated individuals. Intravenous administration of bisphosphonates was associated with severe bone pain and flu-like symptoms. Larger trials will be needed to determine if there are effects on fracture rates.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h3\">",
"     Pulmonary function testing",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pulmonary function testing (PFT) is not a measure of nutritional status, but there is a close correlation between PFT results and nutritional status (",
"    <a class=\"graphic graphic_figure graphicRef85552 \" href=\"UTD.htm?15/15/15614\">",
"     figure 3",
"    </a>",
"    ). It is unclear whether worsening lung function causes nutritional deterioration (by decreasing intake or by increasing requirements) or whether deteriorating nutritional status causes poor performance on PFT testing (by weakening respiratory musculature or other mechanisms) [",
"    <a class=\"abstract\" href=\"UTD.htm?15/24/15754/abstract/19-21\">",
"     19-21",
"    </a>",
"    ]. In either case, the two are so closely linked that any child with worsening PFTs should be carefully evaluated for nutritional inadequacies.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h3\">",
"     CF-related diabetes mellitus",
"    </span>",
"    &nbsp;&mdash;&nbsp;Many patients with CF develop CF-related diabetes (CFRD); the risk increases with age and varies with CF genotype and severity. CFRD is associated with clinical deterioration, including poor growth, deterioration of nutritional status, worsening lung function, and early death [",
"    <a class=\"abstract\" href=\"UTD.htm?15/24/15754/abstract/22\">",
"     22",
"    </a>",
"    ]. However, deterioration of nutritional status is not inevitable [",
"    <a class=\"abstract\" href=\"UTD.htm?15/24/15754/abstract/23\">",
"     23",
"    </a>",
"    ]. The prevalence and risk factors for CFRD are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/15/19706?source=see_link&amp;anchor=H22#H22\">",
"     \"Cystic fibrosis: Overview of gastrointestinal disease\", section on 'CF-related diabetes'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The CFF and American Diabetes Association recommend annual screening for CFRD beginning at age 10 years, carried out at a time of clinical stability [",
"    <a class=\"abstract\" href=\"UTD.htm?15/24/15754/abstract/24\">",
"     24",
"    </a>",
"    ]. An oral glucose tolerance test (OGTT) should be used for screening because either fasting plasma glucose or hemoglobin A1C has low sensitivity in this patient group. Recommendations from the UK Cystic Fibrosis Trust are similar, except that routine screening begins at 12 years of age [",
"    <a class=\"abstract\" href=\"UTD.htm?15/24/15754/abstract/25\">",
"     25",
"    </a>",
"    ]. In addition, patients with an acute pulmonary exacerbation requiring intravenous antibiotics",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    systemic glucocorticoids should be screened for CFRD by measuring fasting and 2 hour postprandial blood glucose levels for the first 48 hours of treatment [",
"    <a class=\"abstract\" href=\"UTD.htm?15/24/15754/abstract/24\">",
"     24",
"    </a>",
"    ]. Women with CF who are pregnant or patients undergoing transplantation should have additional screening for CFRD.",
"   </p>",
"   <p>",
"    OGTT results are interpreted as for non-CF related diabetes (two-hour plasma glucose 140 to 200",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    constitutes impaired glucose tolerance; &gt;200",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    constitutes diabetes mellitus). Patients with abnormal results of the OGTT should have confirmatory testing on a different day. Hemoglobin A1C &ge;6.5 percent or fasting plasma glucose &ge;126",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    can be used as a confirmatory test, but if these are normal the OGTT should be repeated [",
"    <a class=\"abstract\" href=\"UTD.htm?15/24/15754/abstract/24\">",
"     24",
"    </a>",
"    ]. In patients with an acute pulmonary exacerbation, the diagnosis of CFRD is made if fasting plasma glucose levels are &ge;126 or if two hour postprandial glucose levels are &ge;200",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    for more than 48 hours.",
"   </p>",
"   <p>",
"    Continuous glucose monitoring is a new technique that might be more sensitive than OGTT for detecting abnormal hyperglycemia. However, this technique requires a sophisticated device and is probably not practical for routine clinical screening [",
"    <a class=\"abstract\" href=\"UTD.htm?15/24/15754/abstract/26,27\">",
"     26,27",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/60/29641?source=see_link&amp;anchor=H13#H13\">",
"     \"Blood glucose self-monitoring in management of adults with diabetes mellitus\", section on 'Continuous glucose monitoring'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h3\">",
"     Small intestine bacterial overgrowth",
"    </span>",
"    &nbsp;&mdash;&nbsp;Individuals with CF may be susceptible to small intestine bacterial overgrowth (SIBO), primarily because of decreased intestinal motility. The disorder can contribute to malnutrition by decreasing appetite, and by interfering with fat absorption. SIBO should be considered in patients with suggestive clinical symptoms",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    deterioration in nutritional status. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/15/19706?source=see_link&amp;anchor=H17#H17\">",
"     \"Cystic fibrosis: Overview of gastrointestinal disease\", section on 'Small intestine bacterial overgrowth'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h1\">",
"     NUTRIENT DEFICITS AND GOALS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Calories",
"    </span>",
"    &nbsp;&mdash;&nbsp;In the past, the caloric requirement of a CF patient was estimated to be 130 percent of recommended dietary allowance (RDA) for calories [",
"    <a class=\"abstract\" href=\"UTD.htm?15/24/15754/abstract/28\">",
"     28",
"    </a>",
"    ]. This is now considered an unwarranted simplification. A number of recent studies used open and closed indirect calorimetry and doubly-labeled water to determine energy expenditures. These studies consistently show that energy expenditure is directly associated with the severity of the CF gene mutation and inversely associated with pancreatic function [",
"    <a class=\"abstract\" href=\"UTD.htm?15/24/15754/abstract/29-31\">",
"     29-31",
"    </a>",
"    ]. A wide range of energy expenditures are reported in individuals with CF, ranging from normal to 150 percent of normal, depending on the CF mutation, the patient's age and current state of health.",
"   </p>",
"   <p>",
"    Each patient should have a nutritional regimen tailored to his or her needs [",
"    <a class=\"abstract\" href=\"UTD.htm?15/24/15754/abstract/32\">",
"     32",
"    </a>",
"    ]. Ideally, energy expenditure should be measured for each individual; however, techniques of determining energy expenditure can be difficult, especially in patients with CF. Measurement of resting energy expenditure requires either endotracheal intubation or a tight fitting hood to collect expired gases. CF patients do not tolerate either method well. A handheld apparatus for measuring resting energy expenditure is available [",
"    <a class=\"abstract\" href=\"UTD.htm?15/24/15754/abstract/33\">",
"     33",
"    </a>",
"    ]. To date, this device has not been tested in CF patients, and its use could be limited by chronic cough and by problems with contamination. However, if the technique proves feasible and accurate in this population, it could allow more exact matching of patients' needs with nutritional recommendations.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Fat soluble vitamins",
"    </span>",
"    &nbsp;&mdash;&nbsp;CF liver disease and pancreatic dysfunction lead to fat malabsorption that predisposes patients to deficiencies of the fat-soluble vitamins: A, D, E, and K [",
"    <a class=\"abstract\" href=\"UTD.htm?15/24/15754/abstract/34\">",
"     34",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The Cystic Fibrosis Foundation (CFF) recommends supplementation of these vitamins for all children with cystic fibrosis (",
"    <a class=\"graphic graphic_table graphicRef70052 \" href=\"UTD.htm?11/14/11501\">",
"     table 5",
"    </a>",
"    and",
"    <a class=\"graphic graphic_table graphicRef85553 \" href=\"UTD.htm?36/10/37036\">",
"     table 4",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?15/24/15754/abstract/9\">",
"     9",
"    </a>",
"    ]. These doses are considerably higher than those recommended for individuals without CF. Supplements should be started as soon as CF is diagnosed, including in asymptomatic infants and in individuals without pancreatic insufficiency. Several different commercially available vitamin supplements provide doses within the target range (",
"    <a class=\"graphic graphic_table graphicRef58288 graphicRef67006 \" href=\"UTD.htm?31/52/32577\">",
"     table 6A-B",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h3\">",
"     Vitamin A",
"    </span>",
"    &nbsp;&mdash;&nbsp;Because vitamin A is fat-soluble and requires bile acids for absorption, patients with CF are at risk for vitamin A deficiency. However, except at the time of diagnosis, vitamin A deficiency is a rare occurrence in CF. Toxicity from vitamin A supplements is probably a more important clinical issue, as discussed below.",
"   </p>",
"   <p>",
"    Physiology &mdash; Vitamin A is important for vision, gene expression, reproduction, embryonic development, growth, and immune function. It exists as \"preformed vitamin A\" (retinol, retinal, retinoic acid, and retinyl ester) and as \"provitamin A\" (food composition data is available for alpha-carotene,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?20/50/21283?source=see_link\">",
"     beta-carotene",
"    </a>",
"    and cryptoxanthin; other forms of provitamin A are found in nature for which no food composition data is available). Most supplements contain preformed vitamin A. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/14/21736?source=see_link\">",
"     \"Overview of vitamin A\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Recommended intake &mdash; Supplementing CF patients with a water miscible or water soluble form of vitamin A has been a routine component of care for many years, and is recommended by the CFF in the doses found in the table (1 mcg retinol activity equivalent = 3.33 international units vitamin A) (",
"    <a class=\"graphic graphic_table graphicRef70052 \" href=\"UTD.htm?11/14/11501\">",
"     table 5",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Several reports show that vitamin A may reach toxic levels in some CF patients taking supplements [",
"    <a class=\"abstract\" href=\"UTD.htm?15/24/15754/abstract/35,36\">",
"     35,36",
"    </a>",
"    ]. This is particularly concerning because long-term vitamin A toxicity results in bone mineral loss and liver abnormalities, as well as other abnormalities; complications that CF patients cannot afford. Many of the supplements used for patients with CF provide total doses of vitamin A that are well in excess of the CFF recommended intake (",
"    <a class=\"graphic graphic_table graphicRef58288 \" href=\"UTD.htm?30/34/31278\">",
"     table 6A",
"    </a>",
"    ). However, in some supplements, part of the vitamin A is provided in the form of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?20/50/21283?source=see_link\">",
"     beta-carotene",
"    </a>",
"    . Beta-carotene is a provitamin A, and because its conversion to vitamin A is physiologically regulated, it has a lower risk for toxicity than preformed vitamin A [",
"    <a class=\"abstract\" href=\"UTD.htm?15/24/15754/abstract/34\">",
"     34",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Monitoring &mdash; The CFF recommends measurement of serum retinol annually in all patients with CF (",
"    <a class=\"graphic graphic_table graphicRef56711 \" href=\"UTD.htm?27/43/28349\">",
"     table 2",
"    </a>",
"    ), and that serum retinol binding protein and retinyl esters also be measured in those with liver disease [",
"    <a class=\"abstract\" href=\"UTD.htm?15/24/15754/abstract/2,34,37\">",
"     2,34,37",
"    </a>",
"    ]. However, serum retinol is a better marker of deficiency than excess. The optimal forms and dosing of vitamin A supplements, and approach to monitoring is a subject of active study.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h3\">",
"     Vitamin D",
"    </span>",
"    &nbsp;&mdash;&nbsp;Vitamin D deficiency is common among patients with CF, and is probably a major contributor to bone disease [",
"    <a class=\"abstract\" href=\"UTD.htm?15/24/15754/abstract/10,11\">",
"     10,11",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H8\">",
"     'Bone disease'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    Physiology &mdash; Vitamin D3 (cholecalciferol) is the form in most over-the-counter supplements in the United States, and is also the form produced in the skin by sunlight (",
"    <a class=\"graphic graphic_figure graphicRef65360 \" href=\"UTD.htm?20/23/20862\">",
"     figure 4",
"    </a>",
"    ). Vitamin D2 (ergocalciferol) is available by prescription and is in some over-the-counter supplements. Both forms are effective in increasing serum vitamin D levels, and it is unclear if one preparation is more efficacious than the other. The CFF recommends vitamin D3 (cholecalciferol) as an oral supplement, because a small study suggests that it is somewhat more likely to achieve target 25-hydroxyvitamin D levels in patients with CF than vitamin D2 (ergocalciferol) [",
"    <a class=\"abstract\" href=\"UTD.htm?15/24/15754/abstract/38\">",
"     38",
"    </a>",
"    ]. Vitamin D2 and vitamin D3 are hydroxylated in the liver to 25-hydroxyvitamin D (calcidiol), the major circulating form of the hormone. 25-hydroxyvitamin D is then converted in the kidney to the biologically active form of the vitamin, 1,25-dihydroxyvitamin D. In addition to its important role in bone health, vitamin D also has a role in muscle function, innate immunity, cardiovascular disease, and diabetes [",
"    <a class=\"abstract\" href=\"UTD.htm?15/24/15754/abstract/39\">",
"     39",
"    </a>",
"    ]. The metabolism and biological roles of vitamin D are discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/3/39990?source=see_link\">",
"     \"Overview of vitamin D\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/15/9462?source=see_link\">",
"     \"Metabolism of vitamin D\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Recommended intake &mdash; CF clinical practice guidelines recommend that all individuals with CF take vitamin D supplements: recommended doses are 400 to 500 international units daily for patients younger than one year and 800 to 1000 international units daily for those 1 to 10 years of age. For those 10 years and older, the recommended daily intake is 800 to 2000 international units (",
"    <a class=\"graphic graphic_table graphicRef85553 \" href=\"UTD.htm?36/10/37036\">",
"     table 4",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?15/24/15754/abstract/38\">",
"     38",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    There is some evidence that the dose of 800 international units daily that was previously recommended for children older than four years is not adequate; among children taking the recommended doses, at least 45 percent had vitamin D insufficiency (25-OH vitamin D levels &lt;30",
"    <span class=\"nowrap\">",
"     ng/mL)",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?15/24/15754/abstract/40\">",
"     40",
"    </a>",
"    ]. Even with high dose ergocalciferol treatment (50,000 international units three times weekly for eight weeks) vitamin D levels remained below the target range in 57 percent of patients. Similarly, a report from three Canadian CF centers documented that 95 percent of CF patients had suboptimal vitamin D status despite having vitamin D intake above 400 international units [",
"    <a class=\"abstract\" href=\"UTD.htm?15/24/15754/abstract/10\">",
"     10",
"    </a>",
"    ]. Strategies for repletion of vitamin D are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?3/21/3417?source=see_link\">",
"     \"Treatment of vitamin D deficiency in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Monitoring &mdash; Vitamin D status should be assessed annually in all patients with CF by measuring serum 25-hydroxyvitamin D, preferably at the end of winter (",
"    <a class=\"graphic graphic_table graphicRef56711 \" href=\"UTD.htm?27/43/28349\">",
"     table 2",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?15/24/15754/abstract/2,11\">",
"     2,11",
"    </a>",
"    ]. Desirable levels are 30 to 60",
"    <span class=\"nowrap\">",
"     ng/mL",
"    </span>",
"    (75 to 150",
"    <span class=\"nowrap\">",
"     nmol/L).",
"    </span>",
"    If levels fall below 30",
"    <span class=\"nowrap\">",
"     ng/mL,",
"    </span>",
"    assure adherence to previously recommended supplements and supplement with vitamin D2 (cholecalciferol) (",
"    <a class=\"graphic graphic_table graphicRef85553 \" href=\"UTD.htm?36/10/37036\">",
"     table 4",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?15/24/15754/abstract/11,38,40\">",
"     11,38,40",
"    </a>",
"    ]. However, whether achieving 25-OH vitamin D levels in the recommended target range (30 to 60",
"    <span class=\"nowrap\">",
"     ng/mL)",
"    </span>",
"    will cause clinically important improvements in bone health has not been established.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h3\">",
"     Vitamin E",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with CF are at risk for vitamin E deficiency, as they are for other fat-soluble vitamins. Because vitamin E functions as an antioxidant, some have proposed that deficiency of this vitamin may promote inflammation and contribute to CF lung disease.",
"   </p>",
"   <p>",
"    Physiology &mdash; Vitamin E is a fat soluble vitamin with eight different forms, each of which has its own profile of activity. The form most commonly used as a supplement is alpha tocopherol acetate. All forms of vitamin E act as anti-oxidants at cell membranes, preventing membrane damage. Gamma tocopherol may play an important and complementary role to alpha-tocopherol in scavenging free radicals [",
"    <a class=\"abstract\" href=\"UTD.htm?15/24/15754/abstract/41\">",
"     41",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/12/28871?source=see_link\">",
"     \"Overview of vitamin E\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Recommended intake &mdash; The CFF recommends the following intake of vitamin E (as alpha tocopherol) as shown in the following table (",
"    <a class=\"graphic graphic_table graphicRef70052 \" href=\"UTD.htm?11/14/11501\">",
"     table 5",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?15/24/15754/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    These doses are about 20-fold higher than the recommended intake for healthy individuals, and are generally effective in preventing vitamin E deficiency (as measured by alpha tocopherol levels) [",
"    <a class=\"abstract\" href=\"UTD.htm?15/24/15754/abstract/42\">",
"     42",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The known role of vitamin E as an antioxidant has generated interest in the possibility that higher doses of vitamin E, or different forms of vitamin E, alone or in combination with other antioxidants, might reduce inflammation and end-organ damage in CF. This hypothesis is supported by some studies showing a correlation between vitamin E status, polyunsaturated fatty acid status, and inflammation in patients with CF [",
"    <a class=\"abstract\" href=\"UTD.htm?15/24/15754/abstract/42\">",
"     42",
"    </a>",
"    ]. However, clinical efficacy for this approach has not been established, and supplements in excess of the above dosing ranges are not generally recommended.",
"   </p>",
"   <p>",
"    Monitoring &mdash; The CFF currently recommends annual measurements of serum alpha tocopherol to monitor vitamin E status in patients with CF (",
"    <a class=\"graphic graphic_table graphicRef56711 \" href=\"UTD.htm?27/43/28349\">",
"     table 2",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?15/24/15754/abstract/2\">",
"     2",
"    </a>",
"    ]. Serum vitamin E levels are strongly influenced by concentration of serum lipids, and do not accurately reflect tissue vitamin levels, and patients with CF typically have lower serum cholesterol than the reference population. Therefore, the alpha-tocopherol:cholesterol ratio or alpha tocopherol:total serum lipid ratio may be a better measure of sufficiency. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/12/28871?source=see_link&amp;anchor=H10#H10\">",
"     \"Overview of vitamin E\", section on 'Measurement'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h3\">",
"     Vitamin K",
"    </span>",
"    &nbsp;&mdash;&nbsp;Vitamin K deficiency can cause coagulation abnormalities and may also contribute to bone disease in patients with CF. Several reports demonstrate a direct correlation between vitamin K status and measures of bone health [",
"    <a class=\"abstract\" href=\"UTD.htm?15/24/15754/abstract/34,43-45\">",
"     34,43-45",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H8\">",
"     'Bone disease'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    Physiology &mdash; Vitamin K is a fat-soluble vitamin found in a variety of green vegetables, and is also synthesized by intestinal bacteria. Patients with CF are at risk for vitamin K deficiency because of fat malabsorption, and also because of disturbances in the bowel flora caused by small intestine bacterial overgrowth, or frequent use of antibiotics.",
"   </p>",
"   <p>",
"    Vitamin K is a cofactor required for the activity of several key proteins in the coagulation pathways, including prothrombin. Because vitamin-K dependent carboxylation occurs in the liver, its action can be further reduced in patients with severely impaired hepatic function. Vitamin K-dependent carboxylation is also necessary for function of osteocalcin and other bone-related proteins. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/37/15960?source=see_link\">",
"     \"Overview of vitamin K\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Recommended intake &mdash; The CFF recommends vitamin K supplementation of 0.3 to 0.5 mg daily for infants, children, and adolescents with CF [",
"    <a class=\"abstract\" href=\"UTD.htm?15/24/15754/abstract/2\">",
"     2",
"    </a>",
"    ]. Adults should be supplemented with 2.5 to 5 mg weekly, and additional supplementation may be necessary during antibiotic therapy (",
"    <a class=\"graphic graphic_table graphicRef70052 \" href=\"UTD.htm?11/14/11501\">",
"     table 5",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?15/24/15754/abstract/37\">",
"     37",
"    </a>",
"    ]. These doses are over 100-fold higher than the recommended intake for individuals without CF.",
"   </p>",
"   <p>",
"    Monitoring &mdash; The CFF recommends annual screening for vitamin K deficiency in patients with liver disease, hemoptysis, or hematemesis; screening consists of measuring serum prothrombin time and, if possible, also PIVKA-II (Proteins induced by vitamin K absence) levels (",
"    <a class=\"graphic graphic_table graphicRef56711 \" href=\"UTD.htm?27/43/28349\">",
"     table 2",
"    </a>",
"    ). In our practice, we perform these screening tests annually in all CF patients even if there is no known liver disease or bleeding diathesis, because patients may have CF-related liver disease for some time before it becomes clinically apparent.",
"   </p>",
"   <p>",
"    PIVKA-II is more sensitive than prothrombin time in detecting vitamin K deficiency. Using this measure, 82 percent of patients with CF were found to have suboptimal vitamin K status, despite meeting the goals for vitamin K intake recommended by the CFF [",
"    <a class=\"abstract\" href=\"UTD.htm?15/24/15754/abstract/10\">",
"     10",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Essential fatty acids",
"    </span>",
"    &nbsp;&mdash;&nbsp;Essential fatty acid (EFA) deficiency may contribute to inflammatory pathways in CF, and there is preliminary evidence that supplementation may be beneficial.",
"   </p>",
"   <p>",
"    Routine EFA supplementation or monitoring is not currently recommended for patients with CF [",
"    <a class=\"abstract\" href=\"UTD.htm?15/24/15754/abstract/2,9\">",
"     2,9",
"    </a>",
"    ]. However, patients at high risk for EFA deficiency, such as infants with growth failure or other suggestive symptoms, should be evaluated by measuring the triene:tetraene ratio or other biomarker of EFA status (",
"    <a class=\"graphic graphic_table graphicRef56711 \" href=\"UTD.htm?27/43/28349\">",
"     table 2",
"    </a>",
"    ). Diets rich in EFA, including cold-water fish and vegetable oils (eg, flax, canola, or soy), are encouraged [",
"    <a class=\"abstract\" href=\"UTD.htm?15/24/15754/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Physiology &mdash; Long chain polyunsaturated fatty acids of the omega-3 and the omega-6 series are termed \"essential\" because they cannot be synthesized by humans. Fatty acids of the omega-3 series are found as components of cell membranes and exhibit profound anti-inflammatory effects. Fish oil is a rich source of the metabolically active omega-3 fatty acid, docosahexaenoic acid (DHA). Fish oil is found to be beneficial in a number of chronic inflammatory states, such as rheumatoid arthritis and inflammatory bowel disease.",
"   </p>",
"   <p>",
"    EFA deficiency is characterized by scaly dermatitis, alopecia, thrombocytopenia, and growth failure. Overt symptoms of EFA deficiency such as these are uncommon in patients with CF, but there is some evidence for subclinical EFA deficiency in this population. As an example, biochemical markers of EFA deficiency are correlated with poor growth and pulmonary status [",
"    <a class=\"abstract\" href=\"UTD.htm?15/24/15754/abstract/46,47\">",
"     46,47",
"    </a>",
"    ]. EFA deficiency is more common among infants and in patients with pancreatic insufficiency. A systematic review found that short-term supplementation of omega-3 fatty acids improved several indices of CF lung disease, and concluded that the supplements were probably beneficial and have few adverse effects [",
"    <a class=\"abstract\" href=\"UTD.htm?15/24/15754/abstract/48\">",
"     48",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Monitoring &mdash; EFA status is usually measured using a triene:tetraene ratio (eicosatrienoic acid:arachidonic acid). However, some investigators have suggested that serum linoleic acid (an omega-6 fatty acid), expressed as a molar percent of total serum phospholipid fatty acids, is a more clinically relevant biomarker of EFA deficiency [",
"    <a class=\"abstract\" href=\"UTD.htm?15/24/15754/abstract/46\">",
"     46",
"    </a>",
"    ]. In a group of patients with CF, linoleic acid concentration above 21 moles percent was associated with better growth, body composition, and lung function.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Sodium",
"    </span>",
"    &nbsp;&mdash;&nbsp;Individuals with CF are prone to hyponatremic dehydration under conditions of heat stress, especially with exercise. This was described in five patients during a summer heat wave in 1948 who developed heat exhaustion with low serum sodium [",
"    <a class=\"abstract\" href=\"UTD.htm?15/24/15754/abstract/49\">",
"     49",
"    </a>",
"    ]. The risk for hyponatremic dehydration is increased during infancy and in hot climates [",
"    <a class=\"abstract\" href=\"UTD.htm?15/24/15754/abstract/50\">",
"     50",
"    </a>",
"    ]. A similar picture can develop in infants without heat stress [",
"    <a class=\"abstract\" href=\"UTD.htm?15/24/15754/abstract/51\">",
"     51",
"    </a>",
"    ]. To avoid these potentially life-threatening complications, routine supplementation with sodium chloride is recommended, depending upon the patient&rsquo;s age and climate conditions (",
"    <a class=\"graphic graphic_table graphicRef50515 \" href=\"UTD.htm?20/11/20667\">",
"     table 7",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?15/24/15754/abstract/9\">",
"     9",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h2\">",
"     Fluoride",
"    </span>",
"    &nbsp;&mdash;&nbsp;Infants and children with CF require fluoride for dental health at the same levels as healthy children [",
"    <a class=\"abstract\" href=\"UTD.htm?15/24/15754/abstract/9\">",
"     9",
"    </a>",
"    ]. Vitamins formulated for CF do not generally include fluoride. Fluoride supplements should be supplied separately beginning at 6 months of age, if the fluoride concentration of the water supply is not adequate. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/26/33192?source=see_link&amp;anchor=H13#H13\">",
"     \"Preventive dental care and counseling for infants and young children\", section on 'Fluoride'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h2\">",
"     Zinc",
"    </span>",
"    &nbsp;&mdash;&nbsp;For infants with CF under two years of age who are not growing well despite adequate energy intake and pancreatic enzyme supplementation, the CF foundation suggests a trial of zinc supplementation (1 mg elemental",
"    <span class=\"nowrap\">",
"     zinc/kg/day",
"    </span>",
"    in divided doses for six months). This suggestion is based on expert consensus, inferred from the positive effects of zinc on growth in some other clinical settings. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/3/29753?source=see_link&amp;anchor=H28556119#H28556119\">",
"     \"Zinc deficiency and supplementation in children and adolescents\", section on 'Enhancement of growth'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Rarely, infants with undiagnosed CF may present with a dermatitis caused by zinc deficiency, often in combination with EFA deficiency",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    protein-energy malnutrition. The dermatitis resembles acrodermatitis enteropathica. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/3/29753?source=see_link&amp;anchor=H9#H9\">",
"     \"Zinc deficiency and supplementation in children and adolescents\", section on 'Other'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h1\">",
"     NUTRITION SUPPORT",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h2\">",
"     Oral",
"    </span>",
"    &nbsp;&mdash;&nbsp;All individuals with CF should be given dietary advice about a balanced diet with adequate calories to ensure growth at or above the 50",
"    <sup>",
"     th",
"    </sup>",
"    percentile for age. Caloric goals will often be higher than those for the general population. Pancreatic enzyme replacement therapy should be provided for those with pancreatic insufficiency. (See",
"    <a class=\"local\" href=\"#H5\">",
"     'Growth'",
"    </a>",
"    above and",
"    <a class=\"local\" href=\"#H13\">",
"     'Calories'",
"    </a>",
"    above and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/26/29095?source=see_link\">",
"     \"Cystic fibrosis: Assessment and management of pancreatic insufficiency\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    For infants with cystic fibrosis, human milk feeding is specifically encouraged [",
"    <a class=\"abstract\" href=\"UTD.htm?15/24/15754/abstract/9\">",
"     9",
"    </a>",
"    ]. If infants are fed formula, a standard infant formula may be used; formulas containing extensively hydrolyzed protein are not helpful unless the infant has a milk protein intolerance in addition to CF. If weight gain is inadequate, the energy content of the formula or human milk should be increased using standard methods. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/16/30985?source=see_link&amp;anchor=H17#H17\">",
"     \"Management of failure to thrive (undernutrition) in children younger than two years\", section on 'For infants'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Parents should be educated to use behavioral techniques to promote positive feeding behaviors [",
"    <a class=\"abstract\" href=\"UTD.htm?15/24/15754/abstract/9\">",
"     9",
"    </a>",
"    ]. These include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Providing attention and praise for positive eating behaviors",
"     </li>",
"     <li>",
"      Gentle persistence when offering new foods (offer a new food 10 or more times before giving up)",
"     </li>",
"     <li>",
"      Ignoring negative eating behaviors such as food refusal",
"     </li>",
"     <li>",
"      Offer meals and substantive snacks on a regular schedule",
"     </li>",
"     <li>",
"      Keep mealtimes relaxed and time-limited; do not enforce specific goals for intake at each meal",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    For patients with suboptimal growth, the initial intervention is to provide more intensive dietary advice to increase caloric intake [",
"    <a class=\"abstract\" href=\"UTD.htm?15/24/15754/abstract/9\">",
"     9",
"    </a>",
"    ]. A number of studies support this approach and show nutritional benefit through counseling, with the use of behavior modification strategies to support dietary change [",
"    <a class=\"abstract\" href=\"UTD.htm?15/24/15754/abstract/52-56\">",
"     52-56",
"    </a>",
"    ]. As an example, a small randomized trial found that a behavioral intervention substantially increased caloric intake in toddlers and preschool-aged children with CF as compared with standard care, and that these effects persisted 12 months after the intervention [",
"    <a class=\"abstract\" href=\"UTD.htm?15/24/15754/abstract/57,58\">",
"     57,58",
"    </a>",
"    ]. The behavioral techniques included differential attention (parents praised children for desired eating behaviors and ignored non-eating behaviors) and contingencies (rewards to motivate children to meet energy goals). A larger multicenter trial of children aged 4 to 12 years assessed the efficacy of a similar behavioral intervention designed to promote energy intake [",
"    <a class=\"abstract\" href=\"UTD.htm?15/24/15754/abstract/59,60\">",
"     59,60",
"    </a>",
"    ]. The group receiving the behavioral intervention achieved improved energy intake and weight gain at the end of a nine-week intervention, and a slower rate of decline in BMI z-score over the subsequent two years, as compared with control patients receiving nutritional education alone.",
"   </p>",
"   <p>",
"    In addition to nutritional and behavioral counseling, patients with suboptimal growth should also be assessed for the possibility of emerging pancreatic insufficiency or inadequate replacement therapy. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/26/29095?source=see_link\">",
"     \"Cystic fibrosis: Assessment and management of pancreatic insufficiency\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    For infants with CF under two years of age who are not growing well despite adequate energy intake and pancreatic enzyme supplementation, the CF foundation suggests a trial of zinc supplementation. (See",
"    <a class=\"local\" href=\"#H22\">",
"     'Zinc'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    If dietary counseling is not successful, a liquid supplement that is high in calories and protein can be added to the diet. A variety of supplements are available and are appropriate for use by patients with CF (",
"    <a class=\"graphic graphic_table graphicRef69474 \" href=\"UTD.htm?1/9/1181\">",
"     table 8",
"    </a>",
"    ). These supplements are often less efficacious than expected because the supplements tend to displace ordinary food rather than being taken in addition to a usual diet [",
"    <a class=\"abstract\" href=\"UTD.htm?15/24/15754/abstract/61\">",
"     61",
"    </a>",
"    ], and patients often complain of taste fatigue with oral supplements. As an example, a systematic review found that calorie-protein supplements do not confer benefits above dietary advice and monitoring in CF patients who have moderate malnutrition [",
"    <a class=\"abstract\" href=\"UTD.htm?15/24/15754/abstract/62\">",
"     62",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h2\">",
"     Enteral feedings",
"    </span>",
"    &nbsp;&mdash;&nbsp;When oral nutrition support fails, enteral nutrition (EN) (tube feeding) should be employed. Aspects of enteral nutrition that are specific to patients with CF are outlined here. An overview of enteral nutrition in children is presented separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/16/11529?source=see_link\">",
"     \"Enteral nutrition in infants and children\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    EN is widely used for patients with CF and perceived as helpful [",
"    <a class=\"abstract\" href=\"UTD.htm?15/24/15754/abstract/63-65\">",
"     63-65",
"    </a>",
"    ]. This practice is supported by a number of observational studies that suggest improved nutritional status and stabilization of lung function in CF patients receiving EN, as illustrated by the following examples [",
"    <a class=\"abstract\" href=\"UTD.htm?15/24/15754/abstract/64,66,67\">",
"     64,66,67",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A series of 14 patients with moderate to severe lung disease were compared with age- and disease-matched contemporary controls, with a mean follow-up of 1.1 years [",
"      <a class=\"abstract\" href=\"UTD.htm?15/24/15754/abstract/68\">",
"       68",
"      </a>",
"      ]. The patients receiving EN experienced a weight percentile increase, while growth percentiles declined in the comparison group. The FEV1 in the EN group did not change, while the FEV1 of the comparison group worsened.",
"     </li>",
"     <li>",
"      A series of 53 patients with CF, ten of whom were children, showed an increase in expected weight and stabilization of lung function, but these outcomes were not compared to a control group [",
"      <a class=\"abstract\" href=\"UTD.htm?15/24/15754/abstract/64\">",
"       64",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    No randomized studies of EN have been performed in patients with CF. Therefore, the clinical benefits and potential adverse consequences, including effects on quality of life, have not been rigorously addressed [",
"    <a class=\"abstract\" href=\"UTD.htm?15/24/15754/abstract/66\">",
"     66",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h3\">",
"     Route",
"    </span>",
"    &nbsp;&mdash;&nbsp;EN is usually provided to patients with CF via gastrostomy tube (G-tube), because nasogastric tubes are usually poorly tolerated due to chronic cough, nasal polyps, and the sensation of suffocating. Gastrojejunostomy and jejunostomy feeding may also be used, but these tubes are more difficult to place and maintain in position. Additionally, jejunal feeds must be given continuously rather than in boluses, making the route inconvenient for ambulatory patients.",
"   </p>",
"   <p>",
"    G-tubes can be placed surgically, endoscopically, or by an interventional radiologist, with minimal risk. If general anesthesia is not advisable for a particular patient, the procedure can be performed under sedation and local anesthesia. A skin-level device (or \"button\") can be used so that the patient can disconnect from all tubing between feeds, to optimize mobility and cosmesis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27\">",
"    <span class=\"h3\">",
"     Schedule",
"    </span>",
"    &nbsp;&mdash;&nbsp;Schedules for tube feeding vary and should take into account the patient's activities and other therapies. Feeds can be instilled continuously, as boluses, or a combination of these two regimens.",
"   </p>",
"   <p>",
"    For the school-age child, a frequently employed schedule supplies approximately 40 percent of daily requirements via a slow infusion overnight, and the remainder of the requirement is supplied through food taken by mouth during the day. If the child is unable to meet the daily caloric requirements, the nighttime infusions can be lengthened or the rate of infusion increased so that a greater percentage of the requirements are delivered overnight.",
"   </p>",
"   <p>",
"    For the younger patient who is at home during the day, nutritional requirements can be supplied through a combination of nighttime continuous feeds, daytime meals, and daytime bolus feeds. If the child fails to ingest the prescribed amount at any daytime meal, a bolus feed is added to compensate.",
"   </p>",
"   <p>",
"    CF patients often have a complex care schedule because of their need for multiple medications and frequent pulmonary therapies. Feeding schedules should take these other elements of therapy into account.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H28\">",
"    <span class=\"h3\">",
"     Formula",
"    </span>",
"    &nbsp;&mdash;&nbsp;No one class of formula has been shown to be superior to another. Some formulas supply protein that is either elemental (free amino acids) or semi-elemental (",
"    <a class=\"graphic graphic_table graphicRef74962 \" href=\"UTD.htm?18/59/19389\">",
"     table 9",
"    </a>",
"    ). The protein in a semi-elemental formula may be extensively hydrolyzed (containing short peptides) or partially hydrolyzed (containing longer peptide chains). However, more extensive protein digestion does not have a clinical advantage as long as pancreatic enzyme replacement is given, and it may have the disadvantage of increasing the osmolarity of the formula. In one study, a non-elemental formula plus pancreatic enzyme replacement was as well absorbed as a semi-elemental formula without pancreatic enzymes [",
"    <a class=\"abstract\" href=\"UTD.htm?15/24/15754/abstract/69\">",
"     69",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Concentrated formulas with 1.5 to 2",
"    <span class=\"nowrap\">",
"     Kcal/mL",
"    </span>",
"    have the advantage of delivering more calories in a smaller volume. Since nighttime urination is a problem when using high-volume overnight feeds, a smaller volume can make the feeding schedule more tolerable. When using the more concentrated formulas, care must be exercised to avoid carbohydrate overload and possible inadequate supply of free water. Use of formulas with concentrated carbohydrates may uncover CF related diabetes (CFRD). Similarly, in established diabetics, these formulas may complicate diabetes treatment. The complications encountered because of CFRD are surmountable and should not preclude the use of EN.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29\">",
"    <span class=\"h3\">",
"     Enzyme replacement",
"    </span>",
"    &nbsp;&mdash;&nbsp;As with other aspects of EN in CF, there is little information on the best way to administer pancreatic enzyme replacement therapy (PERT) in conjunction with EN. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/26/29095?source=see_link&amp;anchor=H9#H9\">",
"     \"Cystic fibrosis: Assessment and management of pancreatic insufficiency\", section on 'Pancreatic enzyme replacement therapy'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In the absence of evidence-based guidelines, we suggest the following approach:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Start by calculating the grams of long chain triglycerides (LCT) being administered. LCT is the main determinant of the lipase requirement, because",
"      <a class=\"drug drug_general\" href=\"UTD.htm?18/51/19250?source=see_link\">",
"       medium chain triglycerides",
"      </a>",
"      (MCT) require relatively low concentrations of lipase to hydrolyze the fatty acids from the glycerol backbone. Therefore, MCT accounts for little of the fat malabsorption in CF.",
"     </li>",
"     <li>",
"      Supply 1600 to 2000 lipase units per gram LCT (",
"      <a class=\"graphic graphic_table graphicRef57416 \" href=\"UTD.htm?14/29/14814\">",
"       table 10",
"      </a>",
"      ). (See",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?8/14/8422?source=see_link\">",
"       \"Pancrelipase: Pediatric drug information\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      For cycled and continuous overnight feeds, administer three-fourths of the enzymes at the beginning of the feeding and one-fourth of the enzymes at the end of the feeding.",
"     </li>",
"     <li>",
"      For bolus feedings, administer the calculated amount of enzymes just prior to the feeding.",
"     </li>",
"     <li>",
"      For continuous 24-hour feedings, divide the total calculated lipase into six doses, and give each dose at four hour intervals.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H30\">",
"    <span class=\"h2\">",
"     Parenteral nutrition",
"    </span>",
"    &nbsp;&mdash;&nbsp;Parenteral nutrition (PN) should be prescribed for CF patients when GI function is inadequate to supply complete nutrition. This could occur during times of extreme metabolic stress, such as post-transplantation or following GI surgical procedures. The PN solution should contain a balance of amino acids, dextrose, lipids, vitamins, and trace elements to provide appropriate nutrition.",
"   </p>",
"   <p>",
"    One study observed that PN promoted weight gain in patients with CF but was also associated with higher rates of sepsis [",
"    <a class=\"abstract\" href=\"UTD.htm?15/24/15754/abstract/70\">",
"     70",
"    </a>",
"    ]. Moreover, after PN was discontinued, weight decreased again, and no long term gain was achieved. PN should not be a part of palliative care.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topic (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?19/57/20371?source=see_link\">",
"       \"Patient information: Cystic fibrosis (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H31\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Nutritional issues in CF are pervasive, and are not fully explained by pancreatic insufficiency or overcome by pancreatic enzyme replacement therapy.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Early recognition and intensive treatment of undernutrition in patients with CF can minimize the damaging effects of malnutrition on lung disease, longevity, and quality of life. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Pancreatic insufficiency is an important contributor to malnutrition in most individuals with cystic fibrosis. Diagnosing and managing this problem is an important step in nutritional management. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?28/26/29095?source=see_link\">",
"       \"Cystic fibrosis: Assessment and management of pancreatic insufficiency\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      CF-related liver disease, bile salt abnormalities, CF-related diabetes and small bowel bacterial overgrowth also compromise nutrient absorption, while inflammatory lung disease increases energy needs. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Pathophysiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      All patients with CF should have regular nutritional assessments at three monthly intervals for early detection of nutritional deterioration (",
"      <a class=\"graphic graphic_table graphicRef76676 \" href=\"UTD.htm?24/26/25005\">",
"       table 1",
"      </a>",
"      ). Anthropometric measurements are tracked against standard curves, and laboratory tests are performed to monitor for specific deficiencies (",
"      <a class=\"graphic graphic_table graphicRef56711 \" href=\"UTD.htm?27/43/28349\">",
"       table 2",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Assessing and monitoring nutrition'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Bone disease is common in patients with cystic fibrosis, and progresses with age. All individuals with CF should be counseled to ensure recommended intake of calcium, phosphorus, vitamin K, and vitamin D to support bone health (",
"      <a class=\"graphic graphic_table graphicRef82276 \" href=\"UTD.htm?43/5/44124\">",
"       table 3",
"      </a>",
"      and",
"      <a class=\"graphic graphic_table graphicRef85553 \" href=\"UTD.htm?36/10/37036\">",
"       table 4",
"      </a>",
"      ). In addition, serum levels of calcium, phosphorus, intact parathyroid hormone, and 25 hydroxyvitamin D should be measured annually; bone density should be measured in children older than eight years (",
"      <a class=\"graphic graphic_table graphicRef56711 \" href=\"UTD.htm?27/43/28349\">",
"       table 2",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Bone disease'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We recommend that all individuals with cystic fibrosis take supplements to meet disease-specific recommended intakes for fat-soluble vitamins (",
"      <a class=\"graphic graphic_table graphicRef70052 \" href=\"UTD.htm?11/14/11501\">",
"       table 5",
"      </a>",
"      and",
"      <a class=\"graphic graphic_table graphicRef85553 \" href=\"UTD.htm?36/10/37036\">",
"       table 4",
"      </a>",
"      ) (",
"      <a class=\"grade\" href=\"._grade_2?title=Grade 1B\">",
"       Grade 1B",
"      </a>",
"      ). Several different commercially available vitamin supplements provide doses within the target range (",
"      <a class=\"graphic graphic_table graphicRef58288 graphicRef67006 \" href=\"UTD.htm?31/52/32577\">",
"       table 6A-B",
"      </a>",
"      ). The currently available supplements may provide excessive amounts of vitamin A, and suboptimal amounts of vitamin D and K. In addition, serum retinol, vitamin E, and prothrombin time (PT) or PIVKA-II should be monitored annually to assess for deficiency. (See",
"      <a class=\"local\" href=\"#H14\">",
"       'Fat soluble vitamins'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Because of sodium losses in sweat, individuals with CF are prone to hyponatremic dehydration under conditions of heat stress. Most patients will need supplementation of sodium chloride to compensate for estimated sodium losses, which depend on the patient's age and climate conditions (",
"      <a class=\"graphic graphic_table graphicRef50515 \" href=\"UTD.htm?20/11/20667\">",
"       table 7",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H20\">",
"       'Sodium'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      All individuals with CF should be given dietary counseling to ensure a balanced diet with adequate calories to ensure good growth, and caloric goals will often be higher than for the general population. Patients with growth failure can be managed with a series of interventions, beginning with intensive counseling, and escalating to nutritional supplements via the oral or enteral route. Parenteral nutrition has a limited role in the management of this disease (see",
"      <a class=\"local\" href=\"#H23\">",
"       'Nutrition support'",
"      </a>",
"      above).",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     Cystic Fibrosis Foundation. Patient Registry 2010 Annual Report: Cystic Fibrosis Foundation, Bethesda, MD, pp.1-26.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/24/15754/abstract/2\">",
"      Borowitz D, Baker RD, Stallings V. Consensus report on nutrition for pediatric patients with cystic fibrosis. J Pediatr Gastroenterol Nutr 2002; 35:246.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/24/15754/abstract/3\">",
"      Borowitz D, Durie PR, Clarke LL, et al. Gastrointestinal outcomes and confounders in cystic fibrosis. J Pediatr Gastroenterol Nutr 2005; 41:273.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/24/15754/abstract/4\">",
"      Riordan JR, Rommens JM, Kerem B, et al. Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science 1989; 245:1066.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/24/15754/abstract/5\">",
"      Zemel BS, Jawad AF, FitzSimmons S, Stallings VA. Longitudinal relationship among growth, nutritional status, and pulmonary function in children with cystic fibrosis: analysis of the Cystic Fibrosis Foundation National CF Patient Registry. J Pediatr 2000; 137:374.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/24/15754/abstract/6\">",
"      Reilly JJ, Edwards CA, Weaver LT. Malnutrition in children with cystic fibrosis: the energy-balance equation. J Pediatr Gastroenterol Nutr 1997; 25:127.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/24/15754/abstract/7\">",
"      Stallings VA, Stark LJ, Robinson KA, et al. Evidence-based practice recommendations for nutrition-related management of children and adults with cystic fibrosis and pancreatic insufficiency: results of a systematic review. J Am Diet Assoc 2008; 108:832.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/24/15754/abstract/8\">",
"      Kastner-Cole D, Palmer CN, Ogston SA, et al. Overweight and obesity in deltaF508 homozygous cystic fibrosis. J Pediatr 2005; 147:402.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/24/15754/abstract/9\">",
"      Cystic Fibrosis Foundation, Borowitz D, Robinson KA, et al. Cystic Fibrosis Foundation evidence-based guidelines for management of infants with cystic fibrosis. J Pediatr 2009; 155:S73.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/24/15754/abstract/10\">",
"      Grey V, Atkinson S, Drury D, et al. Prevalence of low bone mass and deficiencies of vitamins D and K in pediatric patients with cystic fibrosis from 3 Canadian centers. Pediatrics 2008; 122:1014.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/24/15754/abstract/11\">",
"      Aris RM, Merkel PA, Bachrach LK, et al. Guide to bone health and disease in cystic fibrosis. J Clin Endocrinol Metab 2005; 90:1888.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/24/15754/abstract/12\">",
"      Aris RM, Renner JB, Winders AD, et al. Increased rate of fractures and severe kyphosis: sequelae of living into adulthood with cystic fibrosis. Ann Intern Med 1998; 128:186.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/24/15754/abstract/13\">",
"      Henderson RC, Specter BB. Kyphosis and fractures in children and young adults with cystic fibrosis. J Pediatr 1994; 125:208.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/24/15754/abstract/14\">",
"      Paccou J, Zeboulon N, Combescure C, et al. The prevalence of osteoporosis, osteopenia, and fractures among adults with cystic fibrosis: a systematic literature review with meta-analysis. Calcif Tissue Int 2010; 86:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/24/15754/abstract/15\">",
"      Bhudhikanok GS, Wang MC, Marcus R, et al. Bone acquisition and loss in children and adults with cystic fibrosis: a longitudinal study. J Pediatr 1998; 133:18.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/24/15754/abstract/16\">",
"      Simpson DE, Dontu VS, Stephens SE, et al. Large variations occur in bone density measurements of children when using different software. Nucl Med Commun 2005; 26:483.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/24/15754/abstract/17\">",
"      Marini JC. Do bisphosphonates make children's bones better or brittle? N Engl J Med 2003; 349:423.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/24/15754/abstract/18\">",
"      Conwell LS, Chang AB. Bisphosphonates for osteoporosis in people with cystic fibrosis. Cochrane Database Syst Rev 2012; 4:CD002010.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/24/15754/abstract/19\">",
"      Zemel BS, Kawchak DA, Cnaan A, et al. Prospective evaluation of resting energy expenditure, nutritional status, pulmonary function, and genotype in children with cystic fibrosis. Pediatr Res 1996; 40:578.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/24/15754/abstract/20\">",
"      Peterson ML, Jacobs DR Jr, Milla CE. Longitudinal changes in growth parameters are correlated with changes in pulmonary function in children with cystic fibrosis. Pediatrics 2003; 112:588.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/24/15754/abstract/21\">",
"      Steinkamp G, Wiedemann B. Relationship between nutritional status and lung function in cystic fibrosis: cross sectional and longitudinal analyses from the German CF quality assurance (CFQA) project. Thorax 2002; 57:596.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/24/15754/abstract/22\">",
"      Cheung MS, Bridges NA, Prasad SA, et al. Growth in children with cystic fibrosis-related diabetes. Pediatr Pulmonol 2009; 44:1223.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/24/15754/abstract/23\">",
"      White H, Pollard K, Etherington C, et al. Nutritional decline in cystic fibrosis related diabetes: the effect of intensive nutritional intervention. J Cyst Fibros 2009; 8:179.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/24/15754/abstract/24\">",
"      Moran A, Brunzell C, Cohen RC, et al. Clinical care guidelines for cystic fibrosis-related diabetes: a position statement of the American Diabetes Association and a clinical practice guideline of the Cystic Fibrosis Foundation, endorsed by the Pediatric Endocrine Society. Diabetes Care 2010; 33:2697.",
"     </a>",
"    </li>",
"    <li>",
"     UK Cystic Fibrosis Trust Diabetes Working Group. Management of cystic fibrosis related diabetes mellitus, 2004. Available at: file://www.cftrust.org.uk/aboutcf/publications/consensusdoc/diabetes.pdf (Accessed on October 10, 2011).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/24/15754/abstract/26\">",
"      Jefferies C, Solomon M, Perlman K, et al. Continuous glucose monitoring in adolescents with cystic fibrosis. J Pediatr 2005; 147:396.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/24/15754/abstract/27\">",
"      O'Riordan SM, Hindmarsh P, Hill NR, et al. Validation of continuous glucose monitoring in children and adolescents with cystic fibrosis: a prospective cohort study. Diabetes Care 2009; 32:1020.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/24/15754/abstract/28\">",
"      Roy CC, Darling P, Weber AM. A rational approach to meeting macro- and micronutrient needs in cystic fibrosis. J Pediatr Gastroenterol Nutr 1984; 3 Suppl 1:S154.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/24/15754/abstract/29\">",
"      Magoffin A, Allen JR, McCauley J, et al. Longitudinal analysis of resting energy expenditure in patients with cystic fibrosis. J Pediatr 2008; 152:703.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/24/15754/abstract/30\">",
"      Moudiou T, Galli-Tsinopoulou A, Nousia-Arvanitakis S. Effect of exocrine pancreatic function on resting energy expenditure in cystic fibrosis. Acta Paediatr 2007; 96:1521.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/24/15754/abstract/31\">",
"      Johnson MR, Ferkol TW, Shepherd RW. Energy cost of activity and exercise in children and adolescents with cystic fibrosis. J Cyst Fibros 2006; 5:53.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/24/15754/abstract/32\">",
"      Drumm ML, Konstan MW, Schluchter MD, et al. Genetic modifiers of lung disease in cystic fibrosis. N Engl J Med 2005; 353:1443.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/24/15754/abstract/33\">",
"      Novitsky S, Segal KR, Chatr-Aryamontri B, et al. Validity of a new portable indirect calorimeter: the AeroSport TEEM 100. Eur J Appl Physiol Occup Physiol 1995; 70:462.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/24/15754/abstract/34\">",
"      Maqbool A, Stallings VA. Update on fat-soluble vitamins in cystic fibrosis. Curr Opin Pulm Med 2008; 14:574.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/24/15754/abstract/35\">",
"      Graham-Maar RC, Schall JI, Stettler N, et al. Elevated vitamin A intake and serum retinol in preadolescent children with cystic fibrosis. Am J Clin Nutr 2006; 84:174.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/24/15754/abstract/36\">",
"      Maqbool A, Graham-Maar RC, Schall JI, et al. Vitamin A intake and elevated serum retinol levels in children and young adults with cystic fibrosis. J Cyst Fibros 2008; 7:137.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/24/15754/abstract/37\">",
"      Yankaskas JR, Marshall BC, Sufian B, et al. Cystic fibrosis adult care: consensus conference report. Chest 2004; 125:1S.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/24/15754/abstract/38\">",
"      Tangpricha V, Kelly A, Stephenson A, et al. An update on the screening, diagnosis, management, and treatment of vitamin D deficiency in individuals with cystic fibrosis: evidence-based recommendations from the Cystic Fibrosis Foundation. J Clin Endocrinol Metab 2012; 97:1082.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/24/15754/abstract/39\">",
"      Holick MF. Vitamin D deficiency. N Engl J Med 2007; 357:266.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/24/15754/abstract/40\">",
"      Green D, Carson K, Leonard A, et al. Current treatment recommendations for correcting vitamin D deficiency in pediatric patients with cystic fibrosis are inadequate. J Pediatr 2008; 153:554.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/24/15754/abstract/41\">",
"      Christen S, Woodall AA, Shigenaga MK, et al. gamma-tocopherol traps mutagenic electrophiles such as NO(X) and complements alpha-tocopherol: physiological implications. Proc Natl Acad Sci U S A 1997; 94:3217.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/24/15754/abstract/42\">",
"      Huang SH, Schall JI, Zemel BS, Stallings VA. Vitamin E status in children with cystic fibrosis and pancreatic insufficiency. J Pediatr 2006; 148:556.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/24/15754/abstract/43\">",
"      Conway SP, Morton AM, Oldroyd B, et al. Osteoporosis and osteopenia in adults and adolescents with cystic fibrosis: prevalence and associated factors. Thorax 2000; 55:798.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/24/15754/abstract/44\">",
"      Conway SP, Wolfe SP, Brownlee KG, et al. Vitamin K status among children with cystic fibrosis and its relationship to bone mineral density and bone turnover. Pediatrics 2005; 115:1325.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/24/15754/abstract/45\">",
"      Nicolaidou P, Stavrinadis I, Loukou I, et al. The effect of vitamin K supplementation on biochemical markers of bone formation in children and adolescents with cystic fibrosis. Eur J Pediatr 2006; 165:540.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/24/15754/abstract/46\">",
"      Maqbool A, Schall JI, Garcia-Espana JF, et al. Serum linoleic acid status as a clinical indicator of essential fatty acid status in children with cystic fibrosis. J Pediatr Gastroenterol Nutr 2008; 47:635.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/24/15754/abstract/47\">",
"      Maqbool A, Shall J, Zemel B, et al. Essential fatty acid status and growth and pulmonary function in children with cystic fibrosis. Pediatr Pulmonol 2004; S27:337.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/24/15754/abstract/48\">",
"      McKarney C, Everard M, N'Diaye T. Omega-3 fatty acids (from fish oils) for cystic fibrosis. Cochrane Database Syst Rev 2007; :CD002201.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/24/15754/abstract/49\">",
"      KESSLER WR, ANDERSEN DH. Heat prostration in fibrocystic disease of the pancreas and other conditions. Pediatrics 1951; 8:648.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/24/15754/abstract/50\">",
"      Guimar&atilde;es EV, Schettino GC, Camargos PA, Penna FJ. Prevalence of hyponatremia at diagnosis and factors associated with the longitudinal variation in serum sodium levels in infants with cystic fibrosis. J Pediatr 2012; 161:285.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/24/15754/abstract/51\">",
"      Nussbaum E, Boat TF, Wood RE, Doershuk CF. Cystic fibrosis with acute hypoelectrolytemia and metabolic alkalosis in infancy. Am J Dis Child 1979; 133:965.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/24/15754/abstract/52\">",
"      Singer LT, Nofer JA, Benson-Szekely LJ, Brooks LJ. Behavioral assessment and management of food refusal in children with cystic fibrosis. J Dev Behav Pediatr 1991; 12:115.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/24/15754/abstract/53\">",
"      Stark LJ, Bowen AM, Tyc VL, et al. A behavioral approach to increasing calorie consumption in children with cystic fibrosis. J Pediatr Psychol 1990; 15:309.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/24/15754/abstract/54\">",
"      Stark LJ, Knapp LG, Bowen AM, et al. Increasing calorie consumption in children with cystic fibrosis: replication with 2-year follow-up. J Appl Behav Anal 1993; 26:435.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/24/15754/abstract/55\">",
"      Stark LJ, Jelalian E, Mulvihill MM, et al. Eating in preschool children with cystic fibrosis and healthy peers: behavioral analysis. Pediatrics 1995; 95:210.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/24/15754/abstract/56\">",
"      Jelalian E, Stark LJ, Reynolds L, Seifer R. Nutrition intervention for weight gain in cystic fibrosis: a meta analysis. J Pediatr 1998; 132:486.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/24/15754/abstract/57\">",
"      Powers SW, Jones JS, Ferguson KS, et al. Randomized clinical trial of behavioral and nutrition treatment to improve energy intake and growth in toddlers and preschoolers with cystic fibrosis. Pediatrics 2005; 116:1442.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/24/15754/abstract/58\">",
"      Rowland M, Broderick A, Bourke B. Behavioral and nutritional treatment to improve energy intake and growth in toddlers and preschool-aged children with cystic fibrosis. Pediatrics 2006; 118:432; author reply 432.",
"     </a>",
"    </li>",
"    <li>",
"     Details of the intervention are available at www.oup.com/us/pediatricpsych (Accessed on October 30, 2009).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/24/15754/abstract/60\">",
"      Stark LJ, Opipari-Arrigan L, Quittner AL, et al. The effects of an intensive behavior and nutrition intervention compared to standard of care on weight outcomes in CF. Pediatr Pulmonol 2011; 46:31.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/24/15754/abstract/61\">",
"      Kalnins D, Corey M, Ellis L, et al. Failure of conventional strategies to improve nutritional status in malnourished adolescents and adults with cystic fibrosis. J Pediatr 2005; 147:399.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/24/15754/abstract/62\">",
"      Smyth RL, Walters S. Oral calorie supplements for cystic fibrosis. Cochrane Database Syst Rev 2012; 10:CD000406.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/24/15754/abstract/63\">",
"      Walker SA, Gozal D. Pulmonary function correlates in the prediction of long-term weight gain in cystic fibrosis patients with gastrostomy tube feedings. J Pediatr Gastroenterol Nutr 1998; 27:53.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/24/15754/abstract/64\">",
"      Williams SG, Ashworth F, McAlweenie A, et al. Percutaneous endoscopic gastrostomy feeding in patients with cystic fibrosis. Gut 1999; 44:87.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/24/15754/abstract/65\">",
"      Akobeng AK, Miller V, Thomas A. Percutaneous endoscopic gastrostomy feeding improves nutritional status and stabilizes pulmonary function in patients with cystic fibrosis. J Pediatr Gastroenterol Nutr 1999; 29:485.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/24/15754/abstract/66\">",
"      Conway S, Morton A, Wolfe S. Enteral tube feeding for cystic fibrosis. Cochrane Database Syst Rev 2012; 12:CD001198.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/24/15754/abstract/67\">",
"      Steinkamp G, Rodeck B, Seidenberg J, et al. [Stabilization of lung function in cystic fibrosis during long-term tube feeding via a percutaneous endoscopic gastrostomy]. Pneumologie 1990; 44:1151.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/24/15754/abstract/68\">",
"      Levy LD, Durie PR, Pencharz PB, Corey ML. Effects of long-term nutritional rehabilitation on body composition and clinical status in malnourished children and adolescents with cystic fibrosis. J Pediatr 1985; 107:225.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/24/15754/abstract/69\">",
"      Erskine JM, Lingard CD, Sontag MK, Accurso FJ. Enteral nutrition for patients with cystic fibrosis: comparison of a semi-elemental and nonelemental formula. J Pediatr 1998; 132:265.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/24/15754/abstract/70\">",
"      Munck A, Malbezin S, Bloch J, et al. Follow-up of 452 totally implantable vascular devices in cystic fibrosis patients. Eur Respir J 2004; 23:430.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 5882 Version 17.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1102-221.179.173.170-9A4DD99832-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f15_24_15754=[""].join("\n");
var outline_f15_24_15754=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H31\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      PATHOPHYSIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      PANCREATIC INSUFFICIENCY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      ASSESSING AND MONITORING NUTRITION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Growth",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Blood tests",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Evaluation for comorbidities",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      - Bone disease",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      - Pulmonary function testing",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      - CF-related diabetes mellitus",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      - Small intestine bacterial overgrowth",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      NUTRIENT DEFICITS AND GOALS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Calories",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Fat soluble vitamins",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      - Vitamin A",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      - Vitamin D",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      - Vitamin E",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      - Vitamin K",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Essential fatty acids",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Sodium",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      Fluoride",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      Zinc",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      NUTRITION SUPPORT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      Oral",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      Enteral feedings",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      - Route",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H27\">",
"      - Schedule",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H28\">",
"      - Formula",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H29\">",
"      - Enzyme replacement",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H30\">",
"      Parenteral nutrition",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H31\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PEDS/5882\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/5882|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?25/23/25981\" title=\"figure 1\">",
"      Survival of CF patients",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?15/13/15582\" title=\"figure 2\">",
"      Median BMI percentiles in patients with cystic fibrosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?15/15/15614\" title=\"figure 3\">",
"      FEV1 vs BMI percentile in children with cystic fibrosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?20/23/20862\" title=\"figure 4\">",
"      Vit D metabolism",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/5882|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?24/26/25005\" title=\"table 1\">",
"      CF nutrition monitor",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?27/43/28349\" title=\"table 2\">",
"      CF nutrition tests",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?43/5/44124\" title=\"table 3\">",
"      CF supps bone health",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?36/10/37036\" title=\"table 4\">",
"      Vitamin D recommendations for individuals with cystic fibrosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?11/14/11501\" title=\"table 5\">",
"      Fat soluble vits CF",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?30/34/31278\" title=\"table 6A\">",
"      CF vit preps fat sol",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?16/43/17087\" title=\"table 6B\">",
"      CF vit preps other",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?20/11/20667\" title=\"table 7\">",
"      Salt suppl CF",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?1/9/1181\" title=\"table 8\">",
"      CF oral formulas",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?18/59/19389\" title=\"table 9\">",
"      CF enteral formulas",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?14/29/14814\" title=\"table 10\">",
"      PERT preparations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   CALCULATORS",
"  </h1>",
"  <div id=\"relatedCalculators\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"calc calc_professional\" href=\"UTD.htm?30/3/30769?source=related_link\" title=\"calculator 1\">",
"      Calculator: Mid-parental target height prediction",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/60/29641?source=related_link\">",
"      Blood glucose self-monitoring in management of adults with diabetes mellitus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/26/29095?source=related_link\">",
"      Cystic fibrosis: Assessment and management of pancreatic insufficiency",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/15/19706?source=related_link\">",
"      Cystic fibrosis: Overview of gastrointestinal disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/60/18376?source=related_link\">",
"      Diagnostic approach to short stature",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?11/16/11529?source=related_link\">",
"      Enteral nutrition in infants and children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/16/30985?source=related_link\">",
"      Management of failure to thrive (undernutrition) in children younger than two years",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/14/31976?source=related_link\">",
"      Measurement of growth in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?9/15/9462?source=related_link\">",
"      Metabolism of vitamin D",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/37/42583?source=related_link\">",
"      Overview of dual-energy x-ray absorptiometry",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/14/21736?source=related_link\">",
"      Overview of vitamin A",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/3/39990?source=related_link\">",
"      Overview of vitamin D",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/12/28871?source=related_link\">",
"      Overview of vitamin E",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/37/15960?source=related_link\">",
"      Overview of vitamin K",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?8/14/8422?source=related_link\">",
"      Pancrelipase: Pediatric drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?19/57/20371?source=related_link\">",
"      Patient information: Cystic fibrosis (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/26/33192?source=related_link\">",
"      Preventive dental care and counseling for infants and young children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?3/21/3417?source=related_link\">",
"      Treatment of vitamin D deficiency in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/3/29753?source=related_link\">",
"      Zinc deficiency and supplementation in children and adolescents",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f15_24_15755="Histologic features DIP";
var content_f15_24_15755=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F59081&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F59081&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Histologic features of desquamative interstitial pneumonia",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Key histologic features",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Uniform involvement of lung parenchyma.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Prominent accumulation of alveolar macrophages (may show fine granular positivity with iron stains).",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Mild to moderate fibrotic thickening of alveolar septa.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Mild interstitial chronic inflammation (lymphoid aggregates).",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Pertinent negative findings",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Dense and extensive fibrosis: inconspicuous or absent.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Smooth muscle proliferation: inconspicuous or absent.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Honeycomb fibrosis absent.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Fibroblastic foci and organizing pneumonia: inconspicuous or absent.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Eosinophils: inconspicuous, absent, or only focal.",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f15_24_15755=[""].join("\n");
var outline_f15_24_15755=null;
var title_f15_24_15756="Class gastric ca precurs";
var content_f15_24_15756=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ONC%2F58718&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=15\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ONC%2F58718&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=15\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Classifications of gastric cancer and precursor lesions",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\" rowspan=\"2\">",
"        Padova classification",
"       </td>",
"       <td class=\"subtitle1\" colspan=\"2\">",
"        Japanese classification",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2\">",
"        Category",
"       </td>",
"       <td class=\"subtitle2\">",
"        Definition",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        1. Negative for dysplasia",
"       </td>",
"       <td rowspan=\"6\">",
"        Group I",
"       </td>",
"       <td rowspan=\"6\">",
"        Normal mucosa and benign lesions with no atypia",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        1.0 Normal",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        1.1 Reactive foveolar hyperplasia",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        1.2 Intestinal metaplasia (IM)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        1.2.1 IM Complete type",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        1.2.2 IM Incomplete type",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        2. Indefinite for dysplasia",
"       </td>",
"       <td rowspan=\"3\">",
"        Group II",
"       </td>",
"       <td rowspan=\"3\">",
"        Lesions showing atypia but diagnosed as benign (nonneoplastic)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        2.1 Foveolar hyperproliferation",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        2.2 Hyperproliferative IM",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        3. Non-invasive neoplasia (flat or elevated [synonym adenoma])",
"       </td>",
"       <td rowspan=\"5\">",
"        Group III",
"       </td>",
"       <td rowspan=\"5\">",
"        Borderline lesions between benign and malignant",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        3.1 Low-grade",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        3.2 High-grade",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        3.2.1 Including suspicious for carcinoma without invasion (intreglandular)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        3.2.2 Including carcinoma without invasion (intraglandular)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        4. Suspicious for invasive carcinoma",
"       </td>",
"       <td>",
"        Group IV",
"       </td>",
"       <td>",
"        Lesions strongly suspected of carcinoma",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        5. Invasive adenocarcinoma",
"       </td>",
"       <td>",
"        Group V",
"       </td>",
"       <td>",
"        Carcinoma",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f15_24_15756=[""].join("\n");
var outline_f15_24_15756=null;
var title_f15_24_15757="Canada Guide heart dis kid tx 1";
var content_f15_24_15757=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEPH%2F55418&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=5\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEPH%2F55418&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=5\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Canadian Society of Transplantation consensus guidelines on eligibility for kidney transplantation, continued",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Cardiac disease",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_single\">",
"        Recommendations",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        1. All patients should be assessed for the presence of ischemic heart disease (IHD) before kidney transplantation. The minimum required investigations include history, physical examination, electrocardiogram (ECG) and a chest radiograph (Grade A).",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2_start\">",
"        2. Further testing for IHD depends on the pretest probability of coronary artery disease (CAD). The following patients should have further non-invasive testing:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2\">",
"        I. Symptomatic patients or patients with a prior history of CAD including",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist3\">",
"        Previous history of myocardial infarction (Grade A)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist3\">",
"        Symptoms of angina (Grade A)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist3\">",
"        Signs or symptoms of heart failure (Grade A)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2\">",
"        II. Asymptomatic patients with",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist3\">",
"        Diabetes (type 1 or type 2) (Grade B)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist3\">",
"        Multiple risk factors for CAD (3 or more) (Grade B)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist4\">",
"        - age &gt;50 years",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist4\">",
"        - prolonged duration of chronic kidney disease",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist4\">",
"        - family history of CAD (first-degree relative)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist4\">",
"        - significant smoking history",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist4\">",
"        - dyslipidemia (high-density lipoprotein level &lt;0.9 mmol/L or total cholesterol &gt;5.2 mmol/L), BMI &ge;30 kg/m2",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist4\">",
"        - history of hypertension",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        3. All patients with a positive non-invasive test should be assessed by a cardiologist with a view to undergoing angiography (Grade B).",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        4. Very high-risk patients should be considered for angiography even with a negative non-invasive test (Grade C).",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2_start\">",
"        5. Patients with IHD should be eligible for kidney transplantation if they fall into 1 of the following categories:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2\">",
"        Low-risk asymptomatic patients (Grade A)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2\">",
"        Asymptomatic patients with negative non-invasive testing (Grade B)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2\">",
"        Patients who have undergone successful intervention (Grade B)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2\">",
"        Patients who on angiography have non-critical disease and are on appropriate medical therapy (Grade C)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2_start\">",
"        6. Kidney transplantation is contraindicated in patients with IHD in the following situations:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2\">",
"        Patients with progressive symptoms of angina (Grade A)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2\">",
"        Patients with a myocardial infarction within 6 months (Grade A)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2\">",
"        Patients without an appropriate cardiac workup (Grade C)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2\">",
"        Patients with severe diffuse disease, especially with positive non-invasive tests in whom intervention is not possible and in whom expected survival is sufficiently compromised so that transplantation is not reasonable (Grade C)",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     * The strength of evidence supporting each recommendation was graded using the system developed by the Canadian Task Force on Preventive Health Care as follows:",
"     <br>",
"      Grade A - There is good evidence to support",
"      <br>",
"       Grade B - There is fair evidence to support",
"       <br>",
"        Grade C - The existing evidence is conflicting, but other factors may influence decision-making",
"        <br>",
"         Grade D - There is fair evidence to recommend against",
"         <br>",
"          Grade E - There is good evidence to recommend against",
"         </br>",
"        </br>",
"       </br>",
"      </br>",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Knoll, G, Cockfield, S, Blydt-Hansen, T, et al. Canadian Society of Transplantation: Consensus guidelines on eligibility for kidney transplantation. CMAJ 2005; 173:S1. Copyright &copy; 2005 CMA Media Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f15_24_15757=[""].join("\n");
var outline_f15_24_15757=null;
var title_f15_24_15758="Stents saphenous grafts outcome";
var content_f15_24_15758=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F53319&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F53319&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Long-term outcome of stenting in saphenous vein grafts",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 447px; height: 297px; background-image: url(data:image/gif;base64,R0lGODlhvwEpAeYAAP///4CAgP+AgICZ/wAAAIDMmUBAQP8AAMDAwAAz///AwP9AQACZM0Bm/8DN/9DQ0MDmzSAgIHBwcDAwMFBQUBAQEKCgoLCwsPDw8ODg4ECzZpCQkP8gIGBgYP+wsP/g4CBN//9QUP9wcFBz//8QEP/Q0P/w8P+goP8wMNDZ/7DA/+Dm//9gYHCN/xBA/2CA/zBZ/+Dz5lC5c/+QkKCz/yCmTfDz/wAZf2C/gBCfQIBZv3DGjdDs2fD5838Zf6DZs5Cm/7DfwDCsWX9MGZDTpkBmTUCZmb+Mv4CMWT9ZWb+mjEBZv7+AgAAmv4CMv4CzzEBNgAAzTD8mv0CAzL9AQAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAACH5BAAAAAAALAAAAAC/ASkBAAf/gACCg4SFhoeIiYqLjI2Oj5CRkpOUlZaXmJmam5ydnp+goaKjpKWmp6ipqqusra6vsLGys7S1tre4ubq7vL2+v8DBwsPExcbHyMnKy8zNzs/Q0dLT1NXW19jZ2tvc3d7f4OHi4+Tl5ufo6err7O3u7/Dx8vP09fb3+Pn6+/z9/v8AAwocSLCgwYMIEypcyFARggeHMmwIcGGQRIoNM2Z8EICAAUMZKlSYQEACgJAjS2pcmdAAAY+GJBDYAKACAQwyadrEQAhBgJ9AgwodSrSo0aNIkypdyrSp06dQo0qdSrWq1as/EQRDALOQS61fvwIQO8jJjbNo096AgrWt27dw/+PKnUu3rlUDAbZ2JSQ2LAGwfwkd8UG4sGEpOgQoFqAEAsvHq37q/ViIAoGKJB9YxkwA4iAmVBaLVqwj8WIkBQZhsGCBJ+TXnyT/erCBwAQEPGFaIEDhAoEIAHb3/l1I9qEBS4IWKfLTMgXnRbXCnh7JeC+XLwN3lWBzgmfutj0Psl5oQJO0UZgHaC1oNVG81OM7In+N/iAHA/LnN5J6fl75ACZiXzUDHlJAf40EgBdQ0gUYYIHTQFjIgY/4BBR8Dj74nzYSElKABgeGKGIBjiGioFANZvhYh9CwKMgTSQwho4yoHQhiIhZeuKGKLLnojI8DmKbYAgIMQqF/PELmY/8zQA5AiGJGIsjIiVClmGQ+SzLT5JNFCvLhiCUekqNTGF6pT5bLANmAfkHqoN8U/IV4YyfGWVCRmfWgqYyP+LFZmn5reghiiGFaQmUEEZRkF1JW4umLnslACgCUguRHCAQiznlJjhYAcMGiR5Xp6C+SHiMppQBYisiRP+44ai+lGnNql6k6uaqUWrr66i6xTmLAr8AaYFIqpxJJmq0GDkrongvC1eiul/QqSXbUUoaKpAqI5mYimGaKazFjuiUqtJhIO4y5A6ypnwOKsJqOueQCAG8kmgE77LW6UnKEm/kFmsiXIy4bzrzQEvwISdlZe4q5qKq6KgM7BPyhshKTaI3/wa9i3AgBuwHQQb6jMEyrwwb+gEi3FX95cbNZxUuJxoz8FQECEihsisiDpMvmAOxm4q404Y7rMpKrRBBABy9RoArOgvQJKLKX/FwfyEMrAvMiDzyAwXOu4asJqoaQbInUF1NdtYlmi4KbKwwbu5gCOUM9NsWFRpj22cXdDYpLHdy5tN6NZCsakXFrgrLKK4N61LMFXa2IBQhHQBOxgEvSsLr59YwJwCl37nnAda8SruJBCW2Q41i7ZHMpGqPqtM6Gfy677Jp+gzo6tx8C+UsVTO71J2ATIjYvnM9uPOi8Vt5P7obw7TfloASfM+aZ73L48dgjngvz5XDfU9eRKQ+J/wBuCwB30zv7Cw7ZtHg/jvu4PYDA/A/9DYrgQ9IattzdsD9LlvRjnCOEpQv50c8zFxGPocSXib9g5yWrI8XtpDe9nWkuG/6TRZaoVYFOzScwANjLLR4IkweIJFHPexkDy5UBCwTFg78bBQXRxyb1YZButqBSdAzxkpOQRCsYUFBvBFEzA3TgARngW6c8sgEjgk8WBuQbADaTAeJEa4WZWFsrJqi/RQzPGoernSxGVzpd9TA4vAHABCoQgMwAwGjcicADEjUBk7xkAonqAC6qSIAMjOUyISRAubCICeexYoLlOx8idLazdV0jg7egzxm5YoAHeORoBMgLzQxgE3mBEP8mGBAhLZCmRzRWADuDZMXufuO7hRESEvgjXxcL8br08S8akMyhGQWJxg5QkkG+6Q1JPCmdrohSFnz0oyA+tZsIVueVmHiA6uyXihky4ovQyGUtJPkXC4jEjyKxAAI24MJMXiBRngyAVozpzFV0RYqCyMAFLkCSFE7CfYJYZe+oiQprevGW2aSYxXTBzaR5RjMvicAFMEASRAkyA4lSGjtnAROuVECZAOCKbex5T2hWwpDhU4U/FYHNZ1xPjLoMCD4z+kToVTORjygpNbTJNo++y6a+aifrcArLwc0yETKdBk23yDLFCTBNPK2OTiWY1EmMVHjU49kjv1ULMi7qqHv/auojZGIvfrJClqJRpCFqaUOhCjR7xgtdj7Q6wGp5dRWxlGVMo9rIujoSGNdD6+xQulZurDQRUDqBYjygiFra1a5lHcdQEbLSIv7qXq6sBfk4wAEBiOAAIgirJoLaP6quZKUkXKpqXMgeQmQggEAMoALlxVZLZOsEg/CATzcL0PV5ViN/HYRCHUESl0ygONQSpEYhmDdgPNURnOXGYg+SW0FMQLSeSuNmTDs/mQCHK7epHyF0qM5dHLcRjDysBafKiBhA4LwxqMQONKCJH2iAB63gwXnPC19B9AAC6U3lKopIEqVNKZPpPESiOmVRI2JUENzFKiy+ywjDijexuDyr/4gcUwAGWJgBGujBIzAsCA0wQBMVVqspPHxh9gIAAjJgwG0hAdrsyDFBAO6IrnYDHAA84GO+Le4vGMyJ5Cojr94CQIVTQwQOn1gGGtiBht2rARkEAQA/YEANChADDwdBBjKo7yCY7OQTFyAIONDAkwHAAyR7WMSlkC8EPIwDQVx4xY9oLiRqY5KcGGLAPOTleFobvfKZrxThFa9dL4gMCg1ZEDVgAA+CwAAZ7KDRAHB0ARIdg0fn4L0eroEQpFwISVO6wpe2cAxikIMcfIgBaDZFDERtJBVnorEBMGEEWhqR3yAgUX7sSkdqLC8KKEiUcu7pbEnhYEE/jRmGdjUAzv+c4gMlGgAx+FCiHWNkDwti04WItgamHWIAPBoCRTZZt12BAwa0udVwJpoqOkgBkUD2cYmKgAdBaRO/nTNpTwx2JcA6mrfBwse+SHZ/KO1hEZFaCD8oN7VNbO1lf3gQB084qrsdYoqj2hWrZkB+vaTsK7JCZr6GLp34XIq4joZwrwB4L5KNAxRDDABFlgEEwAyBRq/54lLGb8MbLoiay/zMFj+vzc+simqb+1Llbrl+VREBywSgZm9lBo9BEehGEpp4qamwhadspERDutw52DSFLcyDnT98EGAXe9C9zYCwXzwVHK55DjYOgAtbeOmpqM1FI/DunUZj6p8odr9qi4v/5e7jr0jEgBZj6AzAp0LlsSieXiefslQj1a8kfwW/+/3nlBP+FkCmvOgFZjfMR8Pkw3ZF1a+ONxWafhuO7wRZP4+M+4bpvD2wPe7P8ddPZSDWUbdG7EUBeWHUXNFQtrDQL2z516tCJn+hQCkZj43hh6L4wTh+mzf99rvjLvOJqEAHbqOg4FfD+lSn/TFqPm0pd//s5lipAxHQAZFzQt8i/WnKqcf69au41Ej2fjfFCgaAR5bRSjcDfriAfoFXQ+qXfSr2aEFAdHUHf92jgIdgQndEayGDgbbAgKOAfdajYvflcBBwX8qnYfHngWKyWpEFe34mVrEggrpQcwhyZsen/3y8x4KEgBOVNEQupQ1xhXKzQIN4s1KW8Rcd4F/U1w0g2GNR1X+tZwjy10Q+YX+bgH+aB1OvMHtTmCA8OAiXYQAIYABM+ILgEEtEWIQP2Hor1QEnxDHm9w2b13mq14ZHGIbtYRkV0Hd+Zw5DqH+oYIQFo4c25oJNeA5PaAlVZ2xsIoU8AlpY6AlamAuLWAmCZ2wQdiUrRU811Q6XqAqE2FerEFpzSA6h+Hh4GB+NFSx+2IGg6GeatQuj+FlhWElI9InsgHr5wwu1iFthOIaGiGDDqAyp6Am/mBHukyjBNYmvVozJUIcyOIN0dViQqIxhqBkVEAFdFYT0EIi2kIm2xP+KhihOurgPx3gKybg8wyhNWwSNjSeIvbCO/PBXXPGO/SCNwECPhzeM93hI8NgM4PgL/Hgm/qhnp5gP6Zh+5MgKuWhjB5aAA7GQn1CQWGKIGFJ+3vgPdTga07h/40WKqCBN2/grp5SQ+MCLvUgLXiiSpzBcvMNRsNgQFJkJFikPjQVDIUWTXEgLNxkPiHdAKCkQaiiPrPCT8NBYbrWRGVGTk4CU7yB/bPQTOimRj+GUkgCV7rBSRnOOK4GVkRBo1ygQrSiUTMmTHgkLr7OJjYORS5mIDDGQbNgQK+VCQFGVf0gdYBlTq1iPw+h7wNcI7lFaqqFa8TQR9lSJqGiUotj/l/3ICtCHANLHWx5hG4UAkx+BEiTxboo5Dvp4h4mwAg4wmitQCS3QAJpAAw2QAoSQAg5QmgAgmqzpmqPJmriwUuJHftAVTFMESIOAXfMDEXa2E9vFMgqGEHJ5lLU1AAnQnAnQADbwCM8pCA2QAJuVABdUnSMgCCAwndXZnKh5m4Y4f/UHY3khYz1BAKfUAX7UFyCEYMYJIHu5SMuZAE4CBNMJAA4wAg3QAtGpmg0wAioAADSQACAwACtQnSowAiNgm4Nwmg3wAqyJHyrwAg0woACQAvxZndnZnCugAuBZKfZJUBhpgDNhngE2CDf2a7/lninSmegwn8cRhTkzogDQ/50pAKIj0AIJsJ07OgDduQI86gKrWZ0gAAMGWggH2gIuAAKpkgBE6qEr4AIukC7YSQhG2gIj0J3hyZyOSQg2MJqCEKaj6QAOWgkrpYG2wYGFQGcAYGeH0EPT5UZ7xiMyOlbjKKK2wqEjYJ9Aap0rkC7dyS75WZ2CgKS0dJouYJ3MyS486gD4SQNP2qFAsKj42aU2Wgkv0JxN45z5uUCuoF2NUEUzg2sh9BEBEHK6wRu+wWvEaKeyyHmK8ZHIiCxeyp0JkKB+mh9TCgM0sKmEGp6GCgDDKgg6qgKI2qiTqqzKOgjVaQMJAAMOkJ+3Wgkgyqn6Ga21iXeo0AESEJGMYP8B8TZvH3FvvOEa4OEdOpYhKtlva3h9tpoAL7CfCdACAICfI+AAFTqt+cqhAGCgrzmsxfqkA6AC3Tmpk8qvDuCvzmqdKSCa05kCmyqhlGADVYqt00qkLwCboFqKd0SYaDg0WOkwzNmcB5oz3dmjALCpLoCk7FKyKSCw1jkINoCkIHCwzHqlQ+qyWDqz2Yqa3/mpkTACMPCvMyuxVlq0HscKFyABieKM3BovI/ulzuCp2DoIV4umf9kBTzuUZjK13zCdZdqcLzsCVhqeHasK2DEBG8CmoQCj9wC23iC02GqwzTkC0bm0quCt4BqyLvOZndCIjji4hCtV1PBXipe4Xnv/Jcm5CeJYuDvTnY30AosKAi0AKBd6H2Wat4KQAvlBAxwbDHX5EghQR4v7KndqCQNLoJ4antdqr4LgqS7QMyzbAItKDFyJR1d4uqOSuoOwAhban/9ZsAxqmyoQoAf7u1DKLp4rCJuapLFrnTzqJAUKA3lLta8gf2W4SbzrKL7bNGsyscRqoDYLACAKA39KCPgJuzTbo32Koc05ADAAAqX5vsjAleMXAH3YvXjyvYLwq9UJtDOLqH1amgNbrYNQoDRQoC8QvQ0gueM7ms6Ju4boG7zTtzP5hZMSq7JKq5bAoy0wrQJMndYps4RQoGhbmkgKA0iaANGJrZw6vWGatcCA/3gBsAEYnMFf2K4nx5iSoKAoPL4kTLB2q6TPOQD8mQJHbKVAYLSQmqRTWqXT6rOiG5A7qcHj48ORkAKLGsBCLMQ2YKTJ+7t9aqBAwKMYer5GC562qaEm28DnYsX8+4X+qw5wq8NY3Ah1PIDbcMcLscff53x5rMdarBB+/LZyfJUxuCKJDJeDfAiNS5eGiAETQZVz/MiAPDBumTCXPMiZDA7yl12i6reP/AifbDuGOAHFeMgaccre0FhGY8lnWcqM4Mrd0GKcPMu0rAib58EEkaaGqcu7jAhFKcmtwBE4fMXDbDmF7A+jyzuIiMfLbMrNzI6sUAEUgAD0dIZWOc2RYP/LU/Nx0qGRjjwPH6AA6PwBlSACC6AJJ7AAJUAIJaAA6gwA5xzP84zO8YwI4Fw2rIBHT7e/wiwPAnAABn0AC2ACj4DQgrAAB/A1ByBWDh0CgsABDO3QBt3O/FzN2CBbdvgBMyAA+6y3qaCmE+C2oMDKO3YARTIDDA0AChACCyACCv3OCxAChHUCB1BZH+DQHhACITDSgsDOC8AC8ZwtHsACC0BYAFACMu3QEm3QH+ABGS0IBS2PgPsNCnDQB0BYJUACJGDRTJ22ohPNTMUPV13RB1ACVB0Cl0XRbi0AFv0Bl0UC8OzQHIACO10IlSUCYT0pB2DXUv0BYE0+EU0IeC3/AiFg0Rqd1okQydxwzgDg0u0cAl39AXtN0qYQP8FczgTN0g0d0ZatGBZtz5N12C/t0IKg14WgAOxMAg9d0HBzWQrg0rAl24h9ADMA25Rt1aBNzeWg0ywAAD4NAAYdtaTgQG9Jyvbg2HPt0KJB2ChwAiyA2hqt2sT90LF1ADjN2rgt29992IPg0CZwACiw1Y39247Qz6xgAhxAAuqs04Kt3WR9My30Qp1sDgXNAjGNWZPN3QqQ1FsdAgoA1cbNAfSM3djt2wLgAaUd3ugM4AY+3g9dAufM0CVQ3UYN3OJQAu890rKl0xpd36dgjp4ik6Kg0r5Q0AZdWYMg1wZN0dVN/wJ6DTcsXgIKTt8AYAJ6TVmxfdi4Xdc1ntuDgN7ZXdXrzdHNwNAKANssACVT7QF6PdZaS4D/AXUD7c2E/A0MzeIHDdMGjQJUXuWpAJNJk99azt6togokyY1maNaIrOWX0JGyWud2fudpebjleJxxLueVwMN4HuiC7suXV4pQm4WNPA7sbAggLQAnoNCCgM6QDtPorACT3tSKcQL1zImGSM7K/BoLLgg6fdAaTdX+LQhcTQLnM+MLANt4opTd6Nn78AFKPdM13eBAvc8ecNOlPQiYreqYLgjVndnG/dCXVSQ6jQKQruS2SIDLrQiD2VIcsR7t0dmvWhAFLgAant15vf/XVI0CME4ILi0ChVDeQN3VqM7SKMAB6mzZY24mKq5GlflbhUAtJoGZ60oQ1O3Q7YzdrG3Z6hzqjj0IOn0Cwp3uC2DRRQLVW33c8D6MTQSEjMCb00UInWJJwmUbwZnvAnFZImDkOZ7doU0IIu7rAKDXKKDXB6DQDn/cx24CDf/qhgh9L4Hi2xVjAAYSxFFg7Fkc8QkQPl3yIX/VDq7jAMDYAiDTJYDQQ6LbxV7be03YJGA+Ds/pH5cXWwNd6ImehjBdK5pjxRkUfD4PX43QF63dqm0CeN3rvm7ZOz0Dl8XU317sGb3PTt3iw/3wH3cnWL4IbgqnquESeHlGdernGYL/hB5BEgiICKR6a310qj50SQHwe6pqM/Fu+Lc8yXz4irozroJQUcGlzcxIAfmW6Ji/goJ8+tSRpiQh0FneEIs+CDBf6SYw+4JwziZwzpW++5AO80IdiYb4tCQRhpePDaHe8AYd4U4P3lwd4wcAWwCg0zMg83svCBRw6CTe8QtQ1Efd4Eot97xu9MUe6QZNAiYg2+fs0uetAMke2pueJCtF7fIyfcwdEH391wU931Nt3uEOCACCggcHggoHCwchAgcKh4mDJAcfH4uDmJmam5ydnp+goaKjpKWiAQGmqpsGBK6vBqurqLK1tre4sgoiC5MAjY8ijiGUAIqahZACLImO/5ALg8ICMwceudfY2dq3tNugEgbh4hLenN3l6OnbHoseKIbAv47HxoaZyQCIAiaTzvmRgkoc4MCBhLqDCBOOOqewoblUDiNKzNRIgAcO8JwBq3jRniATiByBPCBAnj9E0Aa9OyBiosuX1xg23GCAwoWIMmHqLGfiHcGMj4CZUPQTU8hCCvQJwvjoX0pBJwp92Em1KqicCCW8InCzIVarYMOKHUv201d1BFJhoBDLK8SycOPKnSvxbDqugsA5tEu3r9+/gM2+bUiBgIEJBDbsHRy4sePHffmWW0ugArnFkDNr3mxVsrcHD1x65ky6tGlujBOGE536tOvXsBe2PnhhAv/r2Lhz6840WlsrWJh3Cx9uunc2cOOCE1/OvLHxzc+bS59+26HWCrMPRqfOvbu67bYubEVQN7v38+i/m/cWIAIGDBHWlwOfvr59UvRlBZiAAMGEDgiE5tZ9BBYYk3zaBLCVK20plJ+BEBL4oCoWiJPcgBFmqKFgxE244YfSefiXiCCWKByJkSFo4orcoUiXiyzGWBqMctEo442Q2QiXjjj2OKKKpPHo45A1AsmZkEQmORaSYjGp5JNUOQmWlFBWORGVVWFp5ZYJabmTl1yGOZ+R0JEp5plhgQmTmmi2aQub1bkpZ5EdmjnnncrtBieefHayZ3l9BpqlnRNhYEEAFmD/oEkGGwTQFQCMOqrJn4IKSqkoiLViGyYZVFABYuR0+ikBlw1yaaV8nvqJeBQAUNijAGilWAUEYCArALQqaiqhEvVHl69zARssebGp6omCqSCLSSvkMcssAM/u+iKvOFGbZ1zGsmetg2kBoOwgzzpLQLPjYhKAAaikq+667Lbr7rvwwhtOvPTWa6+9896r77735svvvwCz62/ABBe8L7pzbUBqrIlh8ioAiD3wcMSYIGDwxfoOjPHG7WrM8ceoeAzyxyKPbPK+xMaVAQERIBABARkAYBgAFhBgE8s02yxeBI5l6+e2DgIddKUWvByBBYLMHCutEwgoAdMCBubzQ9Om/4jqclNvkvWkQnfZ9dVWz7U1b19rVzbYcgkbl9pwsd12ymjHLffcdNdtoqGI6kpWgINEuoHeVPkN+AMIxFzVA40mOgjeZ2NDuOF4/233J5kSsKlYDyjY4G+Wg8X55Q/Q2ngtW7UVumE8Yy46ABhUXgHgk2PCqqt4ifVbgxe89zLcOuUOX7kQuzK6LEivTIAgL0ctFmLdItB5tLHz1u23Yjnf4CAvGw5W9t5a1q1VCGiVygMsv9xqmt6rhdgEEXQQvdbTf1+90oMoXKpV9gNA/gXUU1Xhws7jD2KQZpX9KQsDHajAyyYAu/fl71ZjsR4mtOK+sFBQEArayvBqwSzyxf+if19aUAAUlorCbJBLK2sZ9zCnMP4oqjDxCQDvYAJDVBSuPx0gQAe0BxP/BEArMAPAy2oDvKpkAIc6zEDNBEgAAr4PE0VjmRPDwrlyidAqV8Sg/HSSAeZFoCsPQEwFpjil7z2NZSd8ohrXyMY2uvGNcIyjHOdIxzra8Y54zKMe98jHPvrxj4AMpCAHSchCGnKPhOtPfx5QIeXtRC+HzGMVDWMxHrpEaa2IZB4Jl0MAES4AMTvUBQwgAQQaQEAIYEspOWGxC1CAAhg4FwEf0AFSKioDjgJHKmoWnwy0wpUUEBBNSGlJTarxWwoiVwReVoFW8IxVWjnfpCojxgnQKgP5nZpAAD4FAOcZhlYWuM4pnYkYnuVQAvuZoTHfh8xyZdJ5qcikCdtzPPiRZ2bJVNhNtEK4boknFZisJ2JoRwEZrtON7SRXN7uVyVaoyxxW/OC4kumtccFzoQBtSyahdTwEMg9WB2Xn9yj6ToYeT2EUQMAF3KcwuFEUn+MiX0ojUAGM2pRlhdtoJjuwgfA1LKTHHKk7j3fRjdLTZq5KnakiWlHyRLFpNr1oBh+g0+NtszL3A2ogx6jVrpYjA9L0qljHStaymvWsaE2rWtfK1ra69a1wjatc50rXutr1rnjNq173yte++vWvgA2sYAdL2MIa9rCITaxiYRIIADs=);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Kaplan-Meier survival curves for 186 patients presenting with an acute myocardial infarction or unstable angina who had stenting of a saphenous vein graft. There was a high rate of recurrent events and the need for repeat revascularization with repeat bypass surgery (CABG) or catheter-based intervention (INTV).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data from Frimerman A, Rechavia E, Eigler N, et al. J Am Coll Cardiol 1997; 30:1281.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f15_24_15758=[""].join("\n");
var outline_f15_24_15758=null;
var title_f15_24_15759="12-lead ECG left anterior lateral WPW";
var content_f15_24_15759=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F69928&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F69928&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 522px\">",
"   <div class=\"ttl\">",
"    12-lead electrocardiogram (ECG) of a left anterior lateral accessory pathway",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 502px; height: 280px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Electrocardiogram during atrial pacing in a patient with the Wolff-Parkinson-White syndrome shows QRS complexes that are maximally preexcited. The PR interval is short, there is a right bundle branch morphology, and the axis is rightward. The delta wave is positive in the lateral leads I, avL, and V6, localizing the pathway to the left anterior lateral region.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Morton F Arnsdorf, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f15_24_15759=[""].join("\n");
var outline_f15_24_15759=null;
